Justinslh personal page - To The Moon

Justinslh

Justinslh

No personal profile

6Follow

2Followers

0Topic

0Badge

2022-03-28

Smoking is bad for health, so is alcohol, sugar and carbon. Change the world back to ape-age and all these problems will be solved.Today, everyone are making informed decisions. Don't need to ban or stop sales with these methods.

Walmart Stops Selling Cigarettes in Some Stores

2022-03-26

Maybe will nvr be

Stock-Market Investors Should Watch the "Best Leading Indicator of Trouble Ahead"

2022-03-31

How high can it go?

Micron Is A Bargain At This Price

2022-04-07

With recession lurking around the corner, can the price prediction still hols?

3 COVID-19 Stocks With Monster Upside of Up to 355%, According to Wall Street

2022-04-16

Up up all the way after holidays

Reminder: Holiday Trading Hours during Good Friday and Easter

2022-03-26

What trouble ahead?

Sorry, the original content has been removed

2022-03-31

Didn't sea pull out of India?

Sorry, the original content has been removed

2022-03-27

What about a dozen others too?

2 Stocks I'm Buying No Matter What the Stock Market Does Next

2022-03-31

Is it going to hit the $100 mark?

Micron is Processing Strong Revenues, Can it Continue?

2022-03-31

It's about time to have some good news

Sorry, the original content has been removed

2022-03-28

Is the high iPhone price that is driving the profits?

Sorry, the original content has been removed

2022-03-31

Is there any pharma or industrial stock like these?

3 Growth Stocks With Monster Upside of Up to 331%, According to Wall Street

2022-03-30

iPhone se sales not as expected?

Sorry, the original content has been removed

2022-04-02

When is it ever gg to happen, have been waiting for ages

House Set to Vote on a Bill to Legalize Marijuana Today. What That Means for Cannabis Stocks.

2022-03-28

Can name a few other Buffet stocks?

Have $1,000? 2 Warren Buffett Stocks to Buy

2022-03-25

Up

Cannabis Stocks Rallied in Premarket Trading,with Clever Leaves Surging Over 25% and Sundial Growers Surging Nearly 19%

2022-03-25

Nice

Why Marijuana Stocks Popped on Thursday

2021-05-04

?‍♂️

Yellen says interest rates may have to rise somewhat to make sure economy doesn't overheat

2021-04-29

$ make $

Here’s how Warren Buffett’s top investments fared during the pandemic

2021-04-29

[Call]

India Health Crisis Set to Crimp Nascent Rebound in Gold Demand

Go to Tiger App to see more news

{"i18n":{"language":"en_US"},"userPageInfo":{"id":"3578476625539127","uuid":"3578476625539127","gmtCreate":1615384693811,"gmtModify":1619678638557,"name":"Justinslh","pinyin":"justinslh","introduction":"","introductionEn":null,"signature":"","avatar":"https://static.tigerbbs.com/4aace6371636c60f0a3a97aacd94721c","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":2,"headSize":6,"tweetSize":21,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":1,"name":"萌萌虎","nameTw":"萌萌虎","represent":"呱呱坠地","factor":"评论帖子3次或发布1条主帖（非转发）","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":"success","userBadges":[{"badgeId":"1026c425416b44e0aac28c11a0848493-2","templateUuid":"1026c425416b44e0aac28c11a0848493","name":"Senior Tiger","description":"Join the tiger community for 1000 days","bigImgUrl":"https://static.tigerbbs.com/0063fb68ea29c9ae6858c58630e182d5","smallImgUrl":"https://static.tigerbbs.com/96c699a93be4214d4b49aea6a5a5d1a4","grayImgUrl":"https://static.tigerbbs.com/35b0e542a9ff77046ed69ef602bc105d","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.12.08","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"7a9f168ff73447fe856ed6c938b61789-1","templateUuid":"7a9f168ff73447fe856ed6c938b61789","name":"Knowledgeable Investor","description":"Traded more than 10 stocks","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.04.15","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"a83d7582f45846ffbccbce770ce65d84-1","templateUuid":"a83d7582f45846ffbccbce770ce65d84","name":"Real Trader","description":"Completed a transaction","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":3,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":2,"crmLevelSwitch":0,"location":null,"starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"hot","tweets":[{"id":9083297508,"gmtCreate":1650121013192,"gmtModify":1676534651256,"author":{"id":"3578476625539127","authorId":"3578476625539127","name":"Justinslh","avatar":"https://static.tigerbbs.com/4aace6371636c60f0a3a97aacd94721c","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578476625539127","authorIdStr":"3578476625539127"},"themes":[],"htmlText":"Up up all the way after holidays","listText":"Up up all the way after holidays","text":"Up up all the way after holidays","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9083297508","repostId":"1133070824","repostType":4,"repost":{"id":"1133070824","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1649399100,"share":"https://ttm.financial/m/news/1133070824?lang=&edition=fundamental","pubTime":"2022-04-08 14:25","market":"us","language":"en","title":"Reminder: Holiday Trading Hours during Good Friday and Easter","url":"https://stock-news.laohu8.com/highlight/detail?id=1133070824","media":"Tiger Newspress","summary":"U.S. stock markets will be closed Friday, April 15in observance of Good Friday.The New York Stock Exchange and the Nasdaq will resume normal trading hours on Monday.The Securities Industry and Financi","content":"<html><head></head><body><p>U.S. stock markets will be closed Friday, April 15 in observance of Good Friday.</p><p>The New York Stock Exchange and the Nasdaq will resume normal trading hours on Monday.</p><p>The Securities Industry and Financial Markets Association recommended the U.S. bond market close Friday. It also advised that the bond market shutter early on Thursday, April14 at 2 p.m. Eastern.</p><p>U.S. commodities markets including gold and oil futures also won&#39;t be open for trading Friday.</p><p>Singapore stock markets will also close on Good Friday.</p><p>Stock markets in Europe, Hong Kong and Australia will close on Good Friday and on Monday in observance of Easter.</p><p>A-shares (Northbound) will be closed to April 18 from April 14.</p><p><img src=\"https://static.tigerbbs.com/8d9bbb655e7216a0c27a0cb94e0d0875\" tg-width=\"1482\" tg-height=\"1328\" width=\"100%\" height=\"auto\"/></p><p>Good Friday commemorates the crucifixion of Jesus Christ. It isn’t a federal holiday, which means businesses often stay open. Good Friday is the only time U.S. markets close for the day outside of federal holidays.</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Reminder: Holiday Trading Hours during Good Friday and Easter</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nReminder: Holiday Trading Hours during Good Friday and Easter\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2022-04-08 14:25</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p>U.S. stock markets will be closed Friday, April 15 in observance of Good Friday.</p><p>The New York Stock Exchange and the Nasdaq will resume normal trading hours on Monday.</p><p>The Securities Industry and Financial Markets Association recommended the U.S. bond market close Friday. It also advised that the bond market shutter early on Thursday, April14 at 2 p.m. Eastern.</p><p>U.S. commodities markets including gold and oil futures also won&#39;t be open for trading Friday.</p><p>Singapore stock markets will also close on Good Friday.</p><p>Stock markets in Europe, Hong Kong and Australia will close on Good Friday and on Monday in observance of Easter.</p><p>A-shares (Northbound) will be closed to April 18 from April 14.</p><p><img src=\"https://static.tigerbbs.com/8d9bbb655e7216a0c27a0cb94e0d0875\" tg-width=\"1482\" tg-height=\"1328\" width=\"100%\" height=\"auto\"/></p><p>Good Friday commemorates the crucifixion of Jesus Christ. It isn’t a federal holiday, which means businesses often stay open. Good Friday is the only time U.S. markets close for the day outside of federal holidays.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".DJI":"道琼斯",".SPX":"S&P 500 Index",".IXIC":"NASDAQ Composite"},"source_url":"","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1133070824","content_text":"U.S. stock markets will be closed Friday, April 15 in observance of Good Friday.The New York Stock Exchange and the Nasdaq will resume normal trading hours on Monday.The Securities Industry and Financial Markets Association recommended the U.S. bond market close Friday. It also advised that the bond market shutter early on Thursday, April14 at 2 p.m. Eastern.U.S. commodities markets including gold and oil futures also won't be open for trading Friday.Singapore stock markets will also close on Good Friday.Stock markets in Europe, Hong Kong and Australia will close on Good Friday and on Monday in observance of Easter.A-shares (Northbound) will be closed to April 18 from April 14.Good Friday commemorates the crucifixion of Jesus Christ. It isn’t a federal holiday, which means businesses often stay open. Good Friday is the only time U.S. markets close for the day outside of federal holidays.","news_type":1},"isVote":1,"tweetType":1,"viewCount":208,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9012853831,"gmtCreate":1649307622358,"gmtModify":1676534489747,"author":{"id":"3578476625539127","authorId":"3578476625539127","name":"Justinslh","avatar":"https://static.tigerbbs.com/4aace6371636c60f0a3a97aacd94721c","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578476625539127","authorIdStr":"3578476625539127"},"themes":[],"htmlText":"With recession lurking around the corner, can the price prediction still hols?","listText":"With recession lurking around the corner, can the price prediction still hols?","text":"With recession lurking around the corner, can the price prediction still hols?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9012853831","repostId":"2225568035","repostType":4,"repost":{"id":"2225568035","pubTimestamp":1649289910,"share":"https://ttm.financial/m/news/2225568035?lang=&edition=fundamental","pubTime":"2022-04-07 08:05","market":"us","language":"en","title":"3 COVID-19 Stocks With Monster Upside of Up to 355%, According to Wall Street","url":"https://stock-news.laohu8.com/highlight/detail?id=2225568035","media":"Motley Fool","summary":"Select analysts foresee these coronavirus stocks rocketing higher by 246% to 355% over the next year.","content":"<html><head></head><body><p>For more than two years, the coronavirus disease 2019 (COVID-19) has turned the world upside-down. According to data from the World Health Organization (WHO), more than 486 million cases of COVID-19 had been reported, as of April 1, 2022, leading to over 6.1 million cumulative deaths. Nearly 973,000 of those deaths have occurred in the United States.</p><p>Even though the worst of the pandemic appears to be in the rearview mirror, there&#39;s a real likelihood that COVID-19 becomes an endemic illness. This means initial inoculation campaigns, booster shots, and research into combination vaccines, is almost certain to continue -- and Wall Street knows it.</p><p>Based on the highest issued price targets from Wall Street analysts, the following three COVID-19 stocks offer monster upside over the next 12 months ranging from a &#34;low&#34; of 246% to as much as 355%.</p><h2>Novavax: Implied upside of 257%</h2><p>The first COVID-19 play that offers drool-worthy upside, at least according to <a href=\"https://laohu8.com/S/AONE.U\">one</a> Wall Street analyst, is biotech stock <b>Novavax</b> ( NVAX -13.36% ). Despite a $50 price-target reduction in February, B. Riley analyst Mayank Mamtani still believes Novavax can reach $265 a share.  This represents a cool 257% upside from where shares ended last week.</p><p>Mamtani&#39;s aggressive price target is based on a few factors. For instance, he believes that concerns over Novavax&#39;s near-term manufacturing struggles are overblown. Mamtani explained months ago that Novavax was nearing its monthly manufacturing target of around 150 million doses, and would likely be exporting more than 100 million monthly doses out of India, where it&#39;s working with the Serum Institute of India to produce NVX-CoV2373 vaccines.</p><p>Mamtani also views the U.S. and European Union as core long-term sales opportunities for Novavax. Even though a substantial percentage of the population in these developed markets have already received their initial inoculations, the mutability of the SARS-CoV-2 virus that causes COVID-19 offers recurring revenue opportunities via boosters and combination vaccines. Novavax is one of a handful of companies currently developing a combination influenza/COVID-19 vaccine.</p><p>Something else to consider is that NVX-CoV2373 has been among the most effective vaccine candidates. Among U.S. and EU treatments that have received approval or emergency-use authorization (EUA), only three have managed to reach the 90% vaccine efficacy (VE) plateau. Novavax is one of those three, with the company&#39;s large-scale study in the U.S./Mexico (announced in June 2021) hitting a 90.4% VE. This should allow Novavax to easily supplant other COVID-19 vaccines with lower VEs, such as those from <b>Johnson &amp; Johnson</b> and <b>AstraZeneca</b>.</p><p>Based on Wall Street&#39;s worst-case scenario for 2022, Novavax looks to be on track for a little over $4 billion in sales (the company recorded $1.15 billion in revenue last year) and over $13 in earnings per share. This would put Novavax&#39;s stock at less than six times Wall Street&#39;s most-pessimistic profit forecast in 2022.</p><p>While I don&#39;t expect Mamtani&#39;s lofty price target to hit over the next 12 months, I do believe $265 remains in the picture down the line if Novavax continues to execute and innovate.</p><h2>Vaxart: Implied upside of 246%</h2><p>A second COVID-19 stock that offers monster upside over the next 12 months is clinical-stage drug developer <b>Vaxart.</b> Analyst Yasmeen Rahimi of Piper Sandler holds the high-water price target on Vaxart of $18 a share. If this figure were to become a reality, shareholders would enjoy a 246% gain from where Vaxart&#39;s stock ended this past week.</p><p>Rahimi&#39;s optimism is primarily tied to Vaxart&#39;s proprietary drug development technology known as &#34;Vector-Adjuvant-Antigen Standardized Technology,&#34; or VAAST. While traditional vaccines aim to produce a systemic response, VAAST is intended to produce both a systemic <i>and</i> mucosal response. This dual approach is believed to provide better protection against airborne viruses. In Rahimi&#39;s view, VAAST&#39;s success has been demonstrated in previous clinical trials, which somewhat de-risks Vaxart&#39;s development platform.</p><p>Another unique aspect of Vaxart&#39;s pipeline is that its COVID-19 candidate is an oral tablet and not a jab in the arm. An effective oral COVID-19 treatment would completely change the game globally. It would make distribution substantially easier (i.e., no medical professionals needed to administer shots), and there&#39;s a good likelihood that people would be more willing to swallow a pill than receive a vaccine.</p><p>Last year, early stage data from Vaxart&#39;s COVID-19 oral treatment demonstrated mixed results. Although it did generate an immune response, the level of neutralizing antibodies observed in clinical trials was notably lower than in patients who&#39;d received a traditional COVID-19 vaccine.</p><p>Following this study, Vaxart ran a preclinical trial specifically targeting the S-protein, which is involved in receptor viral attachment and entry into host cells. The initial results of this study, which were released in late February, demonstrated &#34;robust neutralizing antibody responses in mucosal sites&#34; for non-human primates.</p><p>Though these very early stage results are encouraging, Vaxart&#39;s oral S-only COVID-19 candidate, as well as its remaining pipeline, looks to be a long ways off from generating any recurring revenue. This makes Rahimi&#39;s $18 price target unlikely to be hit in 12 months, if ever.</p><h2>Ocugen: Implied upside of 355%</h2><p>However, the crème-de-la-crème of upside opportunity among COVID-19 stocks happens to be small-cap clinical-stage biotech company <b>Ocugen</b>. If Robert LeBoyer of Noble Financial is correct with his price target of $15 a share for Ocugen, investors would enjoy a 355% ride higher over the coming 12 months.</p><p>Since this list is all about COVID-19 stocks, it shouldn&#39;t be a surprise that LeBoyer&#39;s optimism has almost everything to do with Covaxin, which is an experimental COVID-19 vaccine Ocugen has commercially licensed from India&#39;s Bharat Biotech.</p><p>In 2021, Bharat Biotech conducted a large-scale study involving Covaxin with 25,800 participants in India. This clinical trial produced a VE of 78% that ultimately was the basis for Covaxin getting the green light from the WHO. In LeBoyer&#39;s view, Covaxin offers competitive advantages over other available COVID-19 vaccines in North America.</p><p>But there&#39;s a really big asterisk that investors need to be aware of. Ocugen&#39;s commercial licensing of Covaxin only pertains to the U.S. and Canada. Covaxin could theoretically be approved for use in every market around the world except the U.S. and Canada, and Ocugen wouldn&#39;t see a dime. While the U.S. and Canada are generally lucrative markets for brand-name drugs, both countries have already invested heavily in COVID-19 treatments and may not have room on pharmacy shelves for a vaccine that produced &#34;only&#34; a 78% VE.</p><p>The other big problem for Ocugen is that its quick path to revenue was yanked away by the U.S. Food and Drug Administration (FDA) one month earlier. On March 4, the FDA declined Ocugen&#39;s EUA request for pediatric patients aged 2 to 18. This means Covaxin&#39;s U.S. audience will only be adults, and Covaxin will have to go through the standard (i.e., slower) route of drug approval with the FDA.</p><p>Although Ocugen&#39;s eye-disease-related pipeline could one day be worthwhile, it&#39;s hard to see this company getting anywhere near $15 with minimal use for Covaxin in the U.S. and Canada.</p></body></html>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 COVID-19 Stocks With Monster Upside of Up to 355%, According to Wall Street</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 COVID-19 Stocks With Monster Upside of Up to 355%, According to Wall Street\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-04-07 08:05 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2022/04/06/3-covid-19-stocks-monster-upside-355-wall-street/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>For more than two years, the coronavirus disease 2019 (COVID-19) has turned the world upside-down. According to data from the World Health Organization (WHO), more than 486 million cases of COVID-19 ...</p>\n\n<a href=\"https://www.fool.com/investing/2022/04/06/3-covid-19-stocks-monster-upside-355-wall-street/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BNTX":"BioNTech SE","BK4551":"寇图资本持仓","BK4548":"巴美列捷福持仓","VXRT":"Vaxart, Inc","NVAX":"诺瓦瓦克斯医药","BK4568":"美国抗疫概念"},"source_url":"https://www.fool.com/investing/2022/04/06/3-covid-19-stocks-monster-upside-355-wall-street/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2225568035","content_text":"For more than two years, the coronavirus disease 2019 (COVID-19) has turned the world upside-down. According to data from the World Health Organization (WHO), more than 486 million cases of COVID-19 had been reported, as of April 1, 2022, leading to over 6.1 million cumulative deaths. Nearly 973,000 of those deaths have occurred in the United States.Even though the worst of the pandemic appears to be in the rearview mirror, there's a real likelihood that COVID-19 becomes an endemic illness. This means initial inoculation campaigns, booster shots, and research into combination vaccines, is almost certain to continue -- and Wall Street knows it.Based on the highest issued price targets from Wall Street analysts, the following three COVID-19 stocks offer monster upside over the next 12 months ranging from a \"low\" of 246% to as much as 355%.Novavax: Implied upside of 257%The first COVID-19 play that offers drool-worthy upside, at least according to one Wall Street analyst, is biotech stock Novavax ( NVAX -13.36% ). Despite a $50 price-target reduction in February, B. Riley analyst Mayank Mamtani still believes Novavax can reach $265 a share.  This represents a cool 257% upside from where shares ended last week.Mamtani's aggressive price target is based on a few factors. For instance, he believes that concerns over Novavax's near-term manufacturing struggles are overblown. Mamtani explained months ago that Novavax was nearing its monthly manufacturing target of around 150 million doses, and would likely be exporting more than 100 million monthly doses out of India, where it's working with the Serum Institute of India to produce NVX-CoV2373 vaccines.Mamtani also views the U.S. and European Union as core long-term sales opportunities for Novavax. Even though a substantial percentage of the population in these developed markets have already received their initial inoculations, the mutability of the SARS-CoV-2 virus that causes COVID-19 offers recurring revenue opportunities via boosters and combination vaccines. Novavax is one of a handful of companies currently developing a combination influenza/COVID-19 vaccine.Something else to consider is that NVX-CoV2373 has been among the most effective vaccine candidates. Among U.S. and EU treatments that have received approval or emergency-use authorization (EUA), only three have managed to reach the 90% vaccine efficacy (VE) plateau. Novavax is one of those three, with the company's large-scale study in the U.S./Mexico (announced in June 2021) hitting a 90.4% VE. This should allow Novavax to easily supplant other COVID-19 vaccines with lower VEs, such as those from Johnson & Johnson and AstraZeneca.Based on Wall Street's worst-case scenario for 2022, Novavax looks to be on track for a little over $4 billion in sales (the company recorded $1.15 billion in revenue last year) and over $13 in earnings per share. This would put Novavax's stock at less than six times Wall Street's most-pessimistic profit forecast in 2022.While I don't expect Mamtani's lofty price target to hit over the next 12 months, I do believe $265 remains in the picture down the line if Novavax continues to execute and innovate.Vaxart: Implied upside of 246%A second COVID-19 stock that offers monster upside over the next 12 months is clinical-stage drug developer Vaxart. Analyst Yasmeen Rahimi of Piper Sandler holds the high-water price target on Vaxart of $18 a share. If this figure were to become a reality, shareholders would enjoy a 246% gain from where Vaxart's stock ended this past week.Rahimi's optimism is primarily tied to Vaxart's proprietary drug development technology known as \"Vector-Adjuvant-Antigen Standardized Technology,\" or VAAST. While traditional vaccines aim to produce a systemic response, VAAST is intended to produce both a systemic and mucosal response. This dual approach is believed to provide better protection against airborne viruses. In Rahimi's view, VAAST's success has been demonstrated in previous clinical trials, which somewhat de-risks Vaxart's development platform.Another unique aspect of Vaxart's pipeline is that its COVID-19 candidate is an oral tablet and not a jab in the arm. An effective oral COVID-19 treatment would completely change the game globally. It would make distribution substantially easier (i.e., no medical professionals needed to administer shots), and there's a good likelihood that people would be more willing to swallow a pill than receive a vaccine.Last year, early stage data from Vaxart's COVID-19 oral treatment demonstrated mixed results. Although it did generate an immune response, the level of neutralizing antibodies observed in clinical trials was notably lower than in patients who'd received a traditional COVID-19 vaccine.Following this study, Vaxart ran a preclinical trial specifically targeting the S-protein, which is involved in receptor viral attachment and entry into host cells. The initial results of this study, which were released in late February, demonstrated \"robust neutralizing antibody responses in mucosal sites\" for non-human primates.Though these very early stage results are encouraging, Vaxart's oral S-only COVID-19 candidate, as well as its remaining pipeline, looks to be a long ways off from generating any recurring revenue. This makes Rahimi's $18 price target unlikely to be hit in 12 months, if ever.Ocugen: Implied upside of 355%However, the crème-de-la-crème of upside opportunity among COVID-19 stocks happens to be small-cap clinical-stage biotech company Ocugen. If Robert LeBoyer of Noble Financial is correct with his price target of $15 a share for Ocugen, investors would enjoy a 355% ride higher over the coming 12 months.Since this list is all about COVID-19 stocks, it shouldn't be a surprise that LeBoyer's optimism has almost everything to do with Covaxin, which is an experimental COVID-19 vaccine Ocugen has commercially licensed from India's Bharat Biotech.In 2021, Bharat Biotech conducted a large-scale study involving Covaxin with 25,800 participants in India. This clinical trial produced a VE of 78% that ultimately was the basis for Covaxin getting the green light from the WHO. In LeBoyer's view, Covaxin offers competitive advantages over other available COVID-19 vaccines in North America.But there's a really big asterisk that investors need to be aware of. Ocugen's commercial licensing of Covaxin only pertains to the U.S. and Canada. Covaxin could theoretically be approved for use in every market around the world except the U.S. and Canada, and Ocugen wouldn't see a dime. While the U.S. and Canada are generally lucrative markets for brand-name drugs, both countries have already invested heavily in COVID-19 treatments and may not have room on pharmacy shelves for a vaccine that produced \"only\" a 78% VE.The other big problem for Ocugen is that its quick path to revenue was yanked away by the U.S. Food and Drug Administration (FDA) one month earlier. On March 4, the FDA declined Ocugen's EUA request for pediatric patients aged 2 to 18. This means Covaxin's U.S. audience will only be adults, and Covaxin will have to go through the standard (i.e., slower) route of drug approval with the FDA.Although Ocugen's eye-disease-related pipeline could one day be worthwhile, it's hard to see this company getting anywhere near $15 with minimal use for Covaxin in the U.S. and Canada.","news_type":1},"isVote":1,"tweetType":1,"viewCount":380,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9011416043,"gmtCreate":1648905703548,"gmtModify":1676534420357,"author":{"id":"3578476625539127","authorId":"3578476625539127","name":"Justinslh","avatar":"https://static.tigerbbs.com/4aace6371636c60f0a3a97aacd94721c","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578476625539127","authorIdStr":"3578476625539127"},"themes":[],"htmlText":"When is it ever gg to happen,&nbsp; have been waiting for ages","listText":"When is it ever gg to happen,&nbsp; have been waiting for ages","text":"When is it ever gg to happen, have been waiting for ages","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9011416043","repostId":"1104624292","repostType":4,"repost":{"id":"1104624292","pubTimestamp":1648824223,"share":"https://ttm.financial/m/news/1104624292?lang=&edition=fundamental","pubTime":"2022-04-01 22:43","market":"us","language":"en","title":"House Set to Vote on a Bill to Legalize Marijuana Today. What That Means for Cannabis Stocks.","url":"https://stock-news.laohu8.com/highlight/detail?id=1104624292","media":"Barrons","summary":"Cannabis stocks were rising Friday ahead of a highly anticipated House vote on a bill to decriminali","content":"<html><head></head><body><p>Cannabis stocks were rising Friday ahead of a highly anticipated House vote on a bill to decriminalize marijuana.</p><p>The House of Representatives bill, called the Marijuana Opportunity Reinvestment and Expungement Act, or MORE Act, would remove marijuana from the list of scheduled substances and impose a federal tax on marijuana products.  It would also establish a process to expunge prior cannabis convictions.</p><p>On Wednesday, the House Rules Committee voted to move the MORE Act to an official floor vote scheduled for mid-morning Friday.</p><p>Pot stocks traded lower Friday in anticipation of the vote. Aurora Cannabis (ticker: ACB) was up 1.8%, Curaleaf (CURA) was rising 1.7%, and Cronos Group (CRON) climbed 1.7%. Sundial Growers ( SNDL) rose 2.8%, and Canopy Growth (CGC) gained 1.3%. Tilray Brands (TLRY) stock was up 3.4%.</p><p>Thirty six states and the District of Columbia have legalized medical marijuana over the last few years, and 19 states plus D.C. have decriminalized recreational marijuana use for adults, said House Judiciary Committee Chairman Jerrold Nadler, one of the bill’s sponsors.</p><p>“If states are the laboratories of democracy, it is long past time for the federal get to recognize that this experiment in legalization has been a resounding success,” he said at Wednesday’s committee hearing.</p><p>Federal legalization could have major ramifications for cannabis companies, which would no longer be subject to a section of the U.S. internal revenue code that prohibits taxpayers from deducting business expenses associated with controlled substances, wrote Pedro Palandrani, director of research at Global X ETFs, in an emailed statement. Palandrani oversees the firm’s cannabis ETF ( POTX ), which was down 0.4%.</p><p>Legalization also could unlock access to basic financing options, like loans and capital raising on U.S. exchanges, that were previously inaccessible to cannabis companies, he added.</p><p>“Furthermore, the possible establishment of cannabis as a commodity with futures contracts and more relaxed regulations regarding land use for cannabis cultivation could also assist developing supply chain dynamics,” Palandrani wrote.</p><p>Analysts widely expect the bill to clear the House, but are more skeptical about its prospects in the Senate. In 2020, a similar bill passed the House but stalled in the upper chamber after failing to garner sufficient support.</p><p>They are more optimistic that the Secure and Fair Enforcement Banking Act, or SAFE Act, passes later this year. The SAFE Act would prohibit federal banking regulators from penalizing banks that work with cannabis businesses legalized by states. The House passed the measure in February.</p><p>But the SAFE Act would have a limited positive impact on cannabis operators, analysts said. Weed would remain illegal at a federal level, creating an obstacle for Canadian companies like Tilray to move into the U.S.</p></body></html>","source":"lsy1601382232898","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>House Set to Vote on a Bill to Legalize Marijuana Today. What That Means for Cannabis Stocks.</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHouse Set to Vote on a Bill to Legalize Marijuana Today. What That Means for Cannabis Stocks.\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-04-01 22:43 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.barrons.com/articles/marijuana-legalization-vote-cannabis-pot-stocks-tilray-51648813285?mod=hp_LATEST><strong>Barrons</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Cannabis stocks were rising Friday ahead of a highly anticipated House vote on a bill to decriminalize marijuana.The House of Representatives bill, called the Marijuana Opportunity Reinvestment and ...</p>\n\n<a href=\"https://www.barrons.com/articles/marijuana-legalization-vote-cannabis-pot-stocks-tilray-51648813285?mod=hp_LATEST\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"CRON":"Cronos Group Inc.","POTX":"Global X Cannabis ETF","TLRY":"Tilray Inc.","CURLF":"Curaleaf Hldgs Inc.","ACB":"奥罗拉大麻公司","CGC":"Canopy Growth Corporation","SNDL":"SNDL Inc."},"source_url":"https://www.barrons.com/articles/marijuana-legalization-vote-cannabis-pot-stocks-tilray-51648813285?mod=hp_LATEST","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1104624292","content_text":"Cannabis stocks were rising Friday ahead of a highly anticipated House vote on a bill to decriminalize marijuana.The House of Representatives bill, called the Marijuana Opportunity Reinvestment and Expungement Act, or MORE Act, would remove marijuana from the list of scheduled substances and impose a federal tax on marijuana products.  It would also establish a process to expunge prior cannabis convictions.On Wednesday, the House Rules Committee voted to move the MORE Act to an official floor vote scheduled for mid-morning Friday.Pot stocks traded lower Friday in anticipation of the vote. Aurora Cannabis (ticker: ACB) was up 1.8%, Curaleaf (CURA) was rising 1.7%, and Cronos Group (CRON) climbed 1.7%. Sundial Growers ( SNDL) rose 2.8%, and Canopy Growth (CGC) gained 1.3%. Tilray Brands (TLRY) stock was up 3.4%.Thirty six states and the District of Columbia have legalized medical marijuana over the last few years, and 19 states plus D.C. have decriminalized recreational marijuana use for adults, said House Judiciary Committee Chairman Jerrold Nadler, one of the bill’s sponsors.“If states are the laboratories of democracy, it is long past time for the federal get to recognize that this experiment in legalization has been a resounding success,” he said at Wednesday’s committee hearing.Federal legalization could have major ramifications for cannabis companies, which would no longer be subject to a section of the U.S. internal revenue code that prohibits taxpayers from deducting business expenses associated with controlled substances, wrote Pedro Palandrani, director of research at Global X ETFs, in an emailed statement. Palandrani oversees the firm’s cannabis ETF ( POTX ), which was down 0.4%.Legalization also could unlock access to basic financing options, like loans and capital raising on U.S. exchanges, that were previously inaccessible to cannabis companies, he added.“Furthermore, the possible establishment of cannabis as a commodity with futures contracts and more relaxed regulations regarding land use for cannabis cultivation could also assist developing supply chain dynamics,” Palandrani wrote.Analysts widely expect the bill to clear the House, but are more skeptical about its prospects in the Senate. In 2020, a similar bill passed the House but stalled in the upper chamber after failing to garner sufficient support.They are more optimistic that the Secure and Fair Enforcement Banking Act, or SAFE Act, passes later this year. The SAFE Act would prohibit federal banking regulators from penalizing banks that work with cannabis businesses legalized by states. The House passed the measure in February.But the SAFE Act would have a limited positive impact on cannabis operators, analysts said. Weed would remain illegal at a federal level, creating an obstacle for Canadian companies like Tilray to move into the U.S.","news_type":1},"isVote":1,"tweetType":1,"viewCount":194,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9013295890,"gmtCreate":1648732375353,"gmtModify":1676534387446,"author":{"id":"3578476625539127","authorId":"3578476625539127","name":"Justinslh","avatar":"https://static.tigerbbs.com/4aace6371636c60f0a3a97aacd94721c","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578476625539127","authorIdStr":"3578476625539127"},"themes":[],"htmlText":"Is it going to hit the $100 mark?","listText":"Is it going to hit the $100 mark?","text":"Is it going to hit the $100 mark?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9013295890","repostId":"1141361635","repostType":4,"repost":{"id":"1141361635","pubTimestamp":1648731658,"share":"https://ttm.financial/m/news/1141361635?lang=&edition=fundamental","pubTime":"2022-03-31 21:00","market":"us","language":"en","title":"Micron is Processing Strong Revenues, Can it Continue?","url":"https://stock-news.laohu8.com/highlight/detail?id=1141361635","media":"TipRanks","summary":"Micron Technology, Inc. (MU) is a major player in the rapidly growing semiconductor sector. Despite ","content":"<div>\n<p>Micron Technology, Inc. (MU) is a major player in the rapidly growing semiconductor sector. Despite a significant sell-off like most other semiconductor stocks over the last month due to macro issues ...</p>\n\n<a href=\"https://www.tipranks.com/news/article/micron-is-processing-strong-revenues-can-it-continue/\">Web Link</a>\n\n</div>\n","source":"lsy1606183248679","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Micron is Processing Strong Revenues, Can it Continue?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMicron is Processing Strong Revenues, Can it Continue?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-03-31 21:00 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.tipranks.com/news/article/micron-is-processing-strong-revenues-can-it-continue/><strong>TipRanks</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Micron Technology, Inc. (MU) is a major player in the rapidly growing semiconductor sector. Despite a significant sell-off like most other semiconductor stocks over the last month due to macro issues ...</p>\n\n<a href=\"https://www.tipranks.com/news/article/micron-is-processing-strong-revenues-can-it-continue/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MU":"美光科技"},"source_url":"https://www.tipranks.com/news/article/micron-is-processing-strong-revenues-can-it-continue/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1141361635","content_text":"Micron Technology, Inc. (MU) is a major player in the rapidly growing semiconductor sector. Despite a significant sell-off like most other semiconductor stocks over the last month due to macro issues and investor worries, the stock has risen about 12% in the last six months.The corporation recently reported excellent fiscal second-quarter financial results, with both revenues and profitability surpassed analyst expectations. In addition, the firm provided a positive fiscal Q3 outlook, which explains the stock’s gain on Wednesday.What do its Q2 Earnings Results Indicate?Micron has been delivering substantial growth, especially over the past couple of years. The company’s Q2 2022 results crushed the market’s expectations by reporting a nearly 25% year-over-year surge in revenues. According to MU, revenues were primarily driven by robust performance across data centers.Meanwhile, adjusted earnings per share increased 8.6% to $2.14 per share year-over-year.In addition to the exceptional results, Micron’s guidance for the upcoming quarter thrilled the market. Adjusted revenue is expected to be in the range of $8.5-$8.9 billion, with adjusted earnings of $2.36 to $2.56 per share, which is higher than consensus projections of $8.06 billion and $2.21 per share, respectively.The findings reveal that Micron is benefiting from a better price environment for both its NAND and DRAM memory products. Furthermore, as enterprises spend extensively in digital ecosystems to extend their cloud and hybrid platforms, Micron’s data center processors should continue to remain in high demand.Wall Street’s TakeOn TipRanks, Micron stock commands a Strong Buy consensus rating based on 17 Buys and one Hold. As for price targets, the average MU stock price prediction of $116.83 implies an almost 48% upside potential from the current level.Bottom LineMicron stock is all set to continue its rally in 2022, driven by the high demand for memory, storage, and advanced processors in the market. Further, Micron’s technological leadership across DRAM and NAND, 5G momentum, accelerating demand for data-center chips, strong financials, and, robust product portfolio should all help the company gain traction.However, existing supply challenges and expectations of costs to rise could limit the upside in Micron stock to some extent.","news_type":1},"isVote":1,"tweetType":1,"viewCount":510,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9013298654,"gmtCreate":1648731948452,"gmtModify":1676534387390,"author":{"id":"3578476625539127","authorId":"3578476625539127","name":"Justinslh","avatar":"https://static.tigerbbs.com/4aace6371636c60f0a3a97aacd94721c","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578476625539127","authorIdStr":"3578476625539127"},"themes":[],"htmlText":"It's about time to have some good news","listText":"It's about time to have some good news","text":"It's about time to have some good news","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9013298654","repostId":"1175936357","repostType":4,"repost":{"id":"1175936357","weMediaInfo":{"introduction":"Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals","home_visible":0,"media_name":"Benzinga","id":"1052270027","head_image":"https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa"},"pubTimestamp":1648729492,"share":"https://ttm.financial/m/news/1175936357?lang=&edition=fundamental","pubTime":"2022-03-31 20:24","market":"us","language":"en","title":"Sundial Growers Completes Acquisition Of Alcanna For $255.55M In Stock And Cash","url":"https://stock-news.laohu8.com/highlight/detail?id=1175936357","media":"Benzinga","summary":"Sundial Growers Inc. completed acquisition of all of the issued and outstanding common shares of Alc","content":"<html><head></head><body><p><b>Sundial Growers Inc.</b> <b>completed</b> <b>acquisition</b> <b>of all of the issued and outstanding common shares of Alcanna Inc.</b> pursuant to a plan of arrangement,<b> for total consideration of approximately</b> <b>CA$320 million ($255.55 million) consisting of cash and common shares of Sundial</b>.</p><p>Pursuant to the transaction, <b>former holders of Alcannashares are entitled to receive 8.85 Sundial</b> <b>shares and</b> <b>CA$1.50 in cash for each Alcannashare</b>. Following the transaction, there are approximately 2.4 billion Sundial shares outstanding with existing Sundial shareholders holding approximately 86.6% of such Sundial shares and former Alcanna shareholders holding approximately 13.4% of such Sundial shares.</p><p>As a result of the transaction, <b>Sundial claims it has become Canada’s biggest private sector liquor retailer, operating 171 locations</b> predominantly in Alberta under its three retail banners “<b>Wine and Beyond</b>”, “<b>Liquor Depot</b>” and “<b>Ace Liquor</b>”. The company’s management believes that the liquor segment will add sustainable cash flow from operations and stable adjusted EBITDA generation to Sundial’s business.</p><p>Alcanna’s established liquor segment generated cash provided by operating activities before working capital changes of CA$25.0 million, which net of cash used by cannabis operations of CA$6.7 million resulted in a consolidated total of CA$18.3 million for the twelve months ended December 31, 2021.</p><p>Nova, Alcanna’s majority-owned subsidiary, currently owns or operates a total of 78 cannabis retail stores across Alberta, Saskatchewan, and Ontario under the “<b>Value Buds</b>” banner. Combined with Sundial&#39;s <b>Spiritleaf</b> retail operations, Sundial now owns or operates cannabis retail network with more than 180 locations in Canada.</p><p>“This is an exciting day for Sundial as we become a stronger and more capable regulated products platform. We are developing a business model that has never existed at this scale in Canada, and are committed to continuously improving our business while delighting consumers,” stated <b>Zach George</b>, CEO of Sundial. “We look forward to working closely with the team at Alcanna and applaud <b>James Burns</b>’ leadership in repositioning Alcanna’s business and helping to develop Alcanna and Nova into first-class retail enterprises over the last several years&#34;</p><p>The Alcanna shares are expected to be delisted from the Toronto Stock Exchange on or before April 4, 2022.</p><p>Sundial Growers shares jumped 5% in premarket trading.</p><p><img src=\"https://static.tigerbbs.com/dc61ecf7e4db9c8d6a3deb70a73eced5\" tg-width=\"841\" tg-height=\"618\" width=\"100%\" height=\"auto\"/></p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Sundial Growers Completes Acquisition Of Alcanna For $255.55M In Stock And Cash</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSundial Growers Completes Acquisition Of Alcanna For $255.55M In Stock And Cash\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Benzinga </p>\n<p class=\"h-time\">2022-03-31 20:24</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p><b>Sundial Growers Inc.</b> <b>completed</b> <b>acquisition</b> <b>of all of the issued and outstanding common shares of Alcanna Inc.</b> pursuant to a plan of arrangement,<b> for total consideration of approximately</b> <b>CA$320 million ($255.55 million) consisting of cash and common shares of Sundial</b>.</p><p>Pursuant to the transaction, <b>former holders of Alcannashares are entitled to receive 8.85 Sundial</b> <b>shares and</b> <b>CA$1.50 in cash for each Alcannashare</b>. Following the transaction, there are approximately 2.4 billion Sundial shares outstanding with existing Sundial shareholders holding approximately 86.6% of such Sundial shares and former Alcanna shareholders holding approximately 13.4% of such Sundial shares.</p><p>As a result of the transaction, <b>Sundial claims it has become Canada’s biggest private sector liquor retailer, operating 171 locations</b> predominantly in Alberta under its three retail banners “<b>Wine and Beyond</b>”, “<b>Liquor Depot</b>” and “<b>Ace Liquor</b>”. The company’s management believes that the liquor segment will add sustainable cash flow from operations and stable adjusted EBITDA generation to Sundial’s business.</p><p>Alcanna’s established liquor segment generated cash provided by operating activities before working capital changes of CA$25.0 million, which net of cash used by cannabis operations of CA$6.7 million resulted in a consolidated total of CA$18.3 million for the twelve months ended December 31, 2021.</p><p>Nova, Alcanna’s majority-owned subsidiary, currently owns or operates a total of 78 cannabis retail stores across Alberta, Saskatchewan, and Ontario under the “<b>Value Buds</b>” banner. Combined with Sundial&#39;s <b>Spiritleaf</b> retail operations, Sundial now owns or operates cannabis retail network with more than 180 locations in Canada.</p><p>“This is an exciting day for Sundial as we become a stronger and more capable regulated products platform. We are developing a business model that has never existed at this scale in Canada, and are committed to continuously improving our business while delighting consumers,” stated <b>Zach George</b>, CEO of Sundial. “We look forward to working closely with the team at Alcanna and applaud <b>James Burns</b>’ leadership in repositioning Alcanna’s business and helping to develop Alcanna and Nova into first-class retail enterprises over the last several years&#34;</p><p>The Alcanna shares are expected to be delisted from the Toronto Stock Exchange on or before April 4, 2022.</p><p>Sundial Growers shares jumped 5% in premarket trading.</p><p><img src=\"https://static.tigerbbs.com/dc61ecf7e4db9c8d6a3deb70a73eced5\" tg-width=\"841\" tg-height=\"618\" width=\"100%\" height=\"auto\"/></p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"SNDL":"SNDL Inc."},"source_url":"","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1175936357","content_text":"Sundial Growers Inc. completed acquisition of all of the issued and outstanding common shares of Alcanna Inc. pursuant to a plan of arrangement, for total consideration of approximately CA$320 million ($255.55 million) consisting of cash and common shares of Sundial.Pursuant to the transaction, former holders of Alcannashares are entitled to receive 8.85 Sundial shares and CA$1.50 in cash for each Alcannashare. Following the transaction, there are approximately 2.4 billion Sundial shares outstanding with existing Sundial shareholders holding approximately 86.6% of such Sundial shares and former Alcanna shareholders holding approximately 13.4% of such Sundial shares.As a result of the transaction, Sundial claims it has become Canada’s biggest private sector liquor retailer, operating 171 locations predominantly in Alberta under its three retail banners “Wine and Beyond”, “Liquor Depot” and “Ace Liquor”. The company’s management believes that the liquor segment will add sustainable cash flow from operations and stable adjusted EBITDA generation to Sundial’s business.Alcanna’s established liquor segment generated cash provided by operating activities before working capital changes of CA$25.0 million, which net of cash used by cannabis operations of CA$6.7 million resulted in a consolidated total of CA$18.3 million for the twelve months ended December 31, 2021.Nova, Alcanna’s majority-owned subsidiary, currently owns or operates a total of 78 cannabis retail stores across Alberta, Saskatchewan, and Ontario under the “Value Buds” banner. Combined with Sundial's Spiritleaf retail operations, Sundial now owns or operates cannabis retail network with more than 180 locations in Canada.“This is an exciting day for Sundial as we become a stronger and more capable regulated products platform. We are developing a business model that has never existed at this scale in Canada, and are committed to continuously improving our business while delighting consumers,” stated Zach George, CEO of Sundial. “We look forward to working closely with the team at Alcanna and applaud James Burns’ leadership in repositioning Alcanna’s business and helping to develop Alcanna and Nova into first-class retail enterprises over the last several years\"The Alcanna shares are expected to be delisted from the Toronto Stock Exchange on or before April 4, 2022.Sundial Growers shares jumped 5% in premarket trading.","news_type":1},"isVote":1,"tweetType":1,"viewCount":247,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9013042102,"gmtCreate":1648660229774,"gmtModify":1676534373493,"author":{"id":"3578476625539127","authorId":"3578476625539127","name":"Justinslh","avatar":"https://static.tigerbbs.com/4aace6371636c60f0a3a97aacd94721c","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578476625539127","authorIdStr":"3578476625539127"},"themes":[],"htmlText":"How high can it go?","listText":"How high can it go?","text":"How high can it go?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9013042102","repostId":"2223820099","repostType":4,"repost":{"id":"2223820099","pubTimestamp":1648654316,"share":"https://ttm.financial/m/news/2223820099?lang=&edition=fundamental","pubTime":"2022-03-30 23:31","market":"us","language":"en","title":"Micron Is A Bargain At This Price","url":"https://stock-news.laohu8.com/highlight/detail?id=2223820099","media":"seekingalpha","summary":"SummaryShares of Micron have sold off lately, for no apparent reason.Micron will continue to generat","content":"<html><head></head><body><p><b>Summary</b></p><ul><li>Shares of Micron have sold off lately, for no apparent reason.</li><li>Micron will continue to generate a considerable amount of revenues and free cash flow this year.</li><li>While declining DRAM ASPs provide a challenge for Micron, the firm is still looking at record revenues in FY 2022.</li><li>Micron’s P-E ratio indicates deep undervaluation.</li></ul><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/9900c36936c91a482f9e65b8c20025e4\" tg-width=\"750\" tg-height=\"500\" width=\"100%\" height=\"auto\"/><span>Sundry Photography/iStock Editorial via Getty Images</span></p><p>Shares of Micron Technology (NASDAQ:MU) are too cheap to ignore. With Micron dropping back to the $80 level lately, the memory chip maker has once again become massively undervalued relative to its earnings potential. FY 2022 is set to be another year of strong revenue growth and high gross margins for the firm although there are pricing risks in the DRAM market. Micron&#39;s valuation, based off of earnings, is unreasonably low despite the risks and the stock has considerable recovery potential!</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/19223357d71830483a67987a2c426090\" tg-width=\"635\" tg-height=\"417\" width=\"100%\" height=\"auto\"/><span>Data by YCharts</span></p><p><b>Strong business momentum in the DRAM business</b></p><p>FY 2021 was a fantastic year for Micron. The memory maker saw a surge in revenues due to strong demand for the firm&#39;s memory and storage products, especially in its DRAM segment. Micron&#39;s revenues from DRAM products surged 37% year over year to $5.6B in the firm&#39;s FQ1&#39;22, in part because the DRAM market was heavily undersupplied. DRAM revenues have been supported by strengthening customer demand for Micron&#39;s 1-alpha and 1z DRAM nodes and growing average selling prices throughout the last year. In total, DRAM revenues generated about 73% of revenues for Micron in the last quarter while NAND products generated about 24% of revenues in FQ1-22. NAND revenues are also seeing momentum, especially regarding Micron&#39;s new 176-layer NAND which represents the majority of the firm&#39;s NAND bit production now. NAND-related revenues surged 19% year over year to $1.9B in FQ1-22.</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/a6c31f5e4f420bb8b7c8aa6ecedffd94\" tg-width=\"1280\" tg-height=\"235\" width=\"100%\" height=\"auto\"/><span>Micron</span></p><p><b>Strong outlook in place</b></p><p>Micron has submitted a strong outlook for FQ2-22: The memory chip maker expects to generate $7.5B in revenues +/- $200M in FQ2-22. The forecast implies a 3% quarter over quarter drop in revenues, but revenues are still going to be materially above last year&#39;s level. The company also guided for strong gross margins of at least 45% in the firm&#39;s second fiscal quarter, indicating that Micron expects to be able to defend elevated gross margin levels at least in the first half of the new fiscal year.</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/b5ff05280ac3f4ffb86515eb49c8484f\" tg-width=\"1280\" tg-height=\"305\" width=\"100%\" height=\"auto\"/><span>Micron</span></p><p>Micron is the third-largest DRAM brand in the world, after Samsung and SK Hynix, and has a large market share. Micron has a market share of approximately 23%, based on projections made by Trendforce, a research service with a focus on the chip industry. Growing demand and higher prices for DRAM products immediately benefit Micron.</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/67ca844a79df769dda50bb8355c7f00b\" tg-width=\"513\" tg-height=\"279\" width=\"100%\" height=\"auto\"/><span>Trendforce</span></p><p><b>Risks with Micron</b></p><p>Micron may face headwinds in the DRAM business regarding pricing. Strong demand for storage and memory products have led to an upswing in average selling prices in FY 2021, especially in the DRAM market which has been chronically undersupplied in FY 2021. But DRAM prices have started to drop towards the end of last year and more pricing pressure could build going forward. Lower average selling prices for DRAM products obviously indicate top line and gross margin risks for Micron, although the memory chip maker still expects to generate record revenues in FY 2022. Micron&#39;s DRAM average selling prices decreased in the lower-single digit range in the last quarter while NAND average selling prices decreased in the mid-single digit range. Micron does not make forecasts about expected average selling prices, but forecasts for FQ1-22, made by Trendforce again, indicate additional pricing pressures in the DRAM market due to a seasonal demand downturn.</p><p><b>Strong free cash flow ramp</b></p><p>In the period from FY 2017 to FQ1-22, Micron earned approximately $21B in free cash flow and free cash flow conversion has greatly improved. The biggest contributing factor for Micron&#39;s strong commercial performance was strengthening demand for the firm&#39;s products during the current bull market in the chip industry. Micron generated $4.2B in free cash flow in FY 2021 and, I believe, could earn about $4.0B in free cash flow in FY 2022.</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/b65dcf050f37b99e03c7b7c8c7152137\" tg-width=\"1032\" tg-height=\"702\" width=\"100%\" height=\"auto\"/><span>Micron</span></p><p><b>Extreme undervaluation</b></p><p>Micron&#39;s shares remain deeply undervalued based on earnings. Micron is expected to see 51% EPS growth in FY 2022 and another 35% on top of that in FY 2023. Based off of $12.3 in FY 2023 EPS, shares of Micron trade for only 6.5 X earnings. I believe the P-E ratio really is unreasonably low at this point and the risk profile for shares of Micron are heavily skewed to the upside.</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/ca80eb75a5ec7d3f7fe009ff80402452\" tg-width=\"640\" tg-height=\"126\" width=\"100%\" height=\"auto\"/><span>Micron</span></p><p><b>Final thoughts</b></p><p>Although pricing pressures in the DRAM market may persist, Micron is extremely attractive as an investment. The biggest reason to consider Micron right now is that the company&#39;s earnings potential is widely undervalued. Shares of Micron have a P-E ratio of just 6.5 X although the company is generating a ton of free cash flow and earnings each quarter. While Micron does have risks relating to lower average selling prices, especially in the dominant DRAM business, I believe the risk/reward still heavily favors an investment in the memory chip maker at this time!</p></body></html>","source":"seekingalpha","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Micron Is A Bargain At This Price</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMicron Is A Bargain At This Price\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-03-30 23:31 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/article/4498448-micron-is-a-bargain-at-this-price><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>SummaryShares of Micron have sold off lately, for no apparent reason.Micron will continue to generate a considerable amount of revenues and free cash flow this year.While declining DRAM ASPs provide a...</p>\n\n<a href=\"https://seekingalpha.com/article/4498448-micron-is-a-bargain-at-this-price\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4554":"元宇宙及AR概念","BK4566":"资本集团","BK4532":"文艺复兴科技持仓","BK4553":"喜马拉雅资本持仓","MU":"美光科技","BK4575":"芯片概念","BK4527":"明星科技股","BK4579":"人工智能","BK4533":"AQR资本管理(全球第二大对冲基金)","BK4512":"苹果概念","BK4141":"半导体产品"},"source_url":"https://seekingalpha.com/article/4498448-micron-is-a-bargain-at-this-price","is_english":true,"share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","article_id":"2223820099","content_text":"SummaryShares of Micron have sold off lately, for no apparent reason.Micron will continue to generate a considerable amount of revenues and free cash flow this year.While declining DRAM ASPs provide a challenge for Micron, the firm is still looking at record revenues in FY 2022.Micron’s P-E ratio indicates deep undervaluation.Sundry Photography/iStock Editorial via Getty ImagesShares of Micron Technology (NASDAQ:MU) are too cheap to ignore. With Micron dropping back to the $80 level lately, the memory chip maker has once again become massively undervalued relative to its earnings potential. FY 2022 is set to be another year of strong revenue growth and high gross margins for the firm although there are pricing risks in the DRAM market. Micron's valuation, based off of earnings, is unreasonably low despite the risks and the stock has considerable recovery potential!Data by YChartsStrong business momentum in the DRAM businessFY 2021 was a fantastic year for Micron. The memory maker saw a surge in revenues due to strong demand for the firm's memory and storage products, especially in its DRAM segment. Micron's revenues from DRAM products surged 37% year over year to $5.6B in the firm's FQ1'22, in part because the DRAM market was heavily undersupplied. DRAM revenues have been supported by strengthening customer demand for Micron's 1-alpha and 1z DRAM nodes and growing average selling prices throughout the last year. In total, DRAM revenues generated about 73% of revenues for Micron in the last quarter while NAND products generated about 24% of revenues in FQ1-22. NAND revenues are also seeing momentum, especially regarding Micron's new 176-layer NAND which represents the majority of the firm's NAND bit production now. NAND-related revenues surged 19% year over year to $1.9B in FQ1-22.MicronStrong outlook in placeMicron has submitted a strong outlook for FQ2-22: The memory chip maker expects to generate $7.5B in revenues +/- $200M in FQ2-22. The forecast implies a 3% quarter over quarter drop in revenues, but revenues are still going to be materially above last year's level. The company also guided for strong gross margins of at least 45% in the firm's second fiscal quarter, indicating that Micron expects to be able to defend elevated gross margin levels at least in the first half of the new fiscal year.MicronMicron is the third-largest DRAM brand in the world, after Samsung and SK Hynix, and has a large market share. Micron has a market share of approximately 23%, based on projections made by Trendforce, a research service with a focus on the chip industry. Growing demand and higher prices for DRAM products immediately benefit Micron.TrendforceRisks with MicronMicron may face headwinds in the DRAM business regarding pricing. Strong demand for storage and memory products have led to an upswing in average selling prices in FY 2021, especially in the DRAM market which has been chronically undersupplied in FY 2021. But DRAM prices have started to drop towards the end of last year and more pricing pressure could build going forward. Lower average selling prices for DRAM products obviously indicate top line and gross margin risks for Micron, although the memory chip maker still expects to generate record revenues in FY 2022. Micron's DRAM average selling prices decreased in the lower-single digit range in the last quarter while NAND average selling prices decreased in the mid-single digit range. Micron does not make forecasts about expected average selling prices, but forecasts for FQ1-22, made by Trendforce again, indicate additional pricing pressures in the DRAM market due to a seasonal demand downturn.Strong free cash flow rampIn the period from FY 2017 to FQ1-22, Micron earned approximately $21B in free cash flow and free cash flow conversion has greatly improved. The biggest contributing factor for Micron's strong commercial performance was strengthening demand for the firm's products during the current bull market in the chip industry. Micron generated $4.2B in free cash flow in FY 2021 and, I believe, could earn about $4.0B in free cash flow in FY 2022.MicronExtreme undervaluationMicron's shares remain deeply undervalued based on earnings. Micron is expected to see 51% EPS growth in FY 2022 and another 35% on top of that in FY 2023. Based off of $12.3 in FY 2023 EPS, shares of Micron trade for only 6.5 X earnings. I believe the P-E ratio really is unreasonably low at this point and the risk profile for shares of Micron are heavily skewed to the upside.MicronFinal thoughtsAlthough pricing pressures in the DRAM market may persist, Micron is extremely attractive as an investment. The biggest reason to consider Micron right now is that the company's earnings potential is widely undervalued. Shares of Micron have a P-E ratio of just 6.5 X although the company is generating a ton of free cash flow and earnings each quarter. While Micron does have risks relating to lower average selling prices, especially in the dominant DRAM business, I believe the risk/reward still heavily favors an investment in the memory chip maker at this time!","news_type":1},"isVote":1,"tweetType":1,"viewCount":286,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9013042330,"gmtCreate":1648660192859,"gmtModify":1676534373493,"author":{"id":"3578476625539127","authorId":"3578476625539127","name":"Justinslh","avatar":"https://static.tigerbbs.com/4aace6371636c60f0a3a97aacd94721c","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578476625539127","authorIdStr":"3578476625539127"},"themes":[],"htmlText":"Didn't sea pull out of India?","listText":"Didn't sea pull out of India?","text":"Didn't sea pull out of India?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9013042330","repostId":"2223287458","repostType":4,"repost":{"id":"2223287458","pubTimestamp":1648638854,"share":"https://ttm.financial/m/news/2223287458?lang=&edition=fundamental","pubTime":"2022-03-30 19:14","market":"us","language":"en","title":"3 Gaming Growth Stocks With 72% to 195% Upside, Says Wall Street","url":"https://stock-news.laohu8.com/highlight/detail?id=2223287458","media":"Motley Fool","summary":"The red-hot gaming industry is set to catch a boost with new technologies like the 5G network and the metaverse.","content":"<html><head></head><body><p>The value of the global gaming industry topped $180 billion in 2021, inclusive of the three major segments: mobile, console, and PC. Smartphones and tablets have catapulted the mobile gaming segment to the top spot, exceeding the value of both the console and PC markets combined.</p><p>That trend is likely to continue as adoption of the 5G network expands across the globe, providing a more powerful gaming experience for users.</p><p>Since the stock market is having a turbulent 2022 with the <b>NASDAQ 100</b> technology index down about 10% year to date, there&#39;s an opportunity to buy leading gaming stocks at a steep discount to their all-time highs. In fact, Wall Street analysts predict major upside for these three in particular.</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/295c1b40339d1bd412fe713b190b6ad1\" tg-width=\"700\" tg-height=\"466\" width=\"100%\" height=\"auto\"/><span>Image source: Getty Images.</span></p><h2>1. Sea Limited: Implied upside of 72%</h2><p><b>Sea Limited</b> is a Singapore-based powerhouse of the digital economy with its reach expanding far beyond gaming. It has a market-leading e-commerce platform called Shopee, and its fintech segment, SeaMoney, is making strides in the payments industry.</p><p>But Sea Limited&#39;s gaming business is part of its digital entertainment segment, and it&#39;s led by Garena, the studio responsible for the <i>Free Fire</i> battle royale mobile game. It&#39;s a world leader in more ways than <a href=\"https://laohu8.com/S/AONE.U\">one</a>, topping the charts as the highest-grossing title in both <b>Apple</b>&#39;s App Store and <b>Alphabet</b>&#39;s Play Store across multiple regions. Since launching in 2017, it has amassed over one billion downloads and continues to set records for quarterly active users.</p><p>The industry in general boomed thanks to the pandemic with people spending more time at home engaging with their favorite games. Those tailwinds are set to subside as Sea Limited expects Garena&#39;s gross bookings to contract 35% in 2022 to approximately $3 billion. The weakness comes as <i>Free Fire</i> is the subject of government scrutiny in India, making the game&#39;s future uncertain in the country.</p><p>But that&#39;s no reason to disregard the stock, because e-commerce is rapidly driving the company forward while the gaming segment takes a breather. The e-commerce segment generated $5.1 billion of revenue in 2021, representing 136% year-over-year growth, and the company estimates a further 75% growth to $9.0 billion in 2022.</p><p>With Sea Limited stock, investors get a market-leading gaming business attached to a fast-growing e-commerce platform. Banking giant <b>Barclays</b> thinks the stock could soar 72% from current levels to $201 per share.</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/8cfc4cef5bc0023bd8265e1226ab4165\" tg-width=\"700\" tg-height=\"466\" width=\"100%\" height=\"auto\"/><span>Image source: Getty Images.</span></p><h2>2. Unity Software: Implied upside of 83%</h2><p><b>Unity Software</b> isn&#39;t a game developer itself but rather the leading tool for making games, serving 61% of developers and creators. Last year, over half of all games across all platforms were made with the help of Unity, but that&#39;s just the tip of the iceberg for this company.</p><p>Unity&#39;s software offerings also serve a variety of purposes beyond gaming, including filmmaking, industrial design, and both augmented and virtual reality. Content created with Unity reached over 3.9 billion people every single month of 2021, which represents almost half the planet.</p><p>But for game makers, the company&#39;s Unity Pro suite is the obvious choice for a few reasons. Not only does it offer low-code tools for the development process, but it also supports the game once it&#39;s live in the market. It provides plugins to help generate revenue through advertising and in-app purchases, plus a data analytics suite to fine-tune the user experience.</p><p>Unity is experiencing strong growth in revenue, logging an increase of 44% in 2021 to $1.1 billion. This year, management expects a further jump of approximately 35% to $1.5 billion. The company is still losing money, but it&#39;s working toward building scale and has enormous, potentially multi-trillion dollar opportunities ahead of it in new industries like the metaverse.</p><p>So it&#39;s no surprise <b>Credit Suisse</b> sees a lot of potential in Unity stock, giving it a $180 price target, which represents an 83% gain from its price as of this writing.</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/0c6968f5161b239813b6b2d6291ff6f2\" tg-width=\"700\" tg-height=\"393\" width=\"100%\" height=\"auto\"/><span>Image source: Getty Images.</span></p><h2>3. Skillz: Implied upside of 195%</h2><p><b>Skillz</b> takes yet another approach to the gaming industry. It&#39;s a platform technology company focused on facilitating a brand new way for game makers to generate revenue, which solves a key problem: Only 2% of developers actually deliver a financially successful game to the market, leaving the other 98% fighting for scraps.</p><p>But with Skillz, that 98% can earn income by allowing users to enter paid tournaments with real cash prizes. Players buy in for a fee which builds a prize pool paid out to the winners, while Skillz and the game developer take a cut of the action. It&#39;s staggeringly popular with over 30 million gamers now on the platform.</p><p>The Skillz platform mainly hosts generic games, devoid of big names, because those brands typically don&#39;t need an alternative revenue source like this. But that&#39;s all about to change as Skillz secured a deal last year with the NFL to host a developer competition with the aim of delivering a mobile-based football game. It&#39;s in the final stages right now, and it could catapult the company into the mainstream.</p><p>It&#39;s already working with the UFC joining the fold just last week.</p><p>Skillz grew revenue 67% in 2021 to $384 million, but its net losses remain a concern, so much so the company plans to restructure its marketing expenses during 2022 in order to improve the bottom line. It will sacrifice revenue growth in the short term to achieve that with the $400 million expected this year being only a marginal improvement over 2021.</p><p>But Skillz is onto something special, reinforced by giants like the NFL and the UFC. Wall Street bank <b>Citigroup</b> is betting the company can deliver, placing a $9 price target on Skillz stock, which implies it could soar 195% from where it trades today.</p></body></html>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Gaming Growth Stocks With 72% to 195% Upside, Says Wall Street</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Gaming Growth Stocks With 72% to 195% Upside, Says Wall Street\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-03-30 19:14 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2022/03/29/3-gaming-growth-stocks-72-195-upside-wall-street/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The value of the global gaming industry topped $180 billion in 2021, inclusive of the three major segments: mobile, console, and PC. Smartphones and tablets have catapulted the mobile gaming segment ...</p>\n\n<a href=\"https://www.fool.com/investing/2022/03/29/3-gaming-growth-stocks-72-195-upside-wall-street/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4535":"淡马锡持仓","BK4551":"寇图资本持仓","BK4548":"巴美列捷福持仓","SE":"Sea Ltd","U":"Unity Software Inc.","BK4505":"高瓴资本持仓","BK4554":"元宇宙及AR概念","BK4139":"生物科技","BK4581":"高盛持仓","BK4526":"热门中概股","SKLZ":"Skillz Inc","BK4504":"桥水持仓","BK4503":"景林资产持仓","BK4566":"资本集团"},"source_url":"https://www.fool.com/investing/2022/03/29/3-gaming-growth-stocks-72-195-upside-wall-street/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2223287458","content_text":"The value of the global gaming industry topped $180 billion in 2021, inclusive of the three major segments: mobile, console, and PC. Smartphones and tablets have catapulted the mobile gaming segment to the top spot, exceeding the value of both the console and PC markets combined.That trend is likely to continue as adoption of the 5G network expands across the globe, providing a more powerful gaming experience for users.Since the stock market is having a turbulent 2022 with the NASDAQ 100 technology index down about 10% year to date, there's an opportunity to buy leading gaming stocks at a steep discount to their all-time highs. In fact, Wall Street analysts predict major upside for these three in particular.Image source: Getty Images.1. Sea Limited: Implied upside of 72%Sea Limited is a Singapore-based powerhouse of the digital economy with its reach expanding far beyond gaming. It has a market-leading e-commerce platform called Shopee, and its fintech segment, SeaMoney, is making strides in the payments industry.But Sea Limited's gaming business is part of its digital entertainment segment, and it's led by Garena, the studio responsible for the Free Fire battle royale mobile game. It's a world leader in more ways than one, topping the charts as the highest-grossing title in both Apple's App Store and Alphabet's Play Store across multiple regions. Since launching in 2017, it has amassed over one billion downloads and continues to set records for quarterly active users.The industry in general boomed thanks to the pandemic with people spending more time at home engaging with their favorite games. Those tailwinds are set to subside as Sea Limited expects Garena's gross bookings to contract 35% in 2022 to approximately $3 billion. The weakness comes as Free Fire is the subject of government scrutiny in India, making the game's future uncertain in the country.But that's no reason to disregard the stock, because e-commerce is rapidly driving the company forward while the gaming segment takes a breather. The e-commerce segment generated $5.1 billion of revenue in 2021, representing 136% year-over-year growth, and the company estimates a further 75% growth to $9.0 billion in 2022.With Sea Limited stock, investors get a market-leading gaming business attached to a fast-growing e-commerce platform. Banking giant Barclays thinks the stock could soar 72% from current levels to $201 per share.Image source: Getty Images.2. Unity Software: Implied upside of 83%Unity Software isn't a game developer itself but rather the leading tool for making games, serving 61% of developers and creators. Last year, over half of all games across all platforms were made with the help of Unity, but that's just the tip of the iceberg for this company.Unity's software offerings also serve a variety of purposes beyond gaming, including filmmaking, industrial design, and both augmented and virtual reality. Content created with Unity reached over 3.9 billion people every single month of 2021, which represents almost half the planet.But for game makers, the company's Unity Pro suite is the obvious choice for a few reasons. Not only does it offer low-code tools for the development process, but it also supports the game once it's live in the market. It provides plugins to help generate revenue through advertising and in-app purchases, plus a data analytics suite to fine-tune the user experience.Unity is experiencing strong growth in revenue, logging an increase of 44% in 2021 to $1.1 billion. This year, management expects a further jump of approximately 35% to $1.5 billion. The company is still losing money, but it's working toward building scale and has enormous, potentially multi-trillion dollar opportunities ahead of it in new industries like the metaverse.So it's no surprise Credit Suisse sees a lot of potential in Unity stock, giving it a $180 price target, which represents an 83% gain from its price as of this writing.Image source: Getty Images.3. Skillz: Implied upside of 195%Skillz takes yet another approach to the gaming industry. It's a platform technology company focused on facilitating a brand new way for game makers to generate revenue, which solves a key problem: Only 2% of developers actually deliver a financially successful game to the market, leaving the other 98% fighting for scraps.But with Skillz, that 98% can earn income by allowing users to enter paid tournaments with real cash prizes. Players buy in for a fee which builds a prize pool paid out to the winners, while Skillz and the game developer take a cut of the action. It's staggeringly popular with over 30 million gamers now on the platform.The Skillz platform mainly hosts generic games, devoid of big names, because those brands typically don't need an alternative revenue source like this. But that's all about to change as Skillz secured a deal last year with the NFL to host a developer competition with the aim of delivering a mobile-based football game. It's in the final stages right now, and it could catapult the company into the mainstream.It's already working with the UFC joining the fold just last week.Skillz grew revenue 67% in 2021 to $384 million, but its net losses remain a concern, so much so the company plans to restructure its marketing expenses during 2022 in order to improve the bottom line. It will sacrifice revenue growth in the short term to achieve that with the $400 million expected this year being only a marginal improvement over 2021.But Skillz is onto something special, reinforced by giants like the NFL and the UFC. Wall Street bank Citigroup is betting the company can deliver, placing a $9 price target on Skillz stock, which implies it could soar 195% from where it trades today.","news_type":1},"isVote":1,"tweetType":1,"viewCount":369,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9013042097,"gmtCreate":1648660076788,"gmtModify":1676534373494,"author":{"id":"3578476625539127","authorId":"3578476625539127","name":"Justinslh","avatar":"https://static.tigerbbs.com/4aace6371636c60f0a3a97aacd94721c","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578476625539127","authorIdStr":"3578476625539127"},"themes":[],"htmlText":"Is there any pharma or industrial stock like these?","listText":"Is there any pharma or industrial stock like these?","text":"Is there any pharma or industrial stock like these?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9013042097","repostId":"2223092538","repostType":4,"repost":{"id":"2223092538","pubTimestamp":1648644301,"share":"https://ttm.financial/m/news/2223092538?lang=&edition=fundamental","pubTime":"2022-03-30 20:45","market":"us","language":"en","title":"3 Growth Stocks With Monster Upside of Up to 331%, According to Wall Street","url":"https://stock-news.laohu8.com/highlight/detail?id=2223092538","media":"Motley Fool","summary":"Select analysts believe these fast-paced stocks can soar over the next 12 months.","content":"<html><head></head><body><p><b>KEY POINTS</b></p><ul><li>If these high-water price targets are hit, investors would enjoy upside ranging from 179% to 331%.</li><li>Analysts&#39; lofty price targets often fail to capture the challenges high-growth companies are facing.</li></ul><p>Over the long run, the stock market has proved to be a wealth-building machine. Even though corrections are commonplace, investors are typically doubling their money about once a decade.</p><p>But for a select group of high-growth stocks, simply doubling your money in a decade won&#39;t suffice. According to the high-water 12-month price targets from a group of Wall Street analysts, the following three supercharged growth stocks offer monster upside ranging from 179% on the low end to as much as 331%.</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/eb5c43d2584290008d74d267dba12d47\" tg-width=\"700\" tg-height=\"535\" width=\"100%\" height=\"auto\"/><span>Image source: Getty Images.</span></p><p><b>Rivian Automotive: Implied upside of 218%</b></p><p>The first fast-paced company with significant upside potential is the hottest initial public offering (IPO) of 2021, electric vehicle (EV) manufacturer <b>Rivian Automotive</b>. Analyst Adam Jonas of <b><a href=\"https://laohu8.com/S/MSTLW\">Morgan Stanley</a></b> boasts the highest price target on Wall Street for Rivian. If Jonas&#39;s $147 price target were to hit, it would represent an increase of 218% from where shares ended this past week.</p><p>Jonas&#39;s lofty projection is based on the expectation that Rivian will be producing 1.5 million battery EVs (BEVs) annually by 2030, and will be able to grow its software business from an estimated $641 million in 2025 to approximately $36 billion by 2040 as the installed base of Rivian BEVs grows.</p><p>Pardon the pun, but the bullishness surrounding Rivian does have some fuel behind it. In 2019, the company secured an order for 100,000 electric vans from e-commerce giant <b>Amazon</b>. Even before becoming a publicly traded company, this order provided some level of validation that Rivian was poised to become a major EV player. Also, keep in mind that Rivian&#39;s R1T electric truck looks to be in a class of its own with regard to luxury EV trucks.</p><p>Additionally, Rivian is sitting on a mountain of capital following its IPO. The company ended 2021 with $18.4 billion in cash and cash equivalents, which is allowing management to aggressively invest in production expansion efforts.  For instance, $5 billion is being spent to build a manufacturing plant in Georgia that&#39;ll produce up to 400,000 EVs annually once it begins production in 2024.</p><p>But betting on Rivian to become a $130 billion company seems like a stretch when supply chain issues have cut expected EV production to 25,000 in 2022 from an estimated 50,000.</p><p>What&#39;s more, rising material costs have put Rivian between a rock and a hard place. Earlier this month, the company announced significant price hikes on its quad-motor models, only to walk back to those hikes on people who&#39;d placed reservations with the company prior to March 1. As EV companies like <b>Nikola</b> and <b>Lordstown Motors</b> have shown, overcoming PR flubs can be very difficult. Suffice it to say, $147 doesn&#39;t look achievable anytime soon.</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/1abce5caf5e785b826f62bb98ff77b01\" tg-width=\"700\" tg-height=\"466\" width=\"100%\" height=\"auto\"/><span>Image source: Getty Images.</span></p><p><b>Ocugen: Implied upside of 331%</b></p><p>A second high-growth stock with monster upside potential, at least in the eyes of <a href=\"https://laohu8.com/S/AONE.U\">one</a> Wall Street analyst, is small-cap biotech company <b>Ocugen</b>( OCGN 6.87% ). According to Robert LeBoyer of Noble Financial, Ocugen can hit $15 a share, which would represent jaw-dropping upside of 331% from where it closed this past week.</p><p>In LeBoyer&#39;s view, Ocugen&#39;s upside is tied to COVID-19 vaccine Covaxin, which in his view holds competitive advantages over other COVID-19 vaccines already in use in North America. The U.S. Food and Drug Administration (FDA) recently removed a partial clinical hold on Covaxin in the U.S., which officially clears a path for Ocugen to submit a biologics licensing application on the drug it&#39;s commercially licensed from Bharat Biotech.</p><p>Last year, Bharat Biotech ran a large-scale study involving Covaxin on 25,800 people in India. That trial produced a vaccine efficacy (VE) of 78%. Considering that there are billions of people worldwide still in need of initial COVID-19 inoculations and/or booster shots, we&#39;re still at a stage where new and effective vaccines are welcome on the global stage.</p><p>The issue for Ocugen is that its commercial agreement with Bharat concerning Covaxin only covers the U.S. and Canada. While these are traditionally high-margin markets, the U.S. and Canada have heavily invested in COVID-19 vaccines. A large percentage of the population for both countries have already been vaccinated and/or received booster shots. Further, new vaccine options with a higher VE than Covaxin are waiting in the wings.</p><p>To make matters worse, the FDA declined to grant Covaxin a pathway to emergency-use authorization (EUA) for pediatric patients aged 2 to 18. Despite the company announcing that it would continue to work with the FDA on a possible EUA path for pediatric patients, this revenue channel looks to be shut off.</p><p>Long story short, Ocugen still looks to be a ways away from having any chance of getting Covaxin approved for use in the U.S. -- and even if it&#39;s approved, there&#39;s little assurance it&#39;ll be used over other vaccines with higher VEs. LeBoyer&#39;s $15 price target is highly unlikely to be hit.</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/51b9e73cc74dad844548f15906c23624\" tg-width=\"700\" tg-height=\"466\" width=\"100%\" height=\"auto\"/><span>Image source: Getty Images.</span></p><p><b>Plug Power: Implied upside of 179%</b></p><p>The third growth stock with salivating upside is hydrogen fuel-cell solutions provider <b>Plug Power</b>. According to H.C. Wainwright analyst Amit Dayal, Plug Power can hit $78 a share, which would represent an increase of 179% from where shares ended this past week.</p><p>Dayal&#39;s high-water price target on Plug Power is based on an expansion of the company&#39;s green hydrogen network, and the ongoing deployment of the company&#39;s hydrogen fuel-cell-powered GenDrive units. With most markets promoting clean-energy solutions, Dayal anticipates the company&#39;s margins will improve across the board.</p><p>Plug Power really put itself on the map in early 2021 when it struck two major partnerships within a span of one week. In January 2021, SK Group took a 10% equity stake in the company and formed a joint venture to bring fuel-cell solutions (for vehicles and refilling stations) to numerous Asian markets. Roughly a week later, Plug and French auto company <b>Renault</b> forged a joint venture to tackle Europe&#39;s light commercial vehicle market. These deals signaled that Plug&#39;s fuel-cell solutions were about more than just powering forklifts in warehouses.</p><p>The company has also signaled its willingness to be a key next-gen energy player with acquisitions. In December, it completed its buyout of green hydrogen solutions company Frames Group, which furthers Plug&#39;s ambitions of becoming one of world&#39;s leading green hydrogen ecosystems.</p><p>While there&#39;s little question that developed countries are pushing for green-energy alternative to fight climate change, it&#39;s not yet clear if Plug Power has the solutions that&#39;ll be preferred. Even at a $28 share price, we&#39;re talking about a company with a greater than $16 billion market cap that&#39;s losing money and hasn&#39;t yet demonstrated if it can handle rapid scaling. This isn&#39;t to say that it won&#39;t be able to scale its ecosystem, so much as to point out that its valuation implies everything will go off without a hitch. Rarely is that the case with next-gen technologies and solutions.</p><p>Although Plug Power is a company people can hope is successful, it has a lot of questions to answer at its current valuation, let alone one that would be 179% higher.</p></body></html>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Growth Stocks With Monster Upside of Up to 331%, According to Wall Street</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Growth Stocks With Monster Upside of Up to 331%, According to Wall Street\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-03-30 20:45 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2022/03/30/3-growth-stocks-monster-upside-to-331-wall-street/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>KEY POINTSIf these high-water price targets are hit, investors would enjoy upside ranging from 179% to 331%.Analysts' lofty price targets often fail to capture the challenges high-growth companies are...</p>\n\n<a href=\"https://www.fool.com/investing/2022/03/30/3-growth-stocks-monster-upside-to-331-wall-street/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"RIVN":"Rivian Automotive, Inc.","PLUG":"普拉格能源","OCGN":"Ocugen"},"source_url":"https://www.fool.com/investing/2022/03/30/3-growth-stocks-monster-upside-to-331-wall-street/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2223092538","content_text":"KEY POINTSIf these high-water price targets are hit, investors would enjoy upside ranging from 179% to 331%.Analysts' lofty price targets often fail to capture the challenges high-growth companies are facing.Over the long run, the stock market has proved to be a wealth-building machine. Even though corrections are commonplace, investors are typically doubling their money about once a decade.But for a select group of high-growth stocks, simply doubling your money in a decade won't suffice. According to the high-water 12-month price targets from a group of Wall Street analysts, the following three supercharged growth stocks offer monster upside ranging from 179% on the low end to as much as 331%.Image source: Getty Images.Rivian Automotive: Implied upside of 218%The first fast-paced company with significant upside potential is the hottest initial public offering (IPO) of 2021, electric vehicle (EV) manufacturer Rivian Automotive. Analyst Adam Jonas of Morgan Stanley boasts the highest price target on Wall Street for Rivian. If Jonas's $147 price target were to hit, it would represent an increase of 218% from where shares ended this past week.Jonas's lofty projection is based on the expectation that Rivian will be producing 1.5 million battery EVs (BEVs) annually by 2030, and will be able to grow its software business from an estimated $641 million in 2025 to approximately $36 billion by 2040 as the installed base of Rivian BEVs grows.Pardon the pun, but the bullishness surrounding Rivian does have some fuel behind it. In 2019, the company secured an order for 100,000 electric vans from e-commerce giant Amazon. Even before becoming a publicly traded company, this order provided some level of validation that Rivian was poised to become a major EV player. Also, keep in mind that Rivian's R1T electric truck looks to be in a class of its own with regard to luxury EV trucks.Additionally, Rivian is sitting on a mountain of capital following its IPO. The company ended 2021 with $18.4 billion in cash and cash equivalents, which is allowing management to aggressively invest in production expansion efforts.  For instance, $5 billion is being spent to build a manufacturing plant in Georgia that'll produce up to 400,000 EVs annually once it begins production in 2024.But betting on Rivian to become a $130 billion company seems like a stretch when supply chain issues have cut expected EV production to 25,000 in 2022 from an estimated 50,000.What's more, rising material costs have put Rivian between a rock and a hard place. Earlier this month, the company announced significant price hikes on its quad-motor models, only to walk back to those hikes on people who'd placed reservations with the company prior to March 1. As EV companies like Nikola and Lordstown Motors have shown, overcoming PR flubs can be very difficult. Suffice it to say, $147 doesn't look achievable anytime soon.Image source: Getty Images.Ocugen: Implied upside of 331%A second high-growth stock with monster upside potential, at least in the eyes of one Wall Street analyst, is small-cap biotech company Ocugen( OCGN 6.87% ). According to Robert LeBoyer of Noble Financial, Ocugen can hit $15 a share, which would represent jaw-dropping upside of 331% from where it closed this past week.In LeBoyer's view, Ocugen's upside is tied to COVID-19 vaccine Covaxin, which in his view holds competitive advantages over other COVID-19 vaccines already in use in North America. The U.S. Food and Drug Administration (FDA) recently removed a partial clinical hold on Covaxin in the U.S., which officially clears a path for Ocugen to submit a biologics licensing application on the drug it's commercially licensed from Bharat Biotech.Last year, Bharat Biotech ran a large-scale study involving Covaxin on 25,800 people in India. That trial produced a vaccine efficacy (VE) of 78%. Considering that there are billions of people worldwide still in need of initial COVID-19 inoculations and/or booster shots, we're still at a stage where new and effective vaccines are welcome on the global stage.The issue for Ocugen is that its commercial agreement with Bharat concerning Covaxin only covers the U.S. and Canada. While these are traditionally high-margin markets, the U.S. and Canada have heavily invested in COVID-19 vaccines. A large percentage of the population for both countries have already been vaccinated and/or received booster shots. Further, new vaccine options with a higher VE than Covaxin are waiting in the wings.To make matters worse, the FDA declined to grant Covaxin a pathway to emergency-use authorization (EUA) for pediatric patients aged 2 to 18. Despite the company announcing that it would continue to work with the FDA on a possible EUA path for pediatric patients, this revenue channel looks to be shut off.Long story short, Ocugen still looks to be a ways away from having any chance of getting Covaxin approved for use in the U.S. -- and even if it's approved, there's little assurance it'll be used over other vaccines with higher VEs. LeBoyer's $15 price target is highly unlikely to be hit.Image source: Getty Images.Plug Power: Implied upside of 179%The third growth stock with salivating upside is hydrogen fuel-cell solutions provider Plug Power. According to H.C. Wainwright analyst Amit Dayal, Plug Power can hit $78 a share, which would represent an increase of 179% from where shares ended this past week.Dayal's high-water price target on Plug Power is based on an expansion of the company's green hydrogen network, and the ongoing deployment of the company's hydrogen fuel-cell-powered GenDrive units. With most markets promoting clean-energy solutions, Dayal anticipates the company's margins will improve across the board.Plug Power really put itself on the map in early 2021 when it struck two major partnerships within a span of one week. In January 2021, SK Group took a 10% equity stake in the company and formed a joint venture to bring fuel-cell solutions (for vehicles and refilling stations) to numerous Asian markets. Roughly a week later, Plug and French auto company Renault forged a joint venture to tackle Europe's light commercial vehicle market. These deals signaled that Plug's fuel-cell solutions were about more than just powering forklifts in warehouses.The company has also signaled its willingness to be a key next-gen energy player with acquisitions. In December, it completed its buyout of green hydrogen solutions company Frames Group, which furthers Plug's ambitions of becoming one of world's leading green hydrogen ecosystems.While there's little question that developed countries are pushing for green-energy alternative to fight climate change, it's not yet clear if Plug Power has the solutions that'll be preferred. Even at a $28 share price, we're talking about a company with a greater than $16 billion market cap that's losing money and hasn't yet demonstrated if it can handle rapid scaling. This isn't to say that it won't be able to scale its ecosystem, so much as to point out that its valuation implies everything will go off without a hitch. Rarely is that the case with next-gen technologies and solutions.Although Plug Power is a company people can hope is successful, it has a lot of questions to answer at its current valuation, let alone one that would be 179% higher.","news_type":1},"isVote":1,"tweetType":1,"viewCount":345,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9019813276,"gmtCreate":1648572854376,"gmtModify":1676534356017,"author":{"id":"3578476625539127","authorId":"3578476625539127","name":"Justinslh","avatar":"https://static.tigerbbs.com/4aace6371636c60f0a3a97aacd94721c","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578476625539127","authorIdStr":"3578476625539127"},"themes":[],"htmlText":"iPhone se sales not as expected?","listText":"iPhone se sales not as expected?","text":"iPhone se sales not as expected?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9019813276","repostId":"1127392287","repostType":4,"repost":{"id":"1127392287","pubTimestamp":1648556072,"share":"https://ttm.financial/m/news/1127392287?lang=&edition=fundamental","pubTime":"2022-03-29 20:14","market":"us","language":"en","title":"Apple Stock: $3 Trillion Back in Focus","url":"https://stock-news.laohu8.com/highlight/detail?id=1127392287","media":"Bloomberg","summary":"Stock has risen 11 straight days, adding roughly $400 billionSeen earnings estimates upgraded; defie","content":"<html><head></head><body><ul><li>Stock has risen 11 straight days, adding roughly $400 billion</li><li>Seen earnings estimates upgraded; defies report of output cut</li></ul><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/f80d9929914ce9f818b327a539949945\" tg-width=\"1000\" tg-height=\"666\" referrerpolicy=\"no-referrer\"/><span>Apple iPhone SE 3 smartphones during the sales launch at the Apple Inc. flagship store in New York, U.S., on March 18.Photographer: Gabby Jones/Bloomberg</span></p><p>Apple Inc. shares are heading for their longest winning streak since 2003, when the iPhone hadn’t even launched andNokia Oyjwas still one of the top cellphone makers in the world.</p><p>Shares in the world’s largest company rose 0.2% premarket on Tuesday, extending gains to the 11th straight day -- a rare feat in its 41-year stock market history. During the streak, it has added $407 billion in market value, roughly the size of Walmart Inc.</p><p>Leading the charge in big technology stocks bouncing back after a dismal start to 2022, Apple has seen its earnings estimates being upgraded by 7.2% this year by analysts, much faster than other stocks in the Faang group. Shares have also managed to dodge a Nikkei report about production cuts, leaving the stock just 1% away from covering 2022 losses and 4.7% away from a $3 trillion market value.</p><p><img src=\"https://static.tigerbbs.com/cb13ef164329e3d13c595e46d3f0d2a2\" tg-width=\"930\" tg-height=\"523\" referrerpolicy=\"no-referrer\"/></p><p>The rally in big tech even as 10-year Treasury yields reached 2.5% has left investors scratching their heads. The Cupertino, California-based company is perhaps living up to its reputation as a relative haven in a turbulent time for tech.</p><p>For sales trader Jim Dixon at Mirabaud Securities, it’s the mom-and-pop investors behind the stunning rally. “Quite remarkable for a company trading on more than 28x forward earnings in a rising rates environments with supply chain issues/inflation,” he said.</p><p>Dixon also pointed to the implied volatility of the stock, which is at a discount to realized, commenting that  “investors are effectively saying that it is smooth sailing going forward.”</p><p>What’s more, on Sunday Apple bagged Best Picture Oscar for “CODA,” becoming the first streaming service to win Hollywood’s top award, beating out streaming pioneer Netflix Inc.</p></body></html>","source":"lsy1584095487587","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Apple Stock: $3 Trillion Back in Focus</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nApple Stock: $3 Trillion Back in Focus\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-03-29 20:14 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.bloomberg.com/news/articles/2022-03-29/apple-shares-set-for-the-longest-winning-streak-since-2003?srnd=premium><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Stock has risen 11 straight days, adding roughly $400 billionSeen earnings estimates upgraded; defies report of output cutApple iPhone SE 3 smartphones during the sales launch at the Apple Inc. ...</p>\n\n<a href=\"https://www.bloomberg.com/news/articles/2022-03-29/apple-shares-set-for-the-longest-winning-streak-since-2003?srnd=premium\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AAPL":"苹果"},"source_url":"https://www.bloomberg.com/news/articles/2022-03-29/apple-shares-set-for-the-longest-winning-streak-since-2003?srnd=premium","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1127392287","content_text":"Stock has risen 11 straight days, adding roughly $400 billionSeen earnings estimates upgraded; defies report of output cutApple iPhone SE 3 smartphones during the sales launch at the Apple Inc. flagship store in New York, U.S., on March 18.Photographer: Gabby Jones/BloombergApple Inc. shares are heading for their longest winning streak since 2003, when the iPhone hadn’t even launched andNokia Oyjwas still one of the top cellphone makers in the world.Shares in the world’s largest company rose 0.2% premarket on Tuesday, extending gains to the 11th straight day -- a rare feat in its 41-year stock market history. During the streak, it has added $407 billion in market value, roughly the size of Walmart Inc.Leading the charge in big technology stocks bouncing back after a dismal start to 2022, Apple has seen its earnings estimates being upgraded by 7.2% this year by analysts, much faster than other stocks in the Faang group. Shares have also managed to dodge a Nikkei report about production cuts, leaving the stock just 1% away from covering 2022 losses and 4.7% away from a $3 trillion market value.The rally in big tech even as 10-year Treasury yields reached 2.5% has left investors scratching their heads. The Cupertino, California-based company is perhaps living up to its reputation as a relative haven in a turbulent time for tech.For sales trader Jim Dixon at Mirabaud Securities, it’s the mom-and-pop investors behind the stunning rally. “Quite remarkable for a company trading on more than 28x forward earnings in a rising rates environments with supply chain issues/inflation,” he said.Dixon also pointed to the implied volatility of the stock, which is at a discount to realized, commenting that  “investors are effectively saying that it is smooth sailing going forward.”What’s more, on Sunday Apple bagged Best Picture Oscar for “CODA,” becoming the first streaming service to win Hollywood’s top award, beating out streaming pioneer Netflix Inc.","news_type":1},"isVote":1,"tweetType":1,"viewCount":472,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9010780197,"gmtCreate":1648471713416,"gmtModify":1676534341847,"author":{"id":"3578476625539127","authorId":"3578476625539127","name":"Justinslh","avatar":"https://static.tigerbbs.com/4aace6371636c60f0a3a97aacd94721c","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578476625539127","authorIdStr":"3578476625539127"},"themes":[],"htmlText":"Smoking is bad for health, so is alcohol, sugar and carbon. Change the world back to ape-age and all these problems will be solved.Today, everyone are&nbsp;making informed decisions. &nbsp;Don't need to ban or stop sales with these methods.","listText":"Smoking is bad for health, so is alcohol, sugar and carbon. Change the world back to ape-age and all these problems will be solved.Today, everyone are&nbsp;making informed decisions. &nbsp;Don't need to ban or stop sales with these methods.","text":"Smoking is bad for health, so is alcohol, sugar and carbon. Change the world back to ape-age and all these problems will be solved.Today, everyone are making informed decisions. Don't need to ban or stop sales with these methods.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9010780197","repostId":"2222620860","repostType":4,"isVote":1,"tweetType":1,"viewCount":394,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9010269056,"gmtCreate":1648397104798,"gmtModify":1676534333876,"author":{"id":"3578476625539127","authorId":"3578476625539127","name":"Justinslh","avatar":"https://static.tigerbbs.com/4aace6371636c60f0a3a97aacd94721c","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578476625539127","authorIdStr":"3578476625539127"},"themes":[],"htmlText":"Is the high iPhone price that is driving the profits?&nbsp;","listText":"Is the high iPhone price that is driving the profits?&nbsp;","text":"Is the high iPhone price that is driving the profits?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9010269056","repostId":"1155138099","repostType":4,"repost":{"id":"1155138099","pubTimestamp":1648342031,"share":"https://ttm.financial/m/news/1155138099?lang=&edition=fundamental","pubTime":"2022-03-27 08:47","market":"us","language":"en","title":"Apple: Plan For iPhone Subscriptions Could Be Massive - Here's Why","url":"https://stock-news.laohu8.com/highlight/detail?id=1155138099","media":"seekingalpha","summary":"Bloomberg reported that Apple is considering a hardware subscription strategy for its devices.We dis","content":"<html><head></head><body><ul><li>Bloomberg reported that Apple is considering a hardware subscription strategy for its devices.</li><li>We discuss why it could help Apple penetrate more effectively into Android&#39;s traditional strongholds and take share.</li><li>We also discuss why AAPL stock is a Buy.</li></ul><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/acc9714ab5a74941eaf8758b8b77e3a3\" tg-width=\"750\" tg-height=\"500\" width=\"100%\" height=\"auto\"/><span>PhillDanze/iStock Editorial via Getty Images</span></p><p></p><h2>Investment Thesis</h2><p>Apple Inc. (NASDAQ:AAPL) was reported to be considering a hardware subscription service for its suite of products. So naturally, the attention is on its flagship iPhone segment. Nevertheless, nothing has been confirmed, and plans could continue to be developed or even stalled.</p><p>However, we believe it could mark a significant pivot in Apple&#39;s strategy to reach further into Android&#39;s (GOOGL) (GOOG) installed base. Apple&#39;s 5G launches starting with iPhone 12, have seen tremendous success in the US and China. Furthermore, iPhone 13 has continued its massive momentum. Recent supply chain checks also revealed that it&#39;s trending ahead of estimates, despite the transitory shutdown by its key contract manufacturer Foxconn (OTCPK:HNHAF).</p><p>We discuss why hardware/iPhone subscriptions could be a massive game-changer. We also maintain our Buy rating on AAPL stock. But, we noted a robust recovery from its March bottom, and its price action doesn&#39;t seem ideal to add exposure.</p><p>Therefore, if you are not in a rush, you can consider waiting for the recent spike to be digested first before adding.</p><p><b>AAPL Stock Key Metrics</b></p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/612265ffa4b9faeeddd47fdd0766fca4\" tg-width=\"640\" tg-height=\"384\" width=\"100%\" height=\"auto\"/><span>AAPL stock NTM EBIT valuation (TIKR)</span></p><p></p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/ee1dbf8a24918fcadf0b82caff8e4270\" tg-width=\"640\" tg-height=\"384\" width=\"100%\" height=\"auto\"/><span>AAPL stock consensus price targets Vs. stock performance (TIKR)</span></p><p></p><p>AAPL stock&#39;s NTM EBIT multiple of 22.9x is trading ahead of its 3Y NTM EBIT mean of 20.2x. So, AAPL stock has moved away from the 20x multiple that has supported its stock over the past year.</p><p>Furthermore, the stock has also progressed well ahead of its most conservative price targets ((PTs)) as seen above. Its most conservative PTs have been robust support levels for AAPL stock over time. Therefore, we think the current buy zone is not ideal if you are looking to add exposure. But, if you are not concerned with near-term volatility, its stock is still not significantly overvalued.</p><p>Furthermore, we believe that Apple holds several optionalities that could spur the Street to re-rate its stock. These include its Apple Car project, its burgeoning services segment, and its rapidly growing ad business.</p><h2>Why Apple&#39;s iPhone Subscriptions Could Be A Game-Changer</h2><p>Bloomberg reported that Apple is mulling a subscription service for its hardware, including its iconic iPhone. Therefore, subscribers would only need to pay a monthly fee. Apple would manage the program through a subscriber&#39;s Apple account, similar to how they have subscribed to other Apple services.</p><p>Notably, it&#39;s different from its current installment programs. Bloomberg noted (edited): &#34;The monthly charge wouldn&#39;t be the price of the device split across 12 or 24 months. Rather, it would be a yet-to-be-determined monthly fee that depends on which device the user chooses.&#34;</p><p>We believe that this could be a noteworthy development in Apple&#39;s services strategy. Apple has been moving ahead with monetizing its massive hardware active installed base that has exceeded 1.65B. Of these, it reported that 785M have signed up as subscribers for its suite of services in FQ1&#39;22 (CQ4&#39;21).</p><p>Apple&#39;s premium smartphone leadership has undoubtedly helped it extend its lead in its segment. For example, Counterpoint Research pointed out that Apple has continued to expand its premium segment market share in China. It accentuated thatApple captured 63.5% in the premium segment share in 2021, compared to 55.4% in 2020. Therefore, Apple has capitalized on Huawei&#39;s demise with incredible &#34;ruthlessness,&#34; despite the best efforts from its Chinese smartphone rivals.</p><p>However, according to StatCounter, Android remains the most important mobile OS globally, with adevice share of 71%. Therefore, it&#39;s clear that most users are still equipped with much cheaper Android phones, and Apple has yet to penetrate this segment.</p><p>While the $429 iPhone SE 5G holds promise, the Street has projected just about 30M units this year. Furthermore, DIGITIMES also reported thatApple shipped about 25M to 30M unitsof its previous iPhone SE in 2020 in its first year of release. Moreover, Counterpoint Research also highlighted that it accounted for about &#34;12% of Apple&#39;s total iPhone unit salesfrom its launch in Q2 2020 to Q4 2021 - with Japan and US the biggest markets for the device globally.&#34;</p><p>Therefore, if Apple wants to make its mark in the low to mid-segment and gain share against Android, a subscription service makes tremendous sense. China&#39;s 5G smartphone penetration rate has already reached about 80%. But, the opportunities in the rest of Asia and Europe could offer Apple tremendous potential. Notably, Apple needs to make its iPhone more affordable without impinging on its treasured margins. Bloomberg&#39;s Mark Gurman even suggested that Apple launch a $199 iPhone SE 5G to penetrate the low to mid-tier segment more effectively before its Peek Performance event in March. He emphasized (edited):</p><blockquote><i>A device priced at $200 could make inroads in regions like Africa, South America, and parts of Asia that are currently Android strongholds</i>.</blockquote><blockquote>That would let Apple<i>sign up more customers for services</i>, potentially making a low-end iPhone quite lucrative for Apple in the long run. But so far, the company has steered well clear of that approach.</blockquote><blockquote>In 2013, when carrier subsidies began to disappear and demand for a lower-cost iPhone grew, Apple executives said they wouldn&#39;t release a cheap model just to blindly chase market share. It did put out the lower-end SE in 2016, but the phone was $399-well above the level of many Androids-and the price never came down over the following five years.<i>The company has stuck by Steve Jobs&#39; &#39;don&#39;t ship junk&#39; ethos.</i>-Bloomberg</blockquote><p>Furthermore, the 5G upgrade cycle is still in its early stages and gaining rapid adoption. Counterpoint Research also highlighted in a recent note thatglobal 5G smartphone penetrationsurpassed 4G for the first time in January 2022.</p><p>Therefore, there&#39;s a considerable opportunity for Apple to leverage this 5G wave to encourage switchers from Android to iOS. Hence, we believe a hardware subscription strategy could be massive for the Cupertino company to spur the adoption of its 5G devices.</p><p>We believe that Apple can continue innovating and introducing effective ideas to capture the segment Android has traditionally dominated without necessarily sacrificing its brand value and margins.</p><h2>Is AAPL Stock A Buy, Sell, Or Hold?</h2><p>AAPL stock is slightly overvalued, but not by much. Therefore, if you need a higher margin of safety, you can consider taking a 10-15% haircut.</p><p>Otherwise, if you have a firm conviction of Apple&#39;s execution ability, the current price could offer a suitable opportunity to increase exposure.</p><p>Furthermore, we think Apple has several optionalities that have not been factored into its stock price. And the potential hardware subscription strategy adds to its growing list of monetization potential.</p><p>As such, we reiterate our Buy rating on AAPL stock.</p></body></html>","source":"lsy1638401102509","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Apple: Plan For iPhone Subscriptions Could Be Massive - Here's Why</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nApple: Plan For iPhone Subscriptions Could Be Massive - Here's Why\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-03-27 08:47 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/article/4497874-apple-iphone-subscriptions-could-be-massive><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Bloomberg reported that Apple is considering a hardware subscription strategy for its devices.We discuss why it could help Apple penetrate more effectively into Android's traditional strongholds and ...</p>\n\n<a href=\"https://seekingalpha.com/article/4497874-apple-iphone-subscriptions-could-be-massive\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AAPL":"苹果"},"source_url":"https://seekingalpha.com/article/4497874-apple-iphone-subscriptions-could-be-massive","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1155138099","content_text":"Bloomberg reported that Apple is considering a hardware subscription strategy for its devices.We discuss why it could help Apple penetrate more effectively into Android's traditional strongholds and take share.We also discuss why AAPL stock is a Buy.PhillDanze/iStock Editorial via Getty ImagesInvestment ThesisApple Inc. (NASDAQ:AAPL) was reported to be considering a hardware subscription service for its suite of products. So naturally, the attention is on its flagship iPhone segment. Nevertheless, nothing has been confirmed, and plans could continue to be developed or even stalled.However, we believe it could mark a significant pivot in Apple's strategy to reach further into Android's (GOOGL) (GOOG) installed base. Apple's 5G launches starting with iPhone 12, have seen tremendous success in the US and China. Furthermore, iPhone 13 has continued its massive momentum. Recent supply chain checks also revealed that it's trending ahead of estimates, despite the transitory shutdown by its key contract manufacturer Foxconn (OTCPK:HNHAF).We discuss why hardware/iPhone subscriptions could be a massive game-changer. We also maintain our Buy rating on AAPL stock. But, we noted a robust recovery from its March bottom, and its price action doesn't seem ideal to add exposure.Therefore, if you are not in a rush, you can consider waiting for the recent spike to be digested first before adding.AAPL Stock Key MetricsAAPL stock NTM EBIT valuation (TIKR)AAPL stock consensus price targets Vs. stock performance (TIKR)AAPL stock's NTM EBIT multiple of 22.9x is trading ahead of its 3Y NTM EBIT mean of 20.2x. So, AAPL stock has moved away from the 20x multiple that has supported its stock over the past year.Furthermore, the stock has also progressed well ahead of its most conservative price targets ((PTs)) as seen above. Its most conservative PTs have been robust support levels for AAPL stock over time. Therefore, we think the current buy zone is not ideal if you are looking to add exposure. But, if you are not concerned with near-term volatility, its stock is still not significantly overvalued.Furthermore, we believe that Apple holds several optionalities that could spur the Street to re-rate its stock. These include its Apple Car project, its burgeoning services segment, and its rapidly growing ad business.Why Apple's iPhone Subscriptions Could Be A Game-ChangerBloomberg reported that Apple is mulling a subscription service for its hardware, including its iconic iPhone. Therefore, subscribers would only need to pay a monthly fee. Apple would manage the program through a subscriber's Apple account, similar to how they have subscribed to other Apple services.Notably, it's different from its current installment programs. Bloomberg noted (edited): \"The monthly charge wouldn't be the price of the device split across 12 or 24 months. Rather, it would be a yet-to-be-determined monthly fee that depends on which device the user chooses.\"We believe that this could be a noteworthy development in Apple's services strategy. Apple has been moving ahead with monetizing its massive hardware active installed base that has exceeded 1.65B. Of these, it reported that 785M have signed up as subscribers for its suite of services in FQ1'22 (CQ4'21).Apple's premium smartphone leadership has undoubtedly helped it extend its lead in its segment. For example, Counterpoint Research pointed out that Apple has continued to expand its premium segment market share in China. It accentuated thatApple captured 63.5% in the premium segment share in 2021, compared to 55.4% in 2020. Therefore, Apple has capitalized on Huawei's demise with incredible \"ruthlessness,\" despite the best efforts from its Chinese smartphone rivals.However, according to StatCounter, Android remains the most important mobile OS globally, with adevice share of 71%. Therefore, it's clear that most users are still equipped with much cheaper Android phones, and Apple has yet to penetrate this segment.While the $429 iPhone SE 5G holds promise, the Street has projected just about 30M units this year. Furthermore, DIGITIMES also reported thatApple shipped about 25M to 30M unitsof its previous iPhone SE in 2020 in its first year of release. Moreover, Counterpoint Research also highlighted that it accounted for about \"12% of Apple's total iPhone unit salesfrom its launch in Q2 2020 to Q4 2021 - with Japan and US the biggest markets for the device globally.\"Therefore, if Apple wants to make its mark in the low to mid-segment and gain share against Android, a subscription service makes tremendous sense. China's 5G smartphone penetration rate has already reached about 80%. But, the opportunities in the rest of Asia and Europe could offer Apple tremendous potential. Notably, Apple needs to make its iPhone more affordable without impinging on its treasured margins. Bloomberg's Mark Gurman even suggested that Apple launch a $199 iPhone SE 5G to penetrate the low to mid-tier segment more effectively before its Peek Performance event in March. He emphasized (edited):A device priced at $200 could make inroads in regions like Africa, South America, and parts of Asia that are currently Android strongholds.That would let Applesign up more customers for services, potentially making a low-end iPhone quite lucrative for Apple in the long run. But so far, the company has steered well clear of that approach.In 2013, when carrier subsidies began to disappear and demand for a lower-cost iPhone grew, Apple executives said they wouldn't release a cheap model just to blindly chase market share. It did put out the lower-end SE in 2016, but the phone was $399-well above the level of many Androids-and the price never came down over the following five years.The company has stuck by Steve Jobs' 'don't ship junk' ethos.-BloombergFurthermore, the 5G upgrade cycle is still in its early stages and gaining rapid adoption. Counterpoint Research also highlighted in a recent note thatglobal 5G smartphone penetrationsurpassed 4G for the first time in January 2022.Therefore, there's a considerable opportunity for Apple to leverage this 5G wave to encourage switchers from Android to iOS. Hence, we believe a hardware subscription strategy could be massive for the Cupertino company to spur the adoption of its 5G devices.We believe that Apple can continue innovating and introducing effective ideas to capture the segment Android has traditionally dominated without necessarily sacrificing its brand value and margins.Is AAPL Stock A Buy, Sell, Or Hold?AAPL stock is slightly overvalued, but not by much. Therefore, if you need a higher margin of safety, you can consider taking a 10-15% haircut.Otherwise, if you have a firm conviction of Apple's execution ability, the current price could offer a suitable opportunity to increase exposure.Furthermore, we think Apple has several optionalities that have not been factored into its stock price. And the potential hardware subscription strategy adds to its growing list of monetization potential.As such, we reiterate our Buy rating on AAPL stock.","news_type":1},"isVote":1,"tweetType":1,"viewCount":277,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9010260095,"gmtCreate":1648396920125,"gmtModify":1676534333852,"author":{"id":"3578476625539127","authorId":"3578476625539127","name":"Justinslh","avatar":"https://static.tigerbbs.com/4aace6371636c60f0a3a97aacd94721c","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578476625539127","authorIdStr":"3578476625539127"},"themes":[],"htmlText":"Can name a few other Buffet stocks?","listText":"Can name a few other Buffet stocks?","text":"Can name a few other Buffet stocks?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9010260095","repostId":"2222855376","repostType":4,"repost":{"id":"2222855376","pubTimestamp":1648341227,"share":"https://ttm.financial/m/news/2222855376?lang=&edition=fundamental","pubTime":"2022-03-27 08:33","market":"us","language":"en","title":"Have $1,000? 2 Warren Buffett Stocks to Buy","url":"https://stock-news.laohu8.com/highlight/detail?id=2222855376","media":"Motley Fool","summary":"Through up and down markets, compounding dividends can be a game-changer for long-term investors.","content":"<html><head></head><body><p>Whether you&#39;re an investor just starting out or <a href=\"https://laohu8.com/S/AONE.U\">one</a> who might have a limited budget, it&#39;s a good practice to invest an amount that you&#39;re willing to be without in the short term so that you can build for the long term. If $1,000 is that mark for you, these two Warren Buffett-backed stocks could provide the foundation you want for your long-term investment strategy.</p><p><b>AbbVie</b> ( ABBV 0.66% ) and <b>Verizon Communications</b> ( VZ 0.55% ) offer innovative products in growing markets, combined with a strategy that withstands market volatility, to reward investors with long-term gains. They also carry a special characteristic that is shared by 63% of the stocks owned by Buffett in his <b>Berkshire Hathaway</b> ( BRK.A 1.92% ) ( BRK.B 1.81% ) portfolio.</p><p><img src=\"https://static.tigerbbs.com/139f2005bebaa471067af13c958a38a8\" tg-width=\"700\" tg-height=\"393\" referrerpolicy=\"no-referrer\"/></p><p>Image source: Getty Images.</p><h2>AbbVie: Building a pipeline to keep revenue flowing</h2><p>AbbVie is one of the smallest holdings in Buffett&#39;s Berkshire Hathaway portfolio, at only 0.1% of the portfolio&#39;s total holdings. But that&#39;s the only thing small about this leading innovator in biopharmaceuticals that has seen its stock price grow 53% over the past year -- crushing the <b>S&amp;P 500</b>&#39;s 14.7% one-year return.</p><p>AbbVie has experienced strong growth of its best-selling drug, Humira, which helped the company realize a 22.7% increase in net revenue in 2021. That growth is expected to continue with an 8% increase in sales for Humira during 2022, but could come to a screeching slowdown in 2023. The company estimates a 45% erosion in sales as a result of biosimilar competition entering the U.S. market on the heels of an expiring patent, with a rebound not expected to happen until 2024.</p><p>To offset those losses, the company is depending on a spike in sales of two potential successors to Humira, Rinvoq and Skyrizi. Together these two medications brought in a combined $4.5 billion in 2021 and are expected to reach $15 billion in 2025. AbbVie is also seeing positive results from its Allergan acquisition in 2020, which netted the company Botox, contributing nearly $5 billion to total sales in 2021.</p><p>Going forward, the company has high expectations for a post-COVID rebound in sales of two leading cancer treatment drugs, as well as a pipeline of late-stage programs in cancer treatment. In total, the company has 13 drugs in phase 3 trials across immunology, neuroscience, eye care, oncology, and gastroenterology. Some of these drugs are already approved for certain indications, which could lead to a smoother path toward approval by the U.S. Food and Drug Administration.</p><p>AbbVie also offers a quarterly dividend that can help keep investors engaged during times of trouble. If you include the time before AbbVie was spun off from <b>Abbott Laboratories</b>, the company has been increasing its annual dividend for 50 years, placing it among the elite class of Dividend Kings. At the current share price, the stock&#39;s annual payout of $5.64 per share results in yield of 3.5%. Over the long term, this can be quite a hefty sum due to compounding gains.</p><p>A robust pipeline of drugs combined with a hefty dividend yield of 3.5% that leads most of its big-cap pharma peers makes AbbVie a Buffett-backed stock I&#39;d see no problem investing $1,000 in.</p><h2>Verizon: Checking off boxes to keep investors satisfied</h2><p>Verizon ranks ninth in Buffett&#39;s Berkshire Hathaway portfolio of 47 stocks in terms of portfolio holding and total value. But the company&#39;s investors have not been exempt from the broader market volatility that has impacted tech stocks, as Verizon&#39;s stock price has seen a 15% decline since May of last year.</p><p>Fortunately, CEO Hans Vestberg, who came on board in 2018 after a stint as chief technology officer, has a clear plan in place that could trigger a rebound. It includes reducing the company&#39;s capital intensity to under 12%, growing dividends, paying down debt, and speeding up a timeline for share repurchases.</p><p>Boxes are already being checked off for that plan. Verizon&#39;s Q4 report highlighted a 6.5% year-over-year growth in wireless services revenue, driven by higher revenue per account, meaning existing customers are spending more. Growth is also coming from an increase in subscriptions for wireless and broadband. FiOS (its bundled service for internet, cable, and telephone) finished Q4 of last year with a 5.7% year-over-year spike in revenue, allowing the company to post its best full-year performance for FiOS since 2014.</p><p>The company expects to check off a few more boxes during 2022, starting with a continued quarterly dividend payout of $0.64 per share, to be paid on May 2 to investors of record on April 8. This represents a 5% dividend yield, topping the telecom sector average of 4.36%.</p><p>By year-end, the company is looking to complete an accelerated plan to bring 5G ultra wideband service to an additional 30 major markets serving over 175 million people -- a full year ahead of schedule. And while doing so, Vestberg has his eyes on reducing capital expenditures 9% to $16.5 billion.</p><p>If 2022 goes according to plan, the company is projecting full-year earnings per share that just slightly tops Wall Street estimates. Management is also looking for 9% to 10% growth in services revenue. Ultimately, Verizon&#39;s technological advancements should lead to new revenue, supported by acquisitions in the telecom space and collaborations with companies such as <b><a href=\"https://laohu8.com/S/FB\">Meta Platforms</a></b> (formerly Facebook) as the two work toward building out the immersive digital world referred to as the metaverse.</p><p>Verizon investors should stand to gain from continued dividends and a wireless market that is projected to grow at a 15.4% compound annual rate through 2027. The company&#39;s shares currently trade at a P/E ratio of 9.6, far below the wireless telecom industry average of 30. All in all, Verizon is an excellent opportunity for long-term investors who are looking for somewhere to invest $1,000.</p></body></html>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Have $1,000? 2 Warren Buffett Stocks to Buy</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHave $1,000? 2 Warren Buffett Stocks to Buy\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-03-27 08:33 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2022/03/26/have-1000-2-warren-buffett-stocks-to-buy/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Whether you're an investor just starting out or one who might have a limited budget, it's a good practice to invest an amount that you're willing to be without in the short term so that you can build ...</p>\n\n<a href=\"https://www.fool.com/investing/2022/03/26/have-1000-2-warren-buffett-stocks-to-buy/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4534":"瑞士信贷持仓","BRK.A":"伯克希尔","BK4176":"多领域控股","BK4581":"高盛持仓","BK4550":"红杉资本持仓","BK4533":"AQR资本管理(全球第二大对冲基金)","ABBV":"艾伯维公司","BRK.B":"伯克希尔B","VZ":"威瑞森"},"source_url":"https://www.fool.com/investing/2022/03/26/have-1000-2-warren-buffett-stocks-to-buy/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2222855376","content_text":"Whether you're an investor just starting out or one who might have a limited budget, it's a good practice to invest an amount that you're willing to be without in the short term so that you can build for the long term. If $1,000 is that mark for you, these two Warren Buffett-backed stocks could provide the foundation you want for your long-term investment strategy.AbbVie ( ABBV 0.66% ) and Verizon Communications ( VZ 0.55% ) offer innovative products in growing markets, combined with a strategy that withstands market volatility, to reward investors with long-term gains. They also carry a special characteristic that is shared by 63% of the stocks owned by Buffett in his Berkshire Hathaway ( BRK.A 1.92% ) ( BRK.B 1.81% ) portfolio.Image source: Getty Images.AbbVie: Building a pipeline to keep revenue flowingAbbVie is one of the smallest holdings in Buffett's Berkshire Hathaway portfolio, at only 0.1% of the portfolio's total holdings. But that's the only thing small about this leading innovator in biopharmaceuticals that has seen its stock price grow 53% over the past year -- crushing the S&P 500's 14.7% one-year return.AbbVie has experienced strong growth of its best-selling drug, Humira, which helped the company realize a 22.7% increase in net revenue in 2021. That growth is expected to continue with an 8% increase in sales for Humira during 2022, but could come to a screeching slowdown in 2023. The company estimates a 45% erosion in sales as a result of biosimilar competition entering the U.S. market on the heels of an expiring patent, with a rebound not expected to happen until 2024.To offset those losses, the company is depending on a spike in sales of two potential successors to Humira, Rinvoq and Skyrizi. Together these two medications brought in a combined $4.5 billion in 2021 and are expected to reach $15 billion in 2025. AbbVie is also seeing positive results from its Allergan acquisition in 2020, which netted the company Botox, contributing nearly $5 billion to total sales in 2021.Going forward, the company has high expectations for a post-COVID rebound in sales of two leading cancer treatment drugs, as well as a pipeline of late-stage programs in cancer treatment. In total, the company has 13 drugs in phase 3 trials across immunology, neuroscience, eye care, oncology, and gastroenterology. Some of these drugs are already approved for certain indications, which could lead to a smoother path toward approval by the U.S. Food and Drug Administration.AbbVie also offers a quarterly dividend that can help keep investors engaged during times of trouble. If you include the time before AbbVie was spun off from Abbott Laboratories, the company has been increasing its annual dividend for 50 years, placing it among the elite class of Dividend Kings. At the current share price, the stock's annual payout of $5.64 per share results in yield of 3.5%. Over the long term, this can be quite a hefty sum due to compounding gains.A robust pipeline of drugs combined with a hefty dividend yield of 3.5% that leads most of its big-cap pharma peers makes AbbVie a Buffett-backed stock I'd see no problem investing $1,000 in.Verizon: Checking off boxes to keep investors satisfiedVerizon ranks ninth in Buffett's Berkshire Hathaway portfolio of 47 stocks in terms of portfolio holding and total value. But the company's investors have not been exempt from the broader market volatility that has impacted tech stocks, as Verizon's stock price has seen a 15% decline since May of last year.Fortunately, CEO Hans Vestberg, who came on board in 2018 after a stint as chief technology officer, has a clear plan in place that could trigger a rebound. It includes reducing the company's capital intensity to under 12%, growing dividends, paying down debt, and speeding up a timeline for share repurchases.Boxes are already being checked off for that plan. Verizon's Q4 report highlighted a 6.5% year-over-year growth in wireless services revenue, driven by higher revenue per account, meaning existing customers are spending more. Growth is also coming from an increase in subscriptions for wireless and broadband. FiOS (its bundled service for internet, cable, and telephone) finished Q4 of last year with a 5.7% year-over-year spike in revenue, allowing the company to post its best full-year performance for FiOS since 2014.The company expects to check off a few more boxes during 2022, starting with a continued quarterly dividend payout of $0.64 per share, to be paid on May 2 to investors of record on April 8. This represents a 5% dividend yield, topping the telecom sector average of 4.36%.By year-end, the company is looking to complete an accelerated plan to bring 5G ultra wideband service to an additional 30 major markets serving over 175 million people -- a full year ahead of schedule. And while doing so, Vestberg has his eyes on reducing capital expenditures 9% to $16.5 billion.If 2022 goes according to plan, the company is projecting full-year earnings per share that just slightly tops Wall Street estimates. Management is also looking for 9% to 10% growth in services revenue. Ultimately, Verizon's technological advancements should lead to new revenue, supported by acquisitions in the telecom space and collaborations with companies such as Meta Platforms (formerly Facebook) as the two work toward building out the immersive digital world referred to as the metaverse.Verizon investors should stand to gain from continued dividends and a wireless market that is projected to grow at a 15.4% compound annual rate through 2027. The company's shares currently trade at a P/E ratio of 9.6, far below the wireless telecom industry average of 30. All in all, Verizon is an excellent opportunity for long-term investors who are looking for somewhere to invest $1,000.","news_type":1},"isVote":1,"tweetType":1,"viewCount":236,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9010287279,"gmtCreate":1648396789131,"gmtModify":1676534333844,"author":{"id":"3578476625539127","authorId":"3578476625539127","name":"Justinslh","avatar":"https://static.tigerbbs.com/4aace6371636c60f0a3a97aacd94721c","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578476625539127","authorIdStr":"3578476625539127"},"themes":[],"htmlText":"What about a dozen others too?","listText":"What about a dozen others too?","text":"What about a dozen others too?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9010287279","repostId":"2222855381","repostType":4,"repost":{"id":"2222855381","pubTimestamp":1648341420,"share":"https://ttm.financial/m/news/2222855381?lang=&edition=fundamental","pubTime":"2022-03-27 08:37","market":"us","language":"en","title":"2 Stocks I'm Buying No Matter What the Stock Market Does Next","url":"https://stock-news.laohu8.com/highlight/detail?id=2222855381","media":"Motley Fool","summary":"Investors should use the current market volatility to scoop up these companies and hold them for the next decade.","content":"<html><head></head><body><p>The stock market is known for its volatility, but it might as well be giving investors whiplash because of how fast it&#39;s moving up and down. The <b>Nasdaq Composite</b> index sank in the first three months of 2022, falling 20% by mid-March. After that, it shot right back up. As of this writing, it&#39;s only down 10% year to date.</p><p>Predicting where the market will go over the next week or month is next to impossible, so buying companies that you feel confident in for the next five years is often the best strategy. With this in mind, you should have a watch list full of stocks that you are ready to buy no matter what the stock market does next.</p><p>My watch list is chock-full of companies right now, but <b>Figs </b>( FIGS -2.25% ) and <b>Fiverr</b> ( FVRR -4.12% ) are near the top of it.</p><p><img src=\"https://static.tigerbbs.com/67490ad97506e19cacb499d01cca8217\" tg-width=\"700\" tg-height=\"466\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"/></p><p>Image source: Figs.</p><h2>1. Figs</h2><p>Figs is uniquely positioned with <a href=\"https://laohu8.com/S/AONE.U\">one</a> of the strongest brands in a niche market. The company sells hospital scrubs for nurses and other healthcare professionals, but it carries two characteristics: a strong brand name that no competitor has been able to reach as well as a gold-standard product in the industry. The company&#39;s Net Promoter Score (NPS) -- which measures customer satisfaction on a scale of -100 to 100, with a score of 70 being considered &#34;world-class&#34; -- was over 80 at the end of 2021. This is phenomenal, beating out even some of the strongest brands. <b>Peloton</b> only has an NPS of 68.</p><p>Figs&#39; scrubs are much higher quality than its competition. The company realizes that its customers wear its products every day, often for 10 or more hours, so it has prioritized comfort and utility. As a result of this quality and brand name, Figs has been able to price its products at a pretty penny: The company achieved a nearly 72% gross margin in 2021.</p><p>To be clear, Figs does face stiff competition and pushback from price-sensitive buyers. Jaanuu, another scrubs maker, can be more attractive to the price-sensitive consumer, and with Figs&#39; scrubs being a few dollars more expensive than those of its counterpart, that could hurt the business. Still, Jaanuu has yet to reach Figs&#39; level of brand recognition, which is a major selling point.</p><p>The company&#39;s adoption by healthcare workers has been nothing short of impressive. Figs had 1.9 million active customers in Q4 2021 who generated nearly $420 million in revenue for the year, up 60% from a year ago. And now, the company has expanded into a wider array of products, offering everything from outerwear to lifestyle products like sweatshirts and joggers that can be worn outside of work. Lifestyle products only represented 17% of revenue in Q4, but management believes this segment is just getting started.</p><p>With the U.S. healthcare apparel market worth $12 billion, Figs still has plenty of room to grow. The company also has aspirations to expand internationally, which could push its opportunity to $79 billion.</p><p>There is no doubt that the company&#39;s potential is immense, and considering Figs is trading at just 8.6 times sales -- not much higher than other apparel companies like <b>Lululemon</b> -- it&#39;s near the top of my watch list, and it should be on yours too.</p><h2>2. Fiverr</h2><p>Fiverr has been hammered recently, falling more than 77% from its all-time high set in January 2021. The company is one of the leading platforms for connecting freelancers with businesses, so it naturally gained popularity during the COVID-19 pandemic.</p><p>However, as the world began to reopen, many investors lost faith in the company, thinking that demand for its services would fall. On the contrary, Fiverr has seen continued success. Fiverr posted record revenue of $298 million for 2021, which grew a staggering 57% from 2020.</p><p>A driver of this was the company&#39;s take rate increase -- the portion of revenue that Fiverr keeps to itself from every transaction -- which is now over 29%. Considering that active buyers on the platform grew 23% year over year at the end of 2021, the value that Fiverr brings to its buyers seems to be worth the price hike.</p><p>The company did lose $65 million in 2021, but this is not as worrisome as one might think. Its $35.4 million in 2021 free cash flow can fuel most of this loss, and the $192 million in cash and securities on its balance sheet could help fund the rest.</p><p>It&#39;s clear that Fiverr&#39;s service is still valuable to millions of businesses around the world, and that might not change as long as freelancers continue to enjoy working from home. At nine times sales, the stock looks especially appealing today. Investors might want to consider owning this company, even if the market continues to swing up and down over the coming months.</p></body></html>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>2 Stocks I'm Buying No Matter What the Stock Market Does Next</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n2 Stocks I'm Buying No Matter What the Stock Market Does Next\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-03-27 08:37 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2022/03/26/2-stocks-im-buying-no-matter-what-the-stock-market/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The stock market is known for its volatility, but it might as well be giving investors whiplash because of how fast it's moving up and down. The Nasdaq Composite index sank in the first three months ...</p>\n\n<a href=\"https://www.fool.com/investing/2022/03/26/2-stocks-im-buying-no-matter-what-the-stock-market/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4539":"次新股","BK4198":"医疗保健用品","BK4535":"淡马锡持仓","FIGS":"FIGS, Inc.","BK4561":"索罗斯持仓","FVRR":"Fiverr International Ltd."},"source_url":"https://www.fool.com/investing/2022/03/26/2-stocks-im-buying-no-matter-what-the-stock-market/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2222855381","content_text":"The stock market is known for its volatility, but it might as well be giving investors whiplash because of how fast it's moving up and down. The Nasdaq Composite index sank in the first three months of 2022, falling 20% by mid-March. After that, it shot right back up. As of this writing, it's only down 10% year to date.Predicting where the market will go over the next week or month is next to impossible, so buying companies that you feel confident in for the next five years is often the best strategy. With this in mind, you should have a watch list full of stocks that you are ready to buy no matter what the stock market does next.My watch list is chock-full of companies right now, but Figs ( FIGS -2.25% ) and Fiverr ( FVRR -4.12% ) are near the top of it.Image source: Figs.1. FigsFigs is uniquely positioned with one of the strongest brands in a niche market. The company sells hospital scrubs for nurses and other healthcare professionals, but it carries two characteristics: a strong brand name that no competitor has been able to reach as well as a gold-standard product in the industry. The company's Net Promoter Score (NPS) -- which measures customer satisfaction on a scale of -100 to 100, with a score of 70 being considered \"world-class\" -- was over 80 at the end of 2021. This is phenomenal, beating out even some of the strongest brands. Peloton only has an NPS of 68.Figs' scrubs are much higher quality than its competition. The company realizes that its customers wear its products every day, often for 10 or more hours, so it has prioritized comfort and utility. As a result of this quality and brand name, Figs has been able to price its products at a pretty penny: The company achieved a nearly 72% gross margin in 2021.To be clear, Figs does face stiff competition and pushback from price-sensitive buyers. Jaanuu, another scrubs maker, can be more attractive to the price-sensitive consumer, and with Figs' scrubs being a few dollars more expensive than those of its counterpart, that could hurt the business. Still, Jaanuu has yet to reach Figs' level of brand recognition, which is a major selling point.The company's adoption by healthcare workers has been nothing short of impressive. Figs had 1.9 million active customers in Q4 2021 who generated nearly $420 million in revenue for the year, up 60% from a year ago. And now, the company has expanded into a wider array of products, offering everything from outerwear to lifestyle products like sweatshirts and joggers that can be worn outside of work. Lifestyle products only represented 17% of revenue in Q4, but management believes this segment is just getting started.With the U.S. healthcare apparel market worth $12 billion, Figs still has plenty of room to grow. The company also has aspirations to expand internationally, which could push its opportunity to $79 billion.There is no doubt that the company's potential is immense, and considering Figs is trading at just 8.6 times sales -- not much higher than other apparel companies like Lululemon -- it's near the top of my watch list, and it should be on yours too.2. FiverrFiverr has been hammered recently, falling more than 77% from its all-time high set in January 2021. The company is one of the leading platforms for connecting freelancers with businesses, so it naturally gained popularity during the COVID-19 pandemic.However, as the world began to reopen, many investors lost faith in the company, thinking that demand for its services would fall. On the contrary, Fiverr has seen continued success. Fiverr posted record revenue of $298 million for 2021, which grew a staggering 57% from 2020.A driver of this was the company's take rate increase -- the portion of revenue that Fiverr keeps to itself from every transaction -- which is now over 29%. Considering that active buyers on the platform grew 23% year over year at the end of 2021, the value that Fiverr brings to its buyers seems to be worth the price hike.The company did lose $65 million in 2021, but this is not as worrisome as one might think. Its $35.4 million in 2021 free cash flow can fuel most of this loss, and the $192 million in cash and securities on its balance sheet could help fund the rest.It's clear that Fiverr's service is still valuable to millions of businesses around the world, and that might not change as long as freelancers continue to enjoy working from home. At nine times sales, the stock looks especially appealing today. Investors might want to consider owning this company, even if the market continues to swing up and down over the coming months.","news_type":1},"isVote":1,"tweetType":1,"viewCount":119,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9010156139,"gmtCreate":1648303292472,"gmtModify":1676534326485,"author":{"id":"3578476625539127","authorId":"3578476625539127","name":"Justinslh","avatar":"https://static.tigerbbs.com/4aace6371636c60f0a3a97aacd94721c","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578476625539127","authorIdStr":"3578476625539127"},"themes":[],"htmlText":"Maybe will nvr be","listText":"Maybe will nvr be","text":"Maybe will nvr be","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9010156139","repostId":"1196027616","repostType":4,"repost":{"id":"1196027616","pubTimestamp":1648255536,"share":"https://ttm.financial/m/news/1196027616?lang=&edition=fundamental","pubTime":"2022-03-26 08:45","market":"us","language":"en","title":"Stock-Market Investors Should Watch the \"Best Leading Indicator of Trouble Ahead\"","url":"https://stock-news.laohu8.com/highlight/detail?id=1196027616","media":"MarketWatch","summary":"Investors have been watching the U.S. Treasury yield curve for inversions, a reliable predictor of p","content":"<html><head></head><body><p>Investors have been watching the U.S. Treasury yield curve for inversions, a reliable predictor of past economic downturns.</p><p>They don’t always agree on which part of the curve is best to watch though.</p><p>“Yield curve inversion, and flatting, has been at the forefront for everyone,” said Pete Duffy, chief investment officer at Penn Capital Management Company, in Philadelphia, by phone.</p><p>“That’s because the Fed is so active and rates suddenly have gone up so quickly.”</p><p>An inversion of the yield curve happens when rates on longer bonds fall below those of shorter-term debt, a sign that investors think economic woes could lie ahead. Fears of an economic slowdown have been mounting as the Federal Reserve starts to tighten financial conditions while Russia’s Ukraine invasion threatens to keep key drivers of U.S. inflation high.</p><p>Lately, the attention has been on the 10-year Treasury yield TMUBMUSD10Y, 2.478% and shorter 2-year yield, where the spread fell to 13 basis points on Tuesday, up from a high of about 130 basis points five months ago.</p><p>Read: The yield curve is speeding toward inversion — here’s what investors need to know</p><p>But that’s not the only plot on the Treasury yield curve investors closely watch. The Treasury Department sells securities that mature in a range from a few days to 30 years, providing a lot of plots on the curve to follow.</p><p>“The focus has been on the 10s and 2s,” said Mark Heppenstall, chief investment officer at Penn Mutual Asset Management, in Horsham, Penn, a northern suburb of Philadelphia.</p><p>“I will hold out until the 10s to 3-month bills inverts before I turn too negative on the economic outlook,” he said, calling it “the best leading indicator of trouble ahead.”</p><h2>Watch 10-year, 3-month</h2><p>Instead of falling, that spread climbed in March, continuing its path higher since turning negative two years ago at the onset of the pandemic (see chart).</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/7fe28818cd1806ee5afd5519332cf483\" tg-width=\"700\" tg-height=\"579\" width=\"100%\" height=\"auto\"/><span>The 3-month to 10-year yield spread is climbing Bloomberg data, Goelzer Investment Management</span></p><p>“The 3-month Treasury bill really tracks the Federal Reserve’s target rate,” said Gavin Stephens, director of portfolio management at Goelzer Investment Management in Indiana, by phone.</p><p>“So it gives you a more immediate picture of if the Federal Reserve has entered a restrictive state in terms of monetary policy and, thus, giving the possibility that economic growth is going to contract, which would be bad for stocks.”</p><p>Stocks were lower Friday, but with the S&amp;P 500 index SPX, +0.51% and the Nasdaq Composite Index COMP, -0.16% still up about 1.2% on the week. The three major indexes were 4.5% to 10.1% lower so far in 2022, according to FactSet.</p><p>By watching the 10s and 2s TMUBMUSD02Y, 2.280% spread, “You are looking at the expectations of where Fed Reserve interest rate policy is going to be over a period of two years,” Stephens said. “So, effectively, it’s working with a lag.”</p><p>On average, from the time the 10s and 2s curve inverts, until “there’s a recession, it’s almost two years,” he said, predicting that with unemployment recently pegged around 3.8% that, “this curve is going to invert when the economy is really strong.”</p><p>The Federal Reserve Bank of San Francisco also called the 3-month TMUBMUSD03M, 0.535% and 10-year curve relationship its “preferred spread measure because it has the strongest predictive power for future recessions,” such as in 2019, back when the yield curve was more regularly flashing recession warning signs.</p><p>“Did it see COVID coming?” Duffy said, of earlier yield curve inversions.</p><p>A more likely catalyst was that investors already were on a recession watch, with the American economy in its longest expansion period on record.</p><p>“There are a number of these curves that you need to look at in totality,” Duffy said. “We’ve always said look at many signals.”</p></body></html>","source":"lsy1603348471595","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock-Market Investors Should Watch the \"Best Leading Indicator of Trouble Ahead\"</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock-Market Investors Should Watch the \"Best Leading Indicator of Trouble Ahead\"\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-03-26 08:45 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.marketwatch.com/story/why-this-part-of-the-treasury-yield-curve-may-be-the-best-leading-indicator-of-trouble-ahead-11648210025?mod=home-page><strong>MarketWatch</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Investors have been watching the U.S. Treasury yield curve for inversions, a reliable predictor of past economic downturns.They don’t always agree on which part of the curve is best to watch though.“...</p>\n\n<a href=\"https://www.marketwatch.com/story/why-this-part-of-the-treasury-yield-curve-may-be-the-best-leading-indicator-of-trouble-ahead-11648210025?mod=home-page\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".SPX":"S&P 500 Index",".DJI":"道琼斯",".IXIC":"NASDAQ Composite"},"source_url":"https://www.marketwatch.com/story/why-this-part-of-the-treasury-yield-curve-may-be-the-best-leading-indicator-of-trouble-ahead-11648210025?mod=home-page","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1196027616","content_text":"Investors have been watching the U.S. Treasury yield curve for inversions, a reliable predictor of past economic downturns.They don’t always agree on which part of the curve is best to watch though.“Yield curve inversion, and flatting, has been at the forefront for everyone,” said Pete Duffy, chief investment officer at Penn Capital Management Company, in Philadelphia, by phone.“That’s because the Fed is so active and rates suddenly have gone up so quickly.”An inversion of the yield curve happens when rates on longer bonds fall below those of shorter-term debt, a sign that investors think economic woes could lie ahead. Fears of an economic slowdown have been mounting as the Federal Reserve starts to tighten financial conditions while Russia’s Ukraine invasion threatens to keep key drivers of U.S. inflation high.Lately, the attention has been on the 10-year Treasury yield TMUBMUSD10Y, 2.478% and shorter 2-year yield, where the spread fell to 13 basis points on Tuesday, up from a high of about 130 basis points five months ago.Read: The yield curve is speeding toward inversion — here’s what investors need to knowBut that’s not the only plot on the Treasury yield curve investors closely watch. The Treasury Department sells securities that mature in a range from a few days to 30 years, providing a lot of plots on the curve to follow.“The focus has been on the 10s and 2s,” said Mark Heppenstall, chief investment officer at Penn Mutual Asset Management, in Horsham, Penn, a northern suburb of Philadelphia.“I will hold out until the 10s to 3-month bills inverts before I turn too negative on the economic outlook,” he said, calling it “the best leading indicator of trouble ahead.”Watch 10-year, 3-monthInstead of falling, that spread climbed in March, continuing its path higher since turning negative two years ago at the onset of the pandemic (see chart).The 3-month to 10-year yield spread is climbing Bloomberg data, Goelzer Investment Management“The 3-month Treasury bill really tracks the Federal Reserve’s target rate,” said Gavin Stephens, director of portfolio management at Goelzer Investment Management in Indiana, by phone.“So it gives you a more immediate picture of if the Federal Reserve has entered a restrictive state in terms of monetary policy and, thus, giving the possibility that economic growth is going to contract, which would be bad for stocks.”Stocks were lower Friday, but with the S&P 500 index SPX, +0.51% and the Nasdaq Composite Index COMP, -0.16% still up about 1.2% on the week. The three major indexes were 4.5% to 10.1% lower so far in 2022, according to FactSet.By watching the 10s and 2s TMUBMUSD02Y, 2.280% spread, “You are looking at the expectations of where Fed Reserve interest rate policy is going to be over a period of two years,” Stephens said. “So, effectively, it’s working with a lag.”On average, from the time the 10s and 2s curve inverts, until “there’s a recession, it’s almost two years,” he said, predicting that with unemployment recently pegged around 3.8% that, “this curve is going to invert when the economy is really strong.”The Federal Reserve Bank of San Francisco also called the 3-month TMUBMUSD03M, 0.535% and 10-year curve relationship its “preferred spread measure because it has the strongest predictive power for future recessions,” such as in 2019, back when the yield curve was more regularly flashing recession warning signs.“Did it see COVID coming?” Duffy said, of earlier yield curve inversions.A more likely catalyst was that investors already were on a recession watch, with the American economy in its longest expansion period on record.“There are a number of these curves that you need to look at in totality,” Duffy said. “We’ve always said look at many signals.”","news_type":1},"isVote":1,"tweetType":1,"viewCount":184,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9010158405,"gmtCreate":1648303083647,"gmtModify":1676534326470,"author":{"id":"3578476625539127","authorId":"3578476625539127","name":"Justinslh","avatar":"https://static.tigerbbs.com/4aace6371636c60f0a3a97aacd94721c","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578476625539127","authorIdStr":"3578476625539127"},"themes":[],"htmlText":"What trouble ahead?","listText":"What trouble ahead?","text":"What trouble ahead?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9010158405","repostId":"1196027616","repostType":4,"repost":{"id":"1196027616","pubTimestamp":1648255536,"share":"https://ttm.financial/m/news/1196027616?lang=&edition=fundamental","pubTime":"2022-03-26 08:45","market":"us","language":"en","title":"Stock-Market Investors Should Watch the \"Best Leading Indicator of Trouble Ahead\"","url":"https://stock-news.laohu8.com/highlight/detail?id=1196027616","media":"MarketWatch","summary":"Investors have been watching the U.S. Treasury yield curve for inversions, a reliable predictor of p","content":"<html><head></head><body><p>Investors have been watching the U.S. Treasury yield curve for inversions, a reliable predictor of past economic downturns.</p><p>They don’t always agree on which part of the curve is best to watch though.</p><p>“Yield curve inversion, and flatting, has been at the forefront for everyone,” said Pete Duffy, chief investment officer at Penn Capital Management Company, in Philadelphia, by phone.</p><p>“That’s because the Fed is so active and rates suddenly have gone up so quickly.”</p><p>An inversion of the yield curve happens when rates on longer bonds fall below those of shorter-term debt, a sign that investors think economic woes could lie ahead. Fears of an economic slowdown have been mounting as the Federal Reserve starts to tighten financial conditions while Russia’s Ukraine invasion threatens to keep key drivers of U.S. inflation high.</p><p>Lately, the attention has been on the 10-year Treasury yield TMUBMUSD10Y, 2.478% and shorter 2-year yield, where the spread fell to 13 basis points on Tuesday, up from a high of about 130 basis points five months ago.</p><p>Read: The yield curve is speeding toward inversion — here’s what investors need to know</p><p>But that’s not the only plot on the Treasury yield curve investors closely watch. The Treasury Department sells securities that mature in a range from a few days to 30 years, providing a lot of plots on the curve to follow.</p><p>“The focus has been on the 10s and 2s,” said Mark Heppenstall, chief investment officer at Penn Mutual Asset Management, in Horsham, Penn, a northern suburb of Philadelphia.</p><p>“I will hold out until the 10s to 3-month bills inverts before I turn too negative on the economic outlook,” he said, calling it “the best leading indicator of trouble ahead.”</p><h2>Watch 10-year, 3-month</h2><p>Instead of falling, that spread climbed in March, continuing its path higher since turning negative two years ago at the onset of the pandemic (see chart).</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/7fe28818cd1806ee5afd5519332cf483\" tg-width=\"700\" tg-height=\"579\" width=\"100%\" height=\"auto\"/><span>The 3-month to 10-year yield spread is climbing Bloomberg data, Goelzer Investment Management</span></p><p>“The 3-month Treasury bill really tracks the Federal Reserve’s target rate,” said Gavin Stephens, director of portfolio management at Goelzer Investment Management in Indiana, by phone.</p><p>“So it gives you a more immediate picture of if the Federal Reserve has entered a restrictive state in terms of monetary policy and, thus, giving the possibility that economic growth is going to contract, which would be bad for stocks.”</p><p>Stocks were lower Friday, but with the S&amp;P 500 index SPX, +0.51% and the Nasdaq Composite Index COMP, -0.16% still up about 1.2% on the week. The three major indexes were 4.5% to 10.1% lower so far in 2022, according to FactSet.</p><p>By watching the 10s and 2s TMUBMUSD02Y, 2.280% spread, “You are looking at the expectations of where Fed Reserve interest rate policy is going to be over a period of two years,” Stephens said. “So, effectively, it’s working with a lag.”</p><p>On average, from the time the 10s and 2s curve inverts, until “there’s a recession, it’s almost two years,” he said, predicting that with unemployment recently pegged around 3.8% that, “this curve is going to invert when the economy is really strong.”</p><p>The Federal Reserve Bank of San Francisco also called the 3-month TMUBMUSD03M, 0.535% and 10-year curve relationship its “preferred spread measure because it has the strongest predictive power for future recessions,” such as in 2019, back when the yield curve was more regularly flashing recession warning signs.</p><p>“Did it see COVID coming?” Duffy said, of earlier yield curve inversions.</p><p>A more likely catalyst was that investors already were on a recession watch, with the American economy in its longest expansion period on record.</p><p>“There are a number of these curves that you need to look at in totality,” Duffy said. “We’ve always said look at many signals.”</p></body></html>","source":"lsy1603348471595","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock-Market Investors Should Watch the \"Best Leading Indicator of Trouble Ahead\"</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock-Market Investors Should Watch the \"Best Leading Indicator of Trouble Ahead\"\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-03-26 08:45 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.marketwatch.com/story/why-this-part-of-the-treasury-yield-curve-may-be-the-best-leading-indicator-of-trouble-ahead-11648210025?mod=home-page><strong>MarketWatch</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Investors have been watching the U.S. Treasury yield curve for inversions, a reliable predictor of past economic downturns.They don’t always agree on which part of the curve is best to watch though.“...</p>\n\n<a href=\"https://www.marketwatch.com/story/why-this-part-of-the-treasury-yield-curve-may-be-the-best-leading-indicator-of-trouble-ahead-11648210025?mod=home-page\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".SPX":"S&P 500 Index",".DJI":"道琼斯",".IXIC":"NASDAQ Composite"},"source_url":"https://www.marketwatch.com/story/why-this-part-of-the-treasury-yield-curve-may-be-the-best-leading-indicator-of-trouble-ahead-11648210025?mod=home-page","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1196027616","content_text":"Investors have been watching the U.S. Treasury yield curve for inversions, a reliable predictor of past economic downturns.They don’t always agree on which part of the curve is best to watch though.“Yield curve inversion, and flatting, has been at the forefront for everyone,” said Pete Duffy, chief investment officer at Penn Capital Management Company, in Philadelphia, by phone.“That’s because the Fed is so active and rates suddenly have gone up so quickly.”An inversion of the yield curve happens when rates on longer bonds fall below those of shorter-term debt, a sign that investors think economic woes could lie ahead. Fears of an economic slowdown have been mounting as the Federal Reserve starts to tighten financial conditions while Russia’s Ukraine invasion threatens to keep key drivers of U.S. inflation high.Lately, the attention has been on the 10-year Treasury yield TMUBMUSD10Y, 2.478% and shorter 2-year yield, where the spread fell to 13 basis points on Tuesday, up from a high of about 130 basis points five months ago.Read: The yield curve is speeding toward inversion — here’s what investors need to knowBut that’s not the only plot on the Treasury yield curve investors closely watch. The Treasury Department sells securities that mature in a range from a few days to 30 years, providing a lot of plots on the curve to follow.“The focus has been on the 10s and 2s,” said Mark Heppenstall, chief investment officer at Penn Mutual Asset Management, in Horsham, Penn, a northern suburb of Philadelphia.“I will hold out until the 10s to 3-month bills inverts before I turn too negative on the economic outlook,” he said, calling it “the best leading indicator of trouble ahead.”Watch 10-year, 3-monthInstead of falling, that spread climbed in March, continuing its path higher since turning negative two years ago at the onset of the pandemic (see chart).The 3-month to 10-year yield spread is climbing Bloomberg data, Goelzer Investment Management“The 3-month Treasury bill really tracks the Federal Reserve’s target rate,” said Gavin Stephens, director of portfolio management at Goelzer Investment Management in Indiana, by phone.“So it gives you a more immediate picture of if the Federal Reserve has entered a restrictive state in terms of monetary policy and, thus, giving the possibility that economic growth is going to contract, which would be bad for stocks.”Stocks were lower Friday, but with the S&P 500 index SPX, +0.51% and the Nasdaq Composite Index COMP, -0.16% still up about 1.2% on the week. The three major indexes were 4.5% to 10.1% lower so far in 2022, according to FactSet.By watching the 10s and 2s TMUBMUSD02Y, 2.280% spread, “You are looking at the expectations of where Fed Reserve interest rate policy is going to be over a period of two years,” Stephens said. “So, effectively, it’s working with a lag.”On average, from the time the 10s and 2s curve inverts, until “there’s a recession, it’s almost two years,” he said, predicting that with unemployment recently pegged around 3.8% that, “this curve is going to invert when the economy is really strong.”The Federal Reserve Bank of San Francisco also called the 3-month TMUBMUSD03M, 0.535% and 10-year curve relationship its “preferred spread measure because it has the strongest predictive power for future recessions,” such as in 2019, back when the yield curve was more regularly flashing recession warning signs.“Did it see COVID coming?” Duffy said, of earlier yield curve inversions.A more likely catalyst was that investors already were on a recession watch, with the American economy in its longest expansion period on record.“There are a number of these curves that you need to look at in totality,” Duffy said. “We’ve always said look at many signals.”","news_type":1},"isVote":1,"tweetType":1,"viewCount":275,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9010012278,"gmtCreate":1648203981692,"gmtModify":1676534316820,"author":{"id":"3578476625539127","authorId":"3578476625539127","name":"Justinslh","avatar":"https://static.tigerbbs.com/4aace6371636c60f0a3a97aacd94721c","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578476625539127","authorIdStr":"3578476625539127"},"themes":[],"htmlText":"Up&nbsp;","listText":"Up&nbsp;","text":"Up","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9010012278","repostId":"1153990586","repostType":4,"isVote":1,"tweetType":1,"viewCount":103,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9010016280,"gmtCreate":1648203764375,"gmtModify":1676534316789,"author":{"id":"3578476625539127","authorId":"3578476625539127","name":"Justinslh","avatar":"https://static.tigerbbs.com/4aace6371636c60f0a3a97aacd94721c","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578476625539127","authorIdStr":"3578476625539127"},"themes":[],"htmlText":"Nice","listText":"Nice","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9010016280","repostId":"2222003226","repostType":4,"isVote":1,"tweetType":1,"viewCount":93,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":106479075,"gmtCreate":1620141969797,"gmtModify":1704339287510,"author":{"id":"3578476625539127","authorId":"3578476625539127","name":"Justinslh","avatar":"https://static.tigerbbs.com/4aace6371636c60f0a3a97aacd94721c","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578476625539127","authorIdStr":"3578476625539127"},"themes":[],"htmlText":"?‍♂️","listText":"?‍♂️","text":"?‍♂️","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/106479075","repostId":"1140575890","repostType":4,"repost":{"id":"1140575890","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1620141444,"share":"https://ttm.financial/m/news/1140575890?lang=&edition=fundamental","pubTime":"2021-05-04 23:17","market":"us","language":"en","title":"Yellen says interest rates may have to rise somewhat to make sure economy doesn't overheat","url":"https://stock-news.laohu8.com/highlight/detail?id=1140575890","media":"Tiger Newspress","summary":"(May 4) Treasury Secretary Janet Yellen conceded Tuesday that interest rates may have to rise to kee","content":"<p>(May 4)&nbsp;Treasury Secretary Janet Yellen conceded Tuesday that interest rates may have to rise to keep a lid on the burgeoning growth of the U.S. economy brought on by trillions in government stimulus spending.</p><p>\"It may be that interest rates will have to rise somewhat to make sure that our economy doesn't overheat,\" Yellen said during a economic seminar presented by Th Atlantic. \"Even though additional spending is relatively small to the size of the economy, it could causae some very modest increases in interest rates.\"</p><p>\"But these are investments our economy needs to be competitive and productive,\" she added.</p><p>Nasdaq fell&nbsp;over 2%&nbsp;for&nbsp;now.</p><p><img src=\"https://static.tigerbbs.com/de3525661b3a7db28a0797ab745db67b\" tg-width=\"629\" tg-height=\"479\" referrerpolicy=\"no-referrer\"><img src=\"https://static.tigerbbs.com/ec61efef423e545861c0ca0126af9332\" tg-width=\"1866\" tg-height=\"894\" referrerpolicy=\"no-referrer\"></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Yellen says interest rates may have to rise somewhat to make sure economy doesn't overheat</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nYellen says interest rates may have to rise somewhat to make sure economy doesn't overheat\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-05-04 23:17</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>(May 4)&nbsp;Treasury Secretary Janet Yellen conceded Tuesday that interest rates may have to rise to keep a lid on the burgeoning growth of the U.S. economy brought on by trillions in government stimulus spending.</p><p>\"It may be that interest rates will have to rise somewhat to make sure that our economy doesn't overheat,\" Yellen said during a economic seminar presented by Th Atlantic. \"Even though additional spending is relatively small to the size of the economy, it could causae some very modest increases in interest rates.\"</p><p>\"But these are investments our economy needs to be competitive and productive,\" she added.</p><p>Nasdaq fell&nbsp;over 2%&nbsp;for&nbsp;now.</p><p><img src=\"https://static.tigerbbs.com/de3525661b3a7db28a0797ab745db67b\" tg-width=\"629\" tg-height=\"479\" referrerpolicy=\"no-referrer\"><img src=\"https://static.tigerbbs.com/ec61efef423e545861c0ca0126af9332\" tg-width=\"1866\" tg-height=\"894\" referrerpolicy=\"no-referrer\"></p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".SPX":"S&P 500 Index","SPY":"标普500ETF",".DJI":"道琼斯",".IXIC":"NASDAQ Composite"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1140575890","content_text":"(May 4) Treasury Secretary Janet Yellen conceded Tuesday that interest rates may have to rise to keep a lid on the burgeoning growth of the U.S. economy brought on by trillions in government stimulus spending.\"It may be that interest rates will have to rise somewhat to make sure that our economy doesn't overheat,\" Yellen said during a economic seminar presented by Th Atlantic. \"Even though additional spending is relatively small to the size of the economy, it could causae some very modest increases in interest rates.\"\"But these are investments our economy needs to be competitive and productive,\" she added.Nasdaq fell over 2% for now.","news_type":1},"isVote":1,"tweetType":1,"viewCount":311,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":109648921,"gmtCreate":1619695045063,"gmtModify":1704728126325,"author":{"id":"3578476625539127","authorId":"3578476625539127","name":"Justinslh","avatar":"https://static.tigerbbs.com/4aace6371636c60f0a3a97aacd94721c","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578476625539127","authorIdStr":"3578476625539127"},"themes":[],"htmlText":"$ make $","listText":"$ make $","text":"$ make $","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/109648921","repostId":"1104198438","repostType":4,"repost":{"id":"1104198438","pubTimestamp":1619623222,"share":"https://ttm.financial/m/news/1104198438?lang=&edition=fundamental","pubTime":"2021-04-28 23:20","market":"us","language":"en","title":"Here’s how Warren Buffett’s top investments fared during the pandemic","url":"https://stock-news.laohu8.com/highlight/detail?id=1104198438","media":"Yahoo","summary":"Plenty of Berkshire Hathaway's (BRK-A,BRK-B) top stock picks have been home runs during and prior to","content":"<p>Plenty of Berkshire Hathaway's (BRK-A,BRK-B) top stock picks have been home runs during and prior to the COVID-19 pandemic.</p>\n<p>The famed stock portfolio run by billionaire investor Warren Buffett ballooned to a value of $281.17 billion by the end of 2020, or more than double the cumulative cost of building these stakes at $108.62 billion, according toBerkshire's latest annual shareholder letter.The value of the portfolio's total equity investments carried at market was up 13.4% compared to year-end 2019. However, Berkshire's own stock underperformed the broader market over that time period: The S&amp;P 500 rose 16.3% in 2020, without including reinvested dividends, while Berkshire's Class B shares increased 2.4%.</p>\n<p>Berkshire's stock performance in 2020 relative to the broader market, however, belies what has been, in aggregate, decades of outperformance for the Omaha, Nebraska-based company. Berkshire Hathaway's annual compounded gain between 1965 and 2020 was 20%, versus just 10.2% for the S&amp;P 500. And the firm's cumulative returns over that period have been a whopping 2,810,526% to the S&amp;P 500's 23,454%.</p>\n<p>On May 1, Buffett and long-time business partner Charlie Munger will hold Berkshire Hathaway's annual shareholder meeting in Los Angeles. This may serve as a forum for the pair to discuss additional investments purchased and sold in the first months of 2021, ahead of formal 13-F filing reveals later in the month. Last year, Buffett disclosed at the annual meeting thatBerkshire had sold out of its entire interest in the airline stocksAmerican Airlines (AAL), United Airlines (UAL), Delta Air Lines (DAL) and Southwest Airlines (LUV)in the first quarter of 2020.</p>\n<p>Here's how Berkshire's top 10 stock investments by market value fared over the course of the pandemic, based on the stakes disclosed in the Buffett's latest annual shareholder letter.*</p>\n<p><b>Apple</b></p>\n<p>Buffett pointed to Apple (AAPL) as one of the most valuable assets for Berkshire Hathaway alongside the firm's insurance operation and BNSF Railway, thanks in large part to the iPhone-maker's hefty share repurchases.</p>\n<p>Berkshire owned 907,559,761 shares of Apple as of the end of December for a total market value of $120.4 billion. By contrast, the firm spent just $31 billion accumulating this stake since late 2016.</p>\n<p>That massive holding — comprising 44% of Berkshire's disclosed assets, according to Bloomberg data — came even after the firm pocketed $11 billion after selling a small portion of its position in 2020.</p>\n<p>\"Despite that sale – voila! – Berkshire now owns 5.4% of Apple,\" Buffett said in the shareholder letter. \"That increase was costless to us,<b>coming about because Apple</b>has continuously repurchased its shares, thereby substantially shrinking the number it now has outstanding.\"</p>\n<p>Though Buffett hashistorically steered away from investing in technology companiesin favor of businesses he has understood more deeply, Berkshire's major holding in Apple proved auspicious during the pandemic, when Big Tech companies led the market higher.</p>\n<p>Apple's stock posted a total return of 82% in 2020, outperforming every other \"FAANG\" stock including Facebook, Amazon, Netflix and Alphabet. The run-up has since cooled in early 2021, however, with the stock posting a total return of just 1.4% for the year-to-date through market close on April 27.</p>\n<p><b>Bank of America</b></p>\n<p>While Berkshire Hathaway unloaded many of its bank stock holdings over the course of 2020, it increased its stake in Bank of America (BAC).</p>\n<p>The firm held 1,032,952,006 shares of Bank of America as of the end of 2020, after adding 85.1 million shares in the third quarter alone. This gave Berkshire Hathaway an ownership stake of 11.9%.</p>\n<p>By the end of last year, the value of that holding was worth $31.3 million, and cost $14.6 million to amass.</p>\n<p>The increase in the size of Berkshire Hathaway's Bank of America holding bucked the trend of the other bank stocks in the portfolio last year. Berkshire cut its holdings of Wells Fargo (EFC) from 345.7 million shares at year-end 2019 to 52.4 million by year-end 2020, and completely exited its holdings in JPMorgan Chase (JPM) and M&amp;T Bank Corp (MTB).</p>\n<p>With interest rates sliding amid ultra-accommodative monetary policy during the pandemic, bank stocks were among the worst performers last year. Bank of America shares fell nearly 14% in 2020, underperforming against both the S&amp;P 500 and S&amp;P 500 financials sector, which dropped just 4.1%. However, with interest rates back on the rise and consumer spending accelerating, shares have already started to reverse these declines, and Bank of America shares have risen 32% so far in 2021.</p>\n<p><b>The Coca-Cola Company</b></p>\n<p>Berkshire Hathaway's stake in Coca-Cola (KO) remained unchanged between 2019 and 2020 at 400 million shares, offering 9.3% ownership in the beverage giant. Buffett has been a long-time investor in the firm, having first purchased shares in Berkshire's portfolio in 1988. It has comprised a significant portion of the firm's total holdings and mark value value ever since.</p>\n<p>This long-term investment has paid off for the company, with the market value of the shares held totaling $21.9 billion at the end of 2020. Berkshire spent just under $1.3 billion building its stake in Coca-Cola.</p>\n<p>While Berkshire's overall return on its investment in Coca-Cola has been formidable, the stock did underperform the broader market in 2020. Coca-Cola shares declined 0.9% during the year as a dearth of live events and concessions weighed on sales, though the stock did still eke out a total return of 2.44% during the year with reinvested dividends. Shares have extended a run of underperformance in 2021, with the stock falling 1.5% so far this year.</p>\n<p><b>American Express</b></p>\n<p>Berkshire Hathaway held 151,610,700 shares of American Express (AXP) as of the end of 2020, with the stock comprising another of the firm's long-standing investments. Berkshire began building its stake nearly six decades ago, paying a total of just $1.29 billion to amass a stake worth $18.33 billion at the end of 2020.</p>\n<p>As a business relying heavily on both consumer and corporate spending, however, American Express' suffered a blow in 2020, with its stock dipping 2.9%.</p>\n<p>While Buffett has characterized Berkshire's holdings of marketable stocks as a \"collection of businesses\" in which he shares in long-term prosperity but does not control operations, that hasn't stopped him from imparting advice to executives at some of his top-held companies — especially during the nadir in business and economic activity during the pandemic.</p>\n<p>\"I talked to our largest shareholder, Warren Buffett, and I've talked to him during this time, the one thing he has and will continue to always point out to us is that the brand is special,\" American Express CEO Stephen Squeri said during an analyst day presentation in mid-March 2020. \"And that brand needs to be cared for, the brand needs to be invested in and we will continue to do so through tough times and through the good times.\"</p>\n<p>More recently, however, American Express's operating results and stock have picked back up. The stock outperformed the S&amp;P 500 with a rise of 25% for the year-to-date. And Squeri saidin a fourth-quarter updatethat non-travel and entertainment spend exceeded pre-COVID levels for a second straight quarter, and that trends overall have \"continued to steadily improve,\" despite some lingering impacts from the pandemic.</p>\n<p><b>Verizon Communications</b></p>\n<p>Verizon Communications (VZ), the parent company of Yahoo Finance, was one of Berkshire's new purchases in the second half of 2020.</p>\n<p>Berkshire revealed it amassed a stake of 146,716,496 shares of the telecommunications giant last year, good for a 3.5% ownership of the company.</p>\n<p>The holding was worth $8.62 billion as of year-end, representing one of several major investments Berkshire held below cost, which in this case came in at $8.69 billion. The decline likely would have been greater had Berkshire purchased the sizable stake earlier, however, with Verizon's stock having declined 4.3% excluding reinvested dividends over the the full-year 2020.</p>\n<p>But even given the pandemic, Verizon's business held up relatively strongly. Full-year 2020 sales edged down by just 3%, and adjusted EBITDA was flat year-over-year. Still, the stock has declined by 4% for 2021-to-date, or by 2% with reinvested dividends.</p>\n<p><b>Moody's Corporation</b></p>\n<p>Berkshire Hathaway had a 13.2% ownership stake in Moody's Corporation (MCO) at the end of 2020, with 24,669,778 shares worth a total of $7.16 billion. That generated a notable return for Berkshire, with the cost of building this stake amounting to just $248 million. Berkshire first held shares of Moody's Corporation in 2000.</p>\n<p>The credit rating agency outperformed the S&amp;P 500 in 2020 and has since performed about in-line with the market during the COVID-19 recovery. Shares rose by 22% over the course of 2020 and have increased by 12.5% for the year-to-date.</p>\n<p><b>U.S. Bancorp</b></p>\n<p>U.S. Bancorp (USB) was one of a number of holdings Berkshire Hathaway trimmed during the pandemic.</p>\n<p>The firm's stake in the parent company of U.S. Bank National Association was reduced to 148,176,166 shares by year-end 2020, compared to 149,497,787 in 2019. However, Berkshire Hathaway stopped short of fully exiting its position in the firm, as it did with some other big banks. Berkshire's position in U.S. Bancorp was worth just over $6.9 billion in year-end 2020, compared to total cost of $5.6 billion.</p>\n<p>As was the case for many financial institutions during the pandemic, U.S. Bancorp's stock came under pressure in the low-rate environment of 2020, but has since rebounded. Shares slid by 21.4% in 2020, but have so far risen more than 25% for the year-to-date.</p>\n<p><b>BYD</b></p>\n<p>Shenzhen-based BYD Co. (BYDDF) marks one of just a couple non-U.S. companies in Berkshire Hathaway's portfolio as of the end of 2020. The electric-vehicle manufacturer's stock was also the best-performing in Berkshire's portfolio during the pandemic on a price-appreciation basis, consistent with the outperformance among tech and growth stocks seen over the course of last year in the broader market. In fact, the market value of Berkshire's BYD Co. stake was more than double that of its other major auto-related position in General Motors (GM).</p>\n<p>Berkshire purchased the entirety of his 225 million share stake in BYD back in 2008 for $232 million, afterBuffett's business partner Charlie Munger toutedthe vision of its founder Wang Chuanfu. The value of that stake ballooned to $5.9 billion at the end of 2020. Shares of BYD surged by 432% in 2020 alone, though they have dipped by 13.5% for the year-to-date as some of the exuberance around electric-vehicle stocks moderated at the start of this year.</p>\n<p><b>Chevron</b></p>\n<p>Berkshire Hathaway pounced at the opportunity to purchase Chevron (CVX) during a dip in oil prices and energy stocks last year, snapping up 48,498,965 million shares at a total cost of $4.02 billion. This represented 2.5% of shares outstanding for the stock.</p>\n<p>By year-end, the market value of Berkshire's stake increased slightly to about $4.1 billion, with energy prices back on the rise following the worst points of spring 2020. Chevron's stock slid 30% between year-end 2019 and year-end 2020.</p>\n<p>Berkshire's investment has already begun to appreciate in value in the early months of 2021, with energy as the best-performing sector in the S&amp;P 500 for the year-to-date. Chevron shares have risen 21.6% so far this year for a price appreciation nearly double that of the broader market, not including reinvested dividends.</p>\n<p><b>Charter Communications</b></p>\n<p>Charter Communications (CHTR) marked another holding Berkshire Hathaway trimmed in 2020. In August of last year, Berkshire reported it had cut its stake by 4% to a total of about 5.2 million shares.</p>\n<p>The sale still left Berkshire with a 2.7% stake in the company, and holdings worth $3.45 billion by year-end 2020, at a total cost of just $904 million. Berkshire had beenaccumulating its stake in Charter since 2014.</p>\n<p>Shares of Charter Communications rose 36% in 2020, but have given back some of these gains after dipping 1.2% so far in 2021.</p>\n<p><i>* This analysis excludes Berkshire Hathaway's Kraft Heinz holding of 325,442,152 shares, since this is held using a different accounting method. Berkshire reported that the market value of these shares was $11.3 billion as of December 31, 2020.</i></p>","source":"lsy1584348713084","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Here’s how Warren Buffett’s top investments fared during the pandemic</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHere’s how Warren Buffett’s top investments fared during the pandemic\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-04-28 23:20 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/heres-how-warren-buffetts-top-investments-fared-during-the-pandemic-151003576.html><strong>Yahoo</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Plenty of Berkshire Hathaway's (BRK-A,BRK-B) top stock picks have been home runs during and prior to the COVID-19 pandemic.\nThe famed stock portfolio run by billionaire investor Warren Buffett ...</p>\n\n<a href=\"https://finance.yahoo.com/news/heres-how-warren-buffetts-top-investments-fared-during-the-pandemic-151003576.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AAPL":"苹果","01211":"比亚迪股份","MCO":"穆迪","KO":"可口可乐","AXP":"美国运通","VZ":"威瑞森","CHTR":"特许通讯","USB":"美国合众银行","BAC":"美国银行","CVX":"雪佛龙","002594":"比亚迪"},"source_url":"https://finance.yahoo.com/news/heres-how-warren-buffetts-top-investments-fared-during-the-pandemic-151003576.html","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1104198438","content_text":"Plenty of Berkshire Hathaway's (BRK-A,BRK-B) top stock picks have been home runs during and prior to the COVID-19 pandemic.\nThe famed stock portfolio run by billionaire investor Warren Buffett ballooned to a value of $281.17 billion by the end of 2020, or more than double the cumulative cost of building these stakes at $108.62 billion, according toBerkshire's latest annual shareholder letter.The value of the portfolio's total equity investments carried at market was up 13.4% compared to year-end 2019. However, Berkshire's own stock underperformed the broader market over that time period: The S&P 500 rose 16.3% in 2020, without including reinvested dividends, while Berkshire's Class B shares increased 2.4%.\nBerkshire's stock performance in 2020 relative to the broader market, however, belies what has been, in aggregate, decades of outperformance for the Omaha, Nebraska-based company. Berkshire Hathaway's annual compounded gain between 1965 and 2020 was 20%, versus just 10.2% for the S&P 500. And the firm's cumulative returns over that period have been a whopping 2,810,526% to the S&P 500's 23,454%.\nOn May 1, Buffett and long-time business partner Charlie Munger will hold Berkshire Hathaway's annual shareholder meeting in Los Angeles. This may serve as a forum for the pair to discuss additional investments purchased and sold in the first months of 2021, ahead of formal 13-F filing reveals later in the month. Last year, Buffett disclosed at the annual meeting thatBerkshire had sold out of its entire interest in the airline stocksAmerican Airlines (AAL), United Airlines (UAL), Delta Air Lines (DAL) and Southwest Airlines (LUV)in the first quarter of 2020.\nHere's how Berkshire's top 10 stock investments by market value fared over the course of the pandemic, based on the stakes disclosed in the Buffett's latest annual shareholder letter.*\nApple\nBuffett pointed to Apple (AAPL) as one of the most valuable assets for Berkshire Hathaway alongside the firm's insurance operation and BNSF Railway, thanks in large part to the iPhone-maker's hefty share repurchases.\nBerkshire owned 907,559,761 shares of Apple as of the end of December for a total market value of $120.4 billion. By contrast, the firm spent just $31 billion accumulating this stake since late 2016.\nThat massive holding — comprising 44% of Berkshire's disclosed assets, according to Bloomberg data — came even after the firm pocketed $11 billion after selling a small portion of its position in 2020.\n\"Despite that sale – voila! – Berkshire now owns 5.4% of Apple,\" Buffett said in the shareholder letter. \"That increase was costless to us,coming about because Applehas continuously repurchased its shares, thereby substantially shrinking the number it now has outstanding.\"\nThough Buffett hashistorically steered away from investing in technology companiesin favor of businesses he has understood more deeply, Berkshire's major holding in Apple proved auspicious during the pandemic, when Big Tech companies led the market higher.\nApple's stock posted a total return of 82% in 2020, outperforming every other \"FAANG\" stock including Facebook, Amazon, Netflix and Alphabet. The run-up has since cooled in early 2021, however, with the stock posting a total return of just 1.4% for the year-to-date through market close on April 27.\nBank of America\nWhile Berkshire Hathaway unloaded many of its bank stock holdings over the course of 2020, it increased its stake in Bank of America (BAC).\nThe firm held 1,032,952,006 shares of Bank of America as of the end of 2020, after adding 85.1 million shares in the third quarter alone. This gave Berkshire Hathaway an ownership stake of 11.9%.\nBy the end of last year, the value of that holding was worth $31.3 million, and cost $14.6 million to amass.\nThe increase in the size of Berkshire Hathaway's Bank of America holding bucked the trend of the other bank stocks in the portfolio last year. Berkshire cut its holdings of Wells Fargo (EFC) from 345.7 million shares at year-end 2019 to 52.4 million by year-end 2020, and completely exited its holdings in JPMorgan Chase (JPM) and M&T Bank Corp (MTB).\nWith interest rates sliding amid ultra-accommodative monetary policy during the pandemic, bank stocks were among the worst performers last year. Bank of America shares fell nearly 14% in 2020, underperforming against both the S&P 500 and S&P 500 financials sector, which dropped just 4.1%. However, with interest rates back on the rise and consumer spending accelerating, shares have already started to reverse these declines, and Bank of America shares have risen 32% so far in 2021.\nThe Coca-Cola Company\nBerkshire Hathaway's stake in Coca-Cola (KO) remained unchanged between 2019 and 2020 at 400 million shares, offering 9.3% ownership in the beverage giant. Buffett has been a long-time investor in the firm, having first purchased shares in Berkshire's portfolio in 1988. It has comprised a significant portion of the firm's total holdings and mark value value ever since.\nThis long-term investment has paid off for the company, with the market value of the shares held totaling $21.9 billion at the end of 2020. Berkshire spent just under $1.3 billion building its stake in Coca-Cola.\nWhile Berkshire's overall return on its investment in Coca-Cola has been formidable, the stock did underperform the broader market in 2020. Coca-Cola shares declined 0.9% during the year as a dearth of live events and concessions weighed on sales, though the stock did still eke out a total return of 2.44% during the year with reinvested dividends. Shares have extended a run of underperformance in 2021, with the stock falling 1.5% so far this year.\nAmerican Express\nBerkshire Hathaway held 151,610,700 shares of American Express (AXP) as of the end of 2020, with the stock comprising another of the firm's long-standing investments. Berkshire began building its stake nearly six decades ago, paying a total of just $1.29 billion to amass a stake worth $18.33 billion at the end of 2020.\nAs a business relying heavily on both consumer and corporate spending, however, American Express' suffered a blow in 2020, with its stock dipping 2.9%.\nWhile Buffett has characterized Berkshire's holdings of marketable stocks as a \"collection of businesses\" in which he shares in long-term prosperity but does not control operations, that hasn't stopped him from imparting advice to executives at some of his top-held companies — especially during the nadir in business and economic activity during the pandemic.\n\"I talked to our largest shareholder, Warren Buffett, and I've talked to him during this time, the one thing he has and will continue to always point out to us is that the brand is special,\" American Express CEO Stephen Squeri said during an analyst day presentation in mid-March 2020. \"And that brand needs to be cared for, the brand needs to be invested in and we will continue to do so through tough times and through the good times.\"\nMore recently, however, American Express's operating results and stock have picked back up. The stock outperformed the S&P 500 with a rise of 25% for the year-to-date. And Squeri saidin a fourth-quarter updatethat non-travel and entertainment spend exceeded pre-COVID levels for a second straight quarter, and that trends overall have \"continued to steadily improve,\" despite some lingering impacts from the pandemic.\nVerizon Communications\nVerizon Communications (VZ), the parent company of Yahoo Finance, was one of Berkshire's new purchases in the second half of 2020.\nBerkshire revealed it amassed a stake of 146,716,496 shares of the telecommunications giant last year, good for a 3.5% ownership of the company.\nThe holding was worth $8.62 billion as of year-end, representing one of several major investments Berkshire held below cost, which in this case came in at $8.69 billion. The decline likely would have been greater had Berkshire purchased the sizable stake earlier, however, with Verizon's stock having declined 4.3% excluding reinvested dividends over the the full-year 2020.\nBut even given the pandemic, Verizon's business held up relatively strongly. Full-year 2020 sales edged down by just 3%, and adjusted EBITDA was flat year-over-year. Still, the stock has declined by 4% for 2021-to-date, or by 2% with reinvested dividends.\nMoody's Corporation\nBerkshire Hathaway had a 13.2% ownership stake in Moody's Corporation (MCO) at the end of 2020, with 24,669,778 shares worth a total of $7.16 billion. That generated a notable return for Berkshire, with the cost of building this stake amounting to just $248 million. Berkshire first held shares of Moody's Corporation in 2000.\nThe credit rating agency outperformed the S&P 500 in 2020 and has since performed about in-line with the market during the COVID-19 recovery. Shares rose by 22% over the course of 2020 and have increased by 12.5% for the year-to-date.\nU.S. Bancorp\nU.S. Bancorp (USB) was one of a number of holdings Berkshire Hathaway trimmed during the pandemic.\nThe firm's stake in the parent company of U.S. Bank National Association was reduced to 148,176,166 shares by year-end 2020, compared to 149,497,787 in 2019. However, Berkshire Hathaway stopped short of fully exiting its position in the firm, as it did with some other big banks. Berkshire's position in U.S. Bancorp was worth just over $6.9 billion in year-end 2020, compared to total cost of $5.6 billion.\nAs was the case for many financial institutions during the pandemic, U.S. Bancorp's stock came under pressure in the low-rate environment of 2020, but has since rebounded. Shares slid by 21.4% in 2020, but have so far risen more than 25% for the year-to-date.\nBYD\nShenzhen-based BYD Co. (BYDDF) marks one of just a couple non-U.S. companies in Berkshire Hathaway's portfolio as of the end of 2020. The electric-vehicle manufacturer's stock was also the best-performing in Berkshire's portfolio during the pandemic on a price-appreciation basis, consistent with the outperformance among tech and growth stocks seen over the course of last year in the broader market. In fact, the market value of Berkshire's BYD Co. stake was more than double that of its other major auto-related position in General Motors (GM).\nBerkshire purchased the entirety of his 225 million share stake in BYD back in 2008 for $232 million, afterBuffett's business partner Charlie Munger toutedthe vision of its founder Wang Chuanfu. The value of that stake ballooned to $5.9 billion at the end of 2020. Shares of BYD surged by 432% in 2020 alone, though they have dipped by 13.5% for the year-to-date as some of the exuberance around electric-vehicle stocks moderated at the start of this year.\nChevron\nBerkshire Hathaway pounced at the opportunity to purchase Chevron (CVX) during a dip in oil prices and energy stocks last year, snapping up 48,498,965 million shares at a total cost of $4.02 billion. This represented 2.5% of shares outstanding for the stock.\nBy year-end, the market value of Berkshire's stake increased slightly to about $4.1 billion, with energy prices back on the rise following the worst points of spring 2020. Chevron's stock slid 30% between year-end 2019 and year-end 2020.\nBerkshire's investment has already begun to appreciate in value in the early months of 2021, with energy as the best-performing sector in the S&P 500 for the year-to-date. Chevron shares have risen 21.6% so far this year for a price appreciation nearly double that of the broader market, not including reinvested dividends.\nCharter Communications\nCharter Communications (CHTR) marked another holding Berkshire Hathaway trimmed in 2020. In August of last year, Berkshire reported it had cut its stake by 4% to a total of about 5.2 million shares.\nThe sale still left Berkshire with a 2.7% stake in the company, and holdings worth $3.45 billion by year-end 2020, at a total cost of just $904 million. Berkshire had beenaccumulating its stake in Charter since 2014.\nShares of Charter Communications rose 36% in 2020, but have given back some of these gains after dipping 1.2% so far in 2021.\n* This analysis excludes Berkshire Hathaway's Kraft Heinz holding of 325,442,152 shares, since this is held using a different accounting method. Berkshire reported that the market value of these shares was $11.3 billion as of December 31, 2020.","news_type":1},"isVote":1,"tweetType":1,"viewCount":386,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":109842583,"gmtCreate":1619685826942,"gmtModify":1704727992390,"author":{"id":"3578476625539127","authorId":"3578476625539127","name":"Justinslh","avatar":"https://static.tigerbbs.com/4aace6371636c60f0a3a97aacd94721c","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578476625539127","authorIdStr":"3578476625539127"},"themes":[],"htmlText":"[Call]&nbsp;","listText":"[Call]&nbsp;","text":"[Call]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/109842583","repostId":"1143067327","repostType":4,"isVote":1,"tweetType":1,"viewCount":377,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"hots":[{"id":9010780197,"gmtCreate":1648471713416,"gmtModify":1676534341847,"author":{"id":"3578476625539127","authorId":"3578476625539127","name":"Justinslh","avatar":"https://static.tigerbbs.com/4aace6371636c60f0a3a97aacd94721c","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578476625539127","authorIdStr":"3578476625539127"},"themes":[],"htmlText":"Smoking is bad for health, so is alcohol, sugar and carbon. Change the world back to ape-age and all these problems will be solved.Today, everyone are&nbsp;making informed decisions. &nbsp;Don't need to ban or stop sales with these methods.","listText":"Smoking is bad for health, so is alcohol, sugar and carbon. Change the world back to ape-age and all these problems will be solved.Today, everyone are&nbsp;making informed decisions. &nbsp;Don't need to ban or stop sales with these methods.","text":"Smoking is bad for health, so is alcohol, sugar and carbon. Change the world back to ape-age and all these problems will be solved.Today, everyone are making informed decisions. Don't need to ban or stop sales with these methods.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9010780197","repostId":"2222620860","repostType":4,"repost":{"id":"2222620860","pubTimestamp":1648467971,"share":"https://ttm.financial/m/news/2222620860?lang=&edition=fundamental","pubTime":"2022-03-28 19:46","market":"us","language":"en","title":"Walmart Stops Selling Cigarettes in Some Stores","url":"https://stock-news.laohu8.com/highlight/detail?id=2222620860","media":"The Wall Street Journal","summary":"After years of internal debate, Walmart is removing tobacco products from select stores in Florida, ","content":"<html><head></head><body><p>After years of internal debate, Walmart is removing tobacco products from select stores in Florida, California and elsewhere</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/47700200fcd9e7b9857529d32a900b8e\" tg-width=\"1290\" tg-height=\"860\" width=\"100%\" height=\"auto\"/><span>Walmart’s cigarette sales are generally less profitable than some other items sold near the front of stores.</span></p><p>Walmart Inc. is ending cigarette sales in some U.S. stores after years of debate within the retail company’s leadership ranks about the sale of tobacco products, according to people familiar with the matter.</p><p>Cigarettes are being removed in various markets, including some stores in California, Florida, Arkansas and New Mexico, according to the people and store visits. In some of these stores, Walmart has rolled out a design with more self-checkout registers, as well as other items such as grab-and-go food or candy sold near the front of stores in place of Marlboro, Newport and other tobacco products.</p><p>Walmart, which has more than 4,700 U.S. stores, is removing tobacco products from select locations where the retailer has decided to use the space more efficiently, a spokeswoman said. “We are always looking at ways to meet our customers’ needs while still operating an efficient business,” she said. She declined to say how many locations will continue to sell cigarettes but said Walmart isn’t halting all tobacco sales.</p><p>The shift comes after years of internal debate at Walmart about cigarettes, which U.S. health officials say are linked to 480,000 deaths in the country each year and which are complex for big-box retailers to sell because of regulations. Top Walmart executives decided to start moving out of the category in some locations before the Covid-19 pandemic, some of the people said, a decision now playing out in stores.</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/2c9cf9b4016c263f38b86bb4c66b9377\" tg-width=\"1050\" tg-height=\"700\" width=\"100%\" height=\"auto\"/><span>Tension regarding the issue of cigarette sales has risen as Walmart works to become a larger player in healthcare.</span></p><p>For years Walmart Chief ExecutiveDoug McMillonhas challenged other executives to find a way to stop selling tobacco, without demanding that the company do so, according to people familiar with those discussions.</p><p>Tension around the issue has risen as Walmart works to become a larger player in the healthcare industry, say some of these people. Many top executives argued that cigarettes are legal products that customers want and that Walmart shouldn’t be in the business of morally policing its shoppers, according to some of the people.</p><p>As with tobacco, Walmart has pulled back on sales of firearms in recent years after similar internal discussions. It raised the age to purchase guns to 21 after the 2018 high-school shooting in Parkland, Fla., and discontinued sales of ammunition used in semiautomatic weapons and handguns after a 2019 shooting at a Walmart in El Paso, Texas.</p><p>At Walmart, sales of cigarettes are generally less profitable than some other items sold near the front of stores such as candy, according to the people familiar with the situation. It is also an operationally complex sale, eating into profits. Tobacco is kept in a locked case or blocked from shoppers. Food and Drug Administration regulations require that an employee make the sale. At Walmart, that employee must be over a specific age based on local laws and trained in tobacco sales. Theft is high throughout the supply chain, said some of these people.</p><p>Some retailers stopped selling tobacco products years ago.Target Corp. eliminated all tobacco sales in 1996.CVS Health Corp. said that its decision in 2014 to stop tobacco sales would result in an estimated $2 billion loss in annual revenue but that those sales ran counter to the company’s goals as a healthcare provider.</p><p>U.S. cigarette sales totaled about $95 billion last year, and most of those purchases occur at gas stations and convenience stores, according to data from Euromonitor International. Walmart supercenters and other mixed retailers accounted for 14% of U.S. cigarette sales volume in 2020, according to Euromonitor.</p><p>The volume of cigarettes sold in the U.S. rose in 2020 during the pandemic, reversing a yearslong decline in smoking rates. In 2021, as pandemic restrictions ended and consumer mobility increased, U.S. cigarette industry sales fell 5.5%, according to Marlboro maker Altria Group Inc.</p><p>Walmart has backed away from some tobacco products in recent years. In 2019, Walmart said it would sell tobacco products only to people 21 or older in the midst of regulatory pressure to stop sales to minors. A federal law passed later that year raised the minimum tobacco-purchase age to 21 nationwide. Also that year, Walmart halted its e-cigarette sales, citing regulatory uncertainty around vaping.</p><p>Like other retailers, Walmart doesn’t sell tobacco in municipalities such as New York and parts of Massachusetts that won’t allow locations with retail pharmacies to sell tobacco. Sam’s Club, Walmart’s warehouse chain, started gradually stopping sales of cigarettes in 2018. Sam’s Club now sells tobacco products in fewer than 40 of its approximately 600 U.S. stores, a spokeswoman said.</p><p>In recent years, Walmart has focused on redesigning existing stores rather than building new ones. The redesign often includes adding more self-checkouts to save money on staffing. “When you had mostly self-checkouts, manned by one or two associates, tobacco became really problematic,” said one of the people familiar with Walmart’s business.</p><p>At the same time, Walmart aims to build a larger healthcare business. The company is one of the biggest pharmacy chains in the country. It is opening primary-care clinics, hosting wellness days that offer shoppers free health screenings and has administered millions of Covid-19 vaccines. Last year Walmart boughMeMD, a telehealth provider.</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Walmart Stops Selling Cigarettes in Some Stores</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWalmart Stops Selling Cigarettes in Some Stores\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-03-28 19:46 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.wsj.com/articles/walmart-stops-selling-cigarettes-in-some-stores-11648459800?mod=hp_lead_pos6><strong>The Wall Street Journal</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>After years of internal debate, Walmart is removing tobacco products from select stores in Florida, California and elsewhereWalmart’s cigarette sales are generally less profitable than some other ...</p>\n\n<a href=\"https://www.wsj.com/articles/walmart-stops-selling-cigarettes-in-some-stores-11648459800?mod=hp_lead_pos6\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"WMT":"沃尔玛","BK4533":"AQR资本管理(全球第二大对冲基金)","BK4532":"文艺复兴科技持仓","BK4534":"瑞士信贷持仓","BK4581":"高盛持仓","BK4155":"大卖场与超市","BK4550":"红杉资本持仓","BK4504":"桥水持仓"},"source_url":"https://www.wsj.com/articles/walmart-stops-selling-cigarettes-in-some-stores-11648459800?mod=hp_lead_pos6","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2222620860","content_text":"After years of internal debate, Walmart is removing tobacco products from select stores in Florida, California and elsewhereWalmart’s cigarette sales are generally less profitable than some other items sold near the front of stores.Walmart Inc. is ending cigarette sales in some U.S. stores after years of debate within the retail company’s leadership ranks about the sale of tobacco products, according to people familiar with the matter.Cigarettes are being removed in various markets, including some stores in California, Florida, Arkansas and New Mexico, according to the people and store visits. In some of these stores, Walmart has rolled out a design with more self-checkout registers, as well as other items such as grab-and-go food or candy sold near the front of stores in place of Marlboro, Newport and other tobacco products.Walmart, which has more than 4,700 U.S. stores, is removing tobacco products from select locations where the retailer has decided to use the space more efficiently, a spokeswoman said. “We are always looking at ways to meet our customers’ needs while still operating an efficient business,” she said. She declined to say how many locations will continue to sell cigarettes but said Walmart isn’t halting all tobacco sales.The shift comes after years of internal debate at Walmart about cigarettes, which U.S. health officials say are linked to 480,000 deaths in the country each year and which are complex for big-box retailers to sell because of regulations. Top Walmart executives decided to start moving out of the category in some locations before the Covid-19 pandemic, some of the people said, a decision now playing out in stores.Tension regarding the issue of cigarette sales has risen as Walmart works to become a larger player in healthcare.For years Walmart Chief ExecutiveDoug McMillonhas challenged other executives to find a way to stop selling tobacco, without demanding that the company do so, according to people familiar with those discussions.Tension around the issue has risen as Walmart works to become a larger player in the healthcare industry, say some of these people. Many top executives argued that cigarettes are legal products that customers want and that Walmart shouldn’t be in the business of morally policing its shoppers, according to some of the people.As with tobacco, Walmart has pulled back on sales of firearms in recent years after similar internal discussions. It raised the age to purchase guns to 21 after the 2018 high-school shooting in Parkland, Fla., and discontinued sales of ammunition used in semiautomatic weapons and handguns after a 2019 shooting at a Walmart in El Paso, Texas.At Walmart, sales of cigarettes are generally less profitable than some other items sold near the front of stores such as candy, according to the people familiar with the situation. It is also an operationally complex sale, eating into profits. Tobacco is kept in a locked case or blocked from shoppers. Food and Drug Administration regulations require that an employee make the sale. At Walmart, that employee must be over a specific age based on local laws and trained in tobacco sales. Theft is high throughout the supply chain, said some of these people.Some retailers stopped selling tobacco products years ago.Target Corp. eliminated all tobacco sales in 1996.CVS Health Corp. said that its decision in 2014 to stop tobacco sales would result in an estimated $2 billion loss in annual revenue but that those sales ran counter to the company’s goals as a healthcare provider.U.S. cigarette sales totaled about $95 billion last year, and most of those purchases occur at gas stations and convenience stores, according to data from Euromonitor International. Walmart supercenters and other mixed retailers accounted for 14% of U.S. cigarette sales volume in 2020, according to Euromonitor.The volume of cigarettes sold in the U.S. rose in 2020 during the pandemic, reversing a yearslong decline in smoking rates. In 2021, as pandemic restrictions ended and consumer mobility increased, U.S. cigarette industry sales fell 5.5%, according to Marlboro maker Altria Group Inc.Walmart has backed away from some tobacco products in recent years. In 2019, Walmart said it would sell tobacco products only to people 21 or older in the midst of regulatory pressure to stop sales to minors. A federal law passed later that year raised the minimum tobacco-purchase age to 21 nationwide. Also that year, Walmart halted its e-cigarette sales, citing regulatory uncertainty around vaping.Like other retailers, Walmart doesn’t sell tobacco in municipalities such as New York and parts of Massachusetts that won’t allow locations with retail pharmacies to sell tobacco. Sam’s Club, Walmart’s warehouse chain, started gradually stopping sales of cigarettes in 2018. Sam’s Club now sells tobacco products in fewer than 40 of its approximately 600 U.S. stores, a spokeswoman said.In recent years, Walmart has focused on redesigning existing stores rather than building new ones. The redesign often includes adding more self-checkouts to save money on staffing. “When you had mostly self-checkouts, manned by one or two associates, tobacco became really problematic,” said one of the people familiar with Walmart’s business.At the same time, Walmart aims to build a larger healthcare business. The company is one of the biggest pharmacy chains in the country. It is opening primary-care clinics, hosting wellness days that offer shoppers free health screenings and has administered millions of Covid-19 vaccines. Last year Walmart boughMeMD, a telehealth provider.","news_type":1},"isVote":1,"tweetType":1,"viewCount":394,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9010156139,"gmtCreate":1648303292472,"gmtModify":1676534326485,"author":{"id":"3578476625539127","authorId":"3578476625539127","name":"Justinslh","avatar":"https://static.tigerbbs.com/4aace6371636c60f0a3a97aacd94721c","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578476625539127","authorIdStr":"3578476625539127"},"themes":[],"htmlText":"Maybe will nvr be","listText":"Maybe will nvr be","text":"Maybe will nvr be","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9010156139","repostId":"1196027616","repostType":4,"repost":{"id":"1196027616","pubTimestamp":1648255536,"share":"https://ttm.financial/m/news/1196027616?lang=&edition=fundamental","pubTime":"2022-03-26 08:45","market":"us","language":"en","title":"Stock-Market Investors Should Watch the \"Best Leading Indicator of Trouble Ahead\"","url":"https://stock-news.laohu8.com/highlight/detail?id=1196027616","media":"MarketWatch","summary":"Investors have been watching the U.S. Treasury yield curve for inversions, a reliable predictor of p","content":"<html><head></head><body><p>Investors have been watching the U.S. Treasury yield curve for inversions, a reliable predictor of past economic downturns.</p><p>They don’t always agree on which part of the curve is best to watch though.</p><p>“Yield curve inversion, and flatting, has been at the forefront for everyone,” said Pete Duffy, chief investment officer at Penn Capital Management Company, in Philadelphia, by phone.</p><p>“That’s because the Fed is so active and rates suddenly have gone up so quickly.”</p><p>An inversion of the yield curve happens when rates on longer bonds fall below those of shorter-term debt, a sign that investors think economic woes could lie ahead. Fears of an economic slowdown have been mounting as the Federal Reserve starts to tighten financial conditions while Russia’s Ukraine invasion threatens to keep key drivers of U.S. inflation high.</p><p>Lately, the attention has been on the 10-year Treasury yield TMUBMUSD10Y, 2.478% and shorter 2-year yield, where the spread fell to 13 basis points on Tuesday, up from a high of about 130 basis points five months ago.</p><p>Read: The yield curve is speeding toward inversion — here’s what investors need to know</p><p>But that’s not the only plot on the Treasury yield curve investors closely watch. The Treasury Department sells securities that mature in a range from a few days to 30 years, providing a lot of plots on the curve to follow.</p><p>“The focus has been on the 10s and 2s,” said Mark Heppenstall, chief investment officer at Penn Mutual Asset Management, in Horsham, Penn, a northern suburb of Philadelphia.</p><p>“I will hold out until the 10s to 3-month bills inverts before I turn too negative on the economic outlook,” he said, calling it “the best leading indicator of trouble ahead.”</p><h2>Watch 10-year, 3-month</h2><p>Instead of falling, that spread climbed in March, continuing its path higher since turning negative two years ago at the onset of the pandemic (see chart).</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/7fe28818cd1806ee5afd5519332cf483\" tg-width=\"700\" tg-height=\"579\" width=\"100%\" height=\"auto\"/><span>The 3-month to 10-year yield spread is climbing Bloomberg data, Goelzer Investment Management</span></p><p>“The 3-month Treasury bill really tracks the Federal Reserve’s target rate,” said Gavin Stephens, director of portfolio management at Goelzer Investment Management in Indiana, by phone.</p><p>“So it gives you a more immediate picture of if the Federal Reserve has entered a restrictive state in terms of monetary policy and, thus, giving the possibility that economic growth is going to contract, which would be bad for stocks.”</p><p>Stocks were lower Friday, but with the S&amp;P 500 index SPX, +0.51% and the Nasdaq Composite Index COMP, -0.16% still up about 1.2% on the week. The three major indexes were 4.5% to 10.1% lower so far in 2022, according to FactSet.</p><p>By watching the 10s and 2s TMUBMUSD02Y, 2.280% spread, “You are looking at the expectations of where Fed Reserve interest rate policy is going to be over a period of two years,” Stephens said. “So, effectively, it’s working with a lag.”</p><p>On average, from the time the 10s and 2s curve inverts, until “there’s a recession, it’s almost two years,” he said, predicting that with unemployment recently pegged around 3.8% that, “this curve is going to invert when the economy is really strong.”</p><p>The Federal Reserve Bank of San Francisco also called the 3-month TMUBMUSD03M, 0.535% and 10-year curve relationship its “preferred spread measure because it has the strongest predictive power for future recessions,” such as in 2019, back when the yield curve was more regularly flashing recession warning signs.</p><p>“Did it see COVID coming?” Duffy said, of earlier yield curve inversions.</p><p>A more likely catalyst was that investors already were on a recession watch, with the American economy in its longest expansion period on record.</p><p>“There are a number of these curves that you need to look at in totality,” Duffy said. “We’ve always said look at many signals.”</p></body></html>","source":"lsy1603348471595","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock-Market Investors Should Watch the \"Best Leading Indicator of Trouble Ahead\"</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock-Market Investors Should Watch the \"Best Leading Indicator of Trouble Ahead\"\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-03-26 08:45 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.marketwatch.com/story/why-this-part-of-the-treasury-yield-curve-may-be-the-best-leading-indicator-of-trouble-ahead-11648210025?mod=home-page><strong>MarketWatch</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Investors have been watching the U.S. Treasury yield curve for inversions, a reliable predictor of past economic downturns.They don’t always agree on which part of the curve is best to watch though.“...</p>\n\n<a href=\"https://www.marketwatch.com/story/why-this-part-of-the-treasury-yield-curve-may-be-the-best-leading-indicator-of-trouble-ahead-11648210025?mod=home-page\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".SPX":"S&P 500 Index",".DJI":"道琼斯",".IXIC":"NASDAQ Composite"},"source_url":"https://www.marketwatch.com/story/why-this-part-of-the-treasury-yield-curve-may-be-the-best-leading-indicator-of-trouble-ahead-11648210025?mod=home-page","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1196027616","content_text":"Investors have been watching the U.S. Treasury yield curve for inversions, a reliable predictor of past economic downturns.They don’t always agree on which part of the curve is best to watch though.“Yield curve inversion, and flatting, has been at the forefront for everyone,” said Pete Duffy, chief investment officer at Penn Capital Management Company, in Philadelphia, by phone.“That’s because the Fed is so active and rates suddenly have gone up so quickly.”An inversion of the yield curve happens when rates on longer bonds fall below those of shorter-term debt, a sign that investors think economic woes could lie ahead. Fears of an economic slowdown have been mounting as the Federal Reserve starts to tighten financial conditions while Russia’s Ukraine invasion threatens to keep key drivers of U.S. inflation high.Lately, the attention has been on the 10-year Treasury yield TMUBMUSD10Y, 2.478% and shorter 2-year yield, where the spread fell to 13 basis points on Tuesday, up from a high of about 130 basis points five months ago.Read: The yield curve is speeding toward inversion — here’s what investors need to knowBut that’s not the only plot on the Treasury yield curve investors closely watch. The Treasury Department sells securities that mature in a range from a few days to 30 years, providing a lot of plots on the curve to follow.“The focus has been on the 10s and 2s,” said Mark Heppenstall, chief investment officer at Penn Mutual Asset Management, in Horsham, Penn, a northern suburb of Philadelphia.“I will hold out until the 10s to 3-month bills inverts before I turn too negative on the economic outlook,” he said, calling it “the best leading indicator of trouble ahead.”Watch 10-year, 3-monthInstead of falling, that spread climbed in March, continuing its path higher since turning negative two years ago at the onset of the pandemic (see chart).The 3-month to 10-year yield spread is climbing Bloomberg data, Goelzer Investment Management“The 3-month Treasury bill really tracks the Federal Reserve’s target rate,” said Gavin Stephens, director of portfolio management at Goelzer Investment Management in Indiana, by phone.“So it gives you a more immediate picture of if the Federal Reserve has entered a restrictive state in terms of monetary policy and, thus, giving the possibility that economic growth is going to contract, which would be bad for stocks.”Stocks were lower Friday, but with the S&P 500 index SPX, +0.51% and the Nasdaq Composite Index COMP, -0.16% still up about 1.2% on the week. The three major indexes were 4.5% to 10.1% lower so far in 2022, according to FactSet.By watching the 10s and 2s TMUBMUSD02Y, 2.280% spread, “You are looking at the expectations of where Fed Reserve interest rate policy is going to be over a period of two years,” Stephens said. “So, effectively, it’s working with a lag.”On average, from the time the 10s and 2s curve inverts, until “there’s a recession, it’s almost two years,” he said, predicting that with unemployment recently pegged around 3.8% that, “this curve is going to invert when the economy is really strong.”The Federal Reserve Bank of San Francisco also called the 3-month TMUBMUSD03M, 0.535% and 10-year curve relationship its “preferred spread measure because it has the strongest predictive power for future recessions,” such as in 2019, back when the yield curve was more regularly flashing recession warning signs.“Did it see COVID coming?” Duffy said, of earlier yield curve inversions.A more likely catalyst was that investors already were on a recession watch, with the American economy in its longest expansion period on record.“There are a number of these curves that you need to look at in totality,” Duffy said. “We’ve always said look at many signals.”","news_type":1},"isVote":1,"tweetType":1,"viewCount":184,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9013042102,"gmtCreate":1648660229774,"gmtModify":1676534373493,"author":{"id":"3578476625539127","authorId":"3578476625539127","name":"Justinslh","avatar":"https://static.tigerbbs.com/4aace6371636c60f0a3a97aacd94721c","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578476625539127","authorIdStr":"3578476625539127"},"themes":[],"htmlText":"How high can it go?","listText":"How high can it go?","text":"How high can it go?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9013042102","repostId":"2223820099","repostType":4,"repost":{"id":"2223820099","pubTimestamp":1648654316,"share":"https://ttm.financial/m/news/2223820099?lang=&edition=fundamental","pubTime":"2022-03-30 23:31","market":"us","language":"en","title":"Micron Is A Bargain At This Price","url":"https://stock-news.laohu8.com/highlight/detail?id=2223820099","media":"seekingalpha","summary":"SummaryShares of Micron have sold off lately, for no apparent reason.Micron will continue to generat","content":"<html><head></head><body><p><b>Summary</b></p><ul><li>Shares of Micron have sold off lately, for no apparent reason.</li><li>Micron will continue to generate a considerable amount of revenues and free cash flow this year.</li><li>While declining DRAM ASPs provide a challenge for Micron, the firm is still looking at record revenues in FY 2022.</li><li>Micron’s P-E ratio indicates deep undervaluation.</li></ul><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/9900c36936c91a482f9e65b8c20025e4\" tg-width=\"750\" tg-height=\"500\" width=\"100%\" height=\"auto\"/><span>Sundry Photography/iStock Editorial via Getty Images</span></p><p>Shares of Micron Technology (NASDAQ:MU) are too cheap to ignore. With Micron dropping back to the $80 level lately, the memory chip maker has once again become massively undervalued relative to its earnings potential. FY 2022 is set to be another year of strong revenue growth and high gross margins for the firm although there are pricing risks in the DRAM market. Micron&#39;s valuation, based off of earnings, is unreasonably low despite the risks and the stock has considerable recovery potential!</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/19223357d71830483a67987a2c426090\" tg-width=\"635\" tg-height=\"417\" width=\"100%\" height=\"auto\"/><span>Data by YCharts</span></p><p><b>Strong business momentum in the DRAM business</b></p><p>FY 2021 was a fantastic year for Micron. The memory maker saw a surge in revenues due to strong demand for the firm&#39;s memory and storage products, especially in its DRAM segment. Micron&#39;s revenues from DRAM products surged 37% year over year to $5.6B in the firm&#39;s FQ1&#39;22, in part because the DRAM market was heavily undersupplied. DRAM revenues have been supported by strengthening customer demand for Micron&#39;s 1-alpha and 1z DRAM nodes and growing average selling prices throughout the last year. In total, DRAM revenues generated about 73% of revenues for Micron in the last quarter while NAND products generated about 24% of revenues in FQ1-22. NAND revenues are also seeing momentum, especially regarding Micron&#39;s new 176-layer NAND which represents the majority of the firm&#39;s NAND bit production now. NAND-related revenues surged 19% year over year to $1.9B in FQ1-22.</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/a6c31f5e4f420bb8b7c8aa6ecedffd94\" tg-width=\"1280\" tg-height=\"235\" width=\"100%\" height=\"auto\"/><span>Micron</span></p><p><b>Strong outlook in place</b></p><p>Micron has submitted a strong outlook for FQ2-22: The memory chip maker expects to generate $7.5B in revenues +/- $200M in FQ2-22. The forecast implies a 3% quarter over quarter drop in revenues, but revenues are still going to be materially above last year&#39;s level. The company also guided for strong gross margins of at least 45% in the firm&#39;s second fiscal quarter, indicating that Micron expects to be able to defend elevated gross margin levels at least in the first half of the new fiscal year.</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/b5ff05280ac3f4ffb86515eb49c8484f\" tg-width=\"1280\" tg-height=\"305\" width=\"100%\" height=\"auto\"/><span>Micron</span></p><p>Micron is the third-largest DRAM brand in the world, after Samsung and SK Hynix, and has a large market share. Micron has a market share of approximately 23%, based on projections made by Trendforce, a research service with a focus on the chip industry. Growing demand and higher prices for DRAM products immediately benefit Micron.</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/67ca844a79df769dda50bb8355c7f00b\" tg-width=\"513\" tg-height=\"279\" width=\"100%\" height=\"auto\"/><span>Trendforce</span></p><p><b>Risks with Micron</b></p><p>Micron may face headwinds in the DRAM business regarding pricing. Strong demand for storage and memory products have led to an upswing in average selling prices in FY 2021, especially in the DRAM market which has been chronically undersupplied in FY 2021. But DRAM prices have started to drop towards the end of last year and more pricing pressure could build going forward. Lower average selling prices for DRAM products obviously indicate top line and gross margin risks for Micron, although the memory chip maker still expects to generate record revenues in FY 2022. Micron&#39;s DRAM average selling prices decreased in the lower-single digit range in the last quarter while NAND average selling prices decreased in the mid-single digit range. Micron does not make forecasts about expected average selling prices, but forecasts for FQ1-22, made by Trendforce again, indicate additional pricing pressures in the DRAM market due to a seasonal demand downturn.</p><p><b>Strong free cash flow ramp</b></p><p>In the period from FY 2017 to FQ1-22, Micron earned approximately $21B in free cash flow and free cash flow conversion has greatly improved. The biggest contributing factor for Micron&#39;s strong commercial performance was strengthening demand for the firm&#39;s products during the current bull market in the chip industry. Micron generated $4.2B in free cash flow in FY 2021 and, I believe, could earn about $4.0B in free cash flow in FY 2022.</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/b65dcf050f37b99e03c7b7c8c7152137\" tg-width=\"1032\" tg-height=\"702\" width=\"100%\" height=\"auto\"/><span>Micron</span></p><p><b>Extreme undervaluation</b></p><p>Micron&#39;s shares remain deeply undervalued based on earnings. Micron is expected to see 51% EPS growth in FY 2022 and another 35% on top of that in FY 2023. Based off of $12.3 in FY 2023 EPS, shares of Micron trade for only 6.5 X earnings. I believe the P-E ratio really is unreasonably low at this point and the risk profile for shares of Micron are heavily skewed to the upside.</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/ca80eb75a5ec7d3f7fe009ff80402452\" tg-width=\"640\" tg-height=\"126\" width=\"100%\" height=\"auto\"/><span>Micron</span></p><p><b>Final thoughts</b></p><p>Although pricing pressures in the DRAM market may persist, Micron is extremely attractive as an investment. The biggest reason to consider Micron right now is that the company&#39;s earnings potential is widely undervalued. Shares of Micron have a P-E ratio of just 6.5 X although the company is generating a ton of free cash flow and earnings each quarter. While Micron does have risks relating to lower average selling prices, especially in the dominant DRAM business, I believe the risk/reward still heavily favors an investment in the memory chip maker at this time!</p></body></html>","source":"seekingalpha","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Micron Is A Bargain At This Price</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMicron Is A Bargain At This Price\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-03-30 23:31 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/article/4498448-micron-is-a-bargain-at-this-price><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>SummaryShares of Micron have sold off lately, for no apparent reason.Micron will continue to generate a considerable amount of revenues and free cash flow this year.While declining DRAM ASPs provide a...</p>\n\n<a href=\"https://seekingalpha.com/article/4498448-micron-is-a-bargain-at-this-price\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4554":"元宇宙及AR概念","BK4566":"资本集团","BK4532":"文艺复兴科技持仓","BK4553":"喜马拉雅资本持仓","MU":"美光科技","BK4575":"芯片概念","BK4527":"明星科技股","BK4579":"人工智能","BK4533":"AQR资本管理(全球第二大对冲基金)","BK4512":"苹果概念","BK4141":"半导体产品"},"source_url":"https://seekingalpha.com/article/4498448-micron-is-a-bargain-at-this-price","is_english":true,"share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","article_id":"2223820099","content_text":"SummaryShares of Micron have sold off lately, for no apparent reason.Micron will continue to generate a considerable amount of revenues and free cash flow this year.While declining DRAM ASPs provide a challenge for Micron, the firm is still looking at record revenues in FY 2022.Micron’s P-E ratio indicates deep undervaluation.Sundry Photography/iStock Editorial via Getty ImagesShares of Micron Technology (NASDAQ:MU) are too cheap to ignore. With Micron dropping back to the $80 level lately, the memory chip maker has once again become massively undervalued relative to its earnings potential. FY 2022 is set to be another year of strong revenue growth and high gross margins for the firm although there are pricing risks in the DRAM market. Micron's valuation, based off of earnings, is unreasonably low despite the risks and the stock has considerable recovery potential!Data by YChartsStrong business momentum in the DRAM businessFY 2021 was a fantastic year for Micron. The memory maker saw a surge in revenues due to strong demand for the firm's memory and storage products, especially in its DRAM segment. Micron's revenues from DRAM products surged 37% year over year to $5.6B in the firm's FQ1'22, in part because the DRAM market was heavily undersupplied. DRAM revenues have been supported by strengthening customer demand for Micron's 1-alpha and 1z DRAM nodes and growing average selling prices throughout the last year. In total, DRAM revenues generated about 73% of revenues for Micron in the last quarter while NAND products generated about 24% of revenues in FQ1-22. NAND revenues are also seeing momentum, especially regarding Micron's new 176-layer NAND which represents the majority of the firm's NAND bit production now. NAND-related revenues surged 19% year over year to $1.9B in FQ1-22.MicronStrong outlook in placeMicron has submitted a strong outlook for FQ2-22: The memory chip maker expects to generate $7.5B in revenues +/- $200M in FQ2-22. The forecast implies a 3% quarter over quarter drop in revenues, but revenues are still going to be materially above last year's level. The company also guided for strong gross margins of at least 45% in the firm's second fiscal quarter, indicating that Micron expects to be able to defend elevated gross margin levels at least in the first half of the new fiscal year.MicronMicron is the third-largest DRAM brand in the world, after Samsung and SK Hynix, and has a large market share. Micron has a market share of approximately 23%, based on projections made by Trendforce, a research service with a focus on the chip industry. Growing demand and higher prices for DRAM products immediately benefit Micron.TrendforceRisks with MicronMicron may face headwinds in the DRAM business regarding pricing. Strong demand for storage and memory products have led to an upswing in average selling prices in FY 2021, especially in the DRAM market which has been chronically undersupplied in FY 2021. But DRAM prices have started to drop towards the end of last year and more pricing pressure could build going forward. Lower average selling prices for DRAM products obviously indicate top line and gross margin risks for Micron, although the memory chip maker still expects to generate record revenues in FY 2022. Micron's DRAM average selling prices decreased in the lower-single digit range in the last quarter while NAND average selling prices decreased in the mid-single digit range. Micron does not make forecasts about expected average selling prices, but forecasts for FQ1-22, made by Trendforce again, indicate additional pricing pressures in the DRAM market due to a seasonal demand downturn.Strong free cash flow rampIn the period from FY 2017 to FQ1-22, Micron earned approximately $21B in free cash flow and free cash flow conversion has greatly improved. The biggest contributing factor for Micron's strong commercial performance was strengthening demand for the firm's products during the current bull market in the chip industry. Micron generated $4.2B in free cash flow in FY 2021 and, I believe, could earn about $4.0B in free cash flow in FY 2022.MicronExtreme undervaluationMicron's shares remain deeply undervalued based on earnings. Micron is expected to see 51% EPS growth in FY 2022 and another 35% on top of that in FY 2023. Based off of $12.3 in FY 2023 EPS, shares of Micron trade for only 6.5 X earnings. I believe the P-E ratio really is unreasonably low at this point and the risk profile for shares of Micron are heavily skewed to the upside.MicronFinal thoughtsAlthough pricing pressures in the DRAM market may persist, Micron is extremely attractive as an investment. The biggest reason to consider Micron right now is that the company's earnings potential is widely undervalued. Shares of Micron have a P-E ratio of just 6.5 X although the company is generating a ton of free cash flow and earnings each quarter. While Micron does have risks relating to lower average selling prices, especially in the dominant DRAM business, I believe the risk/reward still heavily favors an investment in the memory chip maker at this time!","news_type":1},"isVote":1,"tweetType":1,"viewCount":286,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9012853831,"gmtCreate":1649307622358,"gmtModify":1676534489747,"author":{"id":"3578476625539127","authorId":"3578476625539127","name":"Justinslh","avatar":"https://static.tigerbbs.com/4aace6371636c60f0a3a97aacd94721c","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578476625539127","authorIdStr":"3578476625539127"},"themes":[],"htmlText":"With recession lurking around the corner, can the price prediction still hols?","listText":"With recession lurking around the corner, can the price prediction still hols?","text":"With recession lurking around the corner, can the price prediction still hols?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9012853831","repostId":"2225568035","repostType":4,"repost":{"id":"2225568035","pubTimestamp":1649289910,"share":"https://ttm.financial/m/news/2225568035?lang=&edition=fundamental","pubTime":"2022-04-07 08:05","market":"us","language":"en","title":"3 COVID-19 Stocks With Monster Upside of Up to 355%, According to Wall Street","url":"https://stock-news.laohu8.com/highlight/detail?id=2225568035","media":"Motley Fool","summary":"Select analysts foresee these coronavirus stocks rocketing higher by 246% to 355% over the next year.","content":"<html><head></head><body><p>For more than two years, the coronavirus disease 2019 (COVID-19) has turned the world upside-down. According to data from the World Health Organization (WHO), more than 486 million cases of COVID-19 had been reported, as of April 1, 2022, leading to over 6.1 million cumulative deaths. Nearly 973,000 of those deaths have occurred in the United States.</p><p>Even though the worst of the pandemic appears to be in the rearview mirror, there&#39;s a real likelihood that COVID-19 becomes an endemic illness. This means initial inoculation campaigns, booster shots, and research into combination vaccines, is almost certain to continue -- and Wall Street knows it.</p><p>Based on the highest issued price targets from Wall Street analysts, the following three COVID-19 stocks offer monster upside over the next 12 months ranging from a &#34;low&#34; of 246% to as much as 355%.</p><h2>Novavax: Implied upside of 257%</h2><p>The first COVID-19 play that offers drool-worthy upside, at least according to <a href=\"https://laohu8.com/S/AONE.U\">one</a> Wall Street analyst, is biotech stock <b>Novavax</b> ( NVAX -13.36% ). Despite a $50 price-target reduction in February, B. Riley analyst Mayank Mamtani still believes Novavax can reach $265 a share.  This represents a cool 257% upside from where shares ended last week.</p><p>Mamtani&#39;s aggressive price target is based on a few factors. For instance, he believes that concerns over Novavax&#39;s near-term manufacturing struggles are overblown. Mamtani explained months ago that Novavax was nearing its monthly manufacturing target of around 150 million doses, and would likely be exporting more than 100 million monthly doses out of India, where it&#39;s working with the Serum Institute of India to produce NVX-CoV2373 vaccines.</p><p>Mamtani also views the U.S. and European Union as core long-term sales opportunities for Novavax. Even though a substantial percentage of the population in these developed markets have already received their initial inoculations, the mutability of the SARS-CoV-2 virus that causes COVID-19 offers recurring revenue opportunities via boosters and combination vaccines. Novavax is one of a handful of companies currently developing a combination influenza/COVID-19 vaccine.</p><p>Something else to consider is that NVX-CoV2373 has been among the most effective vaccine candidates. Among U.S. and EU treatments that have received approval or emergency-use authorization (EUA), only three have managed to reach the 90% vaccine efficacy (VE) plateau. Novavax is one of those three, with the company&#39;s large-scale study in the U.S./Mexico (announced in June 2021) hitting a 90.4% VE. This should allow Novavax to easily supplant other COVID-19 vaccines with lower VEs, such as those from <b>Johnson &amp; Johnson</b> and <b>AstraZeneca</b>.</p><p>Based on Wall Street&#39;s worst-case scenario for 2022, Novavax looks to be on track for a little over $4 billion in sales (the company recorded $1.15 billion in revenue last year) and over $13 in earnings per share. This would put Novavax&#39;s stock at less than six times Wall Street&#39;s most-pessimistic profit forecast in 2022.</p><p>While I don&#39;t expect Mamtani&#39;s lofty price target to hit over the next 12 months, I do believe $265 remains in the picture down the line if Novavax continues to execute and innovate.</p><h2>Vaxart: Implied upside of 246%</h2><p>A second COVID-19 stock that offers monster upside over the next 12 months is clinical-stage drug developer <b>Vaxart.</b> Analyst Yasmeen Rahimi of Piper Sandler holds the high-water price target on Vaxart of $18 a share. If this figure were to become a reality, shareholders would enjoy a 246% gain from where Vaxart&#39;s stock ended this past week.</p><p>Rahimi&#39;s optimism is primarily tied to Vaxart&#39;s proprietary drug development technology known as &#34;Vector-Adjuvant-Antigen Standardized Technology,&#34; or VAAST. While traditional vaccines aim to produce a systemic response, VAAST is intended to produce both a systemic <i>and</i> mucosal response. This dual approach is believed to provide better protection against airborne viruses. In Rahimi&#39;s view, VAAST&#39;s success has been demonstrated in previous clinical trials, which somewhat de-risks Vaxart&#39;s development platform.</p><p>Another unique aspect of Vaxart&#39;s pipeline is that its COVID-19 candidate is an oral tablet and not a jab in the arm. An effective oral COVID-19 treatment would completely change the game globally. It would make distribution substantially easier (i.e., no medical professionals needed to administer shots), and there&#39;s a good likelihood that people would be more willing to swallow a pill than receive a vaccine.</p><p>Last year, early stage data from Vaxart&#39;s COVID-19 oral treatment demonstrated mixed results. Although it did generate an immune response, the level of neutralizing antibodies observed in clinical trials was notably lower than in patients who&#39;d received a traditional COVID-19 vaccine.</p><p>Following this study, Vaxart ran a preclinical trial specifically targeting the S-protein, which is involved in receptor viral attachment and entry into host cells. The initial results of this study, which were released in late February, demonstrated &#34;robust neutralizing antibody responses in mucosal sites&#34; for non-human primates.</p><p>Though these very early stage results are encouraging, Vaxart&#39;s oral S-only COVID-19 candidate, as well as its remaining pipeline, looks to be a long ways off from generating any recurring revenue. This makes Rahimi&#39;s $18 price target unlikely to be hit in 12 months, if ever.</p><h2>Ocugen: Implied upside of 355%</h2><p>However, the crème-de-la-crème of upside opportunity among COVID-19 stocks happens to be small-cap clinical-stage biotech company <b>Ocugen</b>. If Robert LeBoyer of Noble Financial is correct with his price target of $15 a share for Ocugen, investors would enjoy a 355% ride higher over the coming 12 months.</p><p>Since this list is all about COVID-19 stocks, it shouldn&#39;t be a surprise that LeBoyer&#39;s optimism has almost everything to do with Covaxin, which is an experimental COVID-19 vaccine Ocugen has commercially licensed from India&#39;s Bharat Biotech.</p><p>In 2021, Bharat Biotech conducted a large-scale study involving Covaxin with 25,800 participants in India. This clinical trial produced a VE of 78% that ultimately was the basis for Covaxin getting the green light from the WHO. In LeBoyer&#39;s view, Covaxin offers competitive advantages over other available COVID-19 vaccines in North America.</p><p>But there&#39;s a really big asterisk that investors need to be aware of. Ocugen&#39;s commercial licensing of Covaxin only pertains to the U.S. and Canada. Covaxin could theoretically be approved for use in every market around the world except the U.S. and Canada, and Ocugen wouldn&#39;t see a dime. While the U.S. and Canada are generally lucrative markets for brand-name drugs, both countries have already invested heavily in COVID-19 treatments and may not have room on pharmacy shelves for a vaccine that produced &#34;only&#34; a 78% VE.</p><p>The other big problem for Ocugen is that its quick path to revenue was yanked away by the U.S. Food and Drug Administration (FDA) one month earlier. On March 4, the FDA declined Ocugen&#39;s EUA request for pediatric patients aged 2 to 18. This means Covaxin&#39;s U.S. audience will only be adults, and Covaxin will have to go through the standard (i.e., slower) route of drug approval with the FDA.</p><p>Although Ocugen&#39;s eye-disease-related pipeline could one day be worthwhile, it&#39;s hard to see this company getting anywhere near $15 with minimal use for Covaxin in the U.S. and Canada.</p></body></html>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 COVID-19 Stocks With Monster Upside of Up to 355%, According to Wall Street</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 COVID-19 Stocks With Monster Upside of Up to 355%, According to Wall Street\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-04-07 08:05 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2022/04/06/3-covid-19-stocks-monster-upside-355-wall-street/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>For more than two years, the coronavirus disease 2019 (COVID-19) has turned the world upside-down. According to data from the World Health Organization (WHO), more than 486 million cases of COVID-19 ...</p>\n\n<a href=\"https://www.fool.com/investing/2022/04/06/3-covid-19-stocks-monster-upside-355-wall-street/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BNTX":"BioNTech SE","BK4551":"寇图资本持仓","BK4548":"巴美列捷福持仓","VXRT":"Vaxart, Inc","NVAX":"诺瓦瓦克斯医药","BK4568":"美国抗疫概念"},"source_url":"https://www.fool.com/investing/2022/04/06/3-covid-19-stocks-monster-upside-355-wall-street/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2225568035","content_text":"For more than two years, the coronavirus disease 2019 (COVID-19) has turned the world upside-down. According to data from the World Health Organization (WHO), more than 486 million cases of COVID-19 had been reported, as of April 1, 2022, leading to over 6.1 million cumulative deaths. Nearly 973,000 of those deaths have occurred in the United States.Even though the worst of the pandemic appears to be in the rearview mirror, there's a real likelihood that COVID-19 becomes an endemic illness. This means initial inoculation campaigns, booster shots, and research into combination vaccines, is almost certain to continue -- and Wall Street knows it.Based on the highest issued price targets from Wall Street analysts, the following three COVID-19 stocks offer monster upside over the next 12 months ranging from a \"low\" of 246% to as much as 355%.Novavax: Implied upside of 257%The first COVID-19 play that offers drool-worthy upside, at least according to one Wall Street analyst, is biotech stock Novavax ( NVAX -13.36% ). Despite a $50 price-target reduction in February, B. Riley analyst Mayank Mamtani still believes Novavax can reach $265 a share.  This represents a cool 257% upside from where shares ended last week.Mamtani's aggressive price target is based on a few factors. For instance, he believes that concerns over Novavax's near-term manufacturing struggles are overblown. Mamtani explained months ago that Novavax was nearing its monthly manufacturing target of around 150 million doses, and would likely be exporting more than 100 million monthly doses out of India, where it's working with the Serum Institute of India to produce NVX-CoV2373 vaccines.Mamtani also views the U.S. and European Union as core long-term sales opportunities for Novavax. Even though a substantial percentage of the population in these developed markets have already received their initial inoculations, the mutability of the SARS-CoV-2 virus that causes COVID-19 offers recurring revenue opportunities via boosters and combination vaccines. Novavax is one of a handful of companies currently developing a combination influenza/COVID-19 vaccine.Something else to consider is that NVX-CoV2373 has been among the most effective vaccine candidates. Among U.S. and EU treatments that have received approval or emergency-use authorization (EUA), only three have managed to reach the 90% vaccine efficacy (VE) plateau. Novavax is one of those three, with the company's large-scale study in the U.S./Mexico (announced in June 2021) hitting a 90.4% VE. This should allow Novavax to easily supplant other COVID-19 vaccines with lower VEs, such as those from Johnson & Johnson and AstraZeneca.Based on Wall Street's worst-case scenario for 2022, Novavax looks to be on track for a little over $4 billion in sales (the company recorded $1.15 billion in revenue last year) and over $13 in earnings per share. This would put Novavax's stock at less than six times Wall Street's most-pessimistic profit forecast in 2022.While I don't expect Mamtani's lofty price target to hit over the next 12 months, I do believe $265 remains in the picture down the line if Novavax continues to execute and innovate.Vaxart: Implied upside of 246%A second COVID-19 stock that offers monster upside over the next 12 months is clinical-stage drug developer Vaxart. Analyst Yasmeen Rahimi of Piper Sandler holds the high-water price target on Vaxart of $18 a share. If this figure were to become a reality, shareholders would enjoy a 246% gain from where Vaxart's stock ended this past week.Rahimi's optimism is primarily tied to Vaxart's proprietary drug development technology known as \"Vector-Adjuvant-Antigen Standardized Technology,\" or VAAST. While traditional vaccines aim to produce a systemic response, VAAST is intended to produce both a systemic and mucosal response. This dual approach is believed to provide better protection against airborne viruses. In Rahimi's view, VAAST's success has been demonstrated in previous clinical trials, which somewhat de-risks Vaxart's development platform.Another unique aspect of Vaxart's pipeline is that its COVID-19 candidate is an oral tablet and not a jab in the arm. An effective oral COVID-19 treatment would completely change the game globally. It would make distribution substantially easier (i.e., no medical professionals needed to administer shots), and there's a good likelihood that people would be more willing to swallow a pill than receive a vaccine.Last year, early stage data from Vaxart's COVID-19 oral treatment demonstrated mixed results. Although it did generate an immune response, the level of neutralizing antibodies observed in clinical trials was notably lower than in patients who'd received a traditional COVID-19 vaccine.Following this study, Vaxart ran a preclinical trial specifically targeting the S-protein, which is involved in receptor viral attachment and entry into host cells. The initial results of this study, which were released in late February, demonstrated \"robust neutralizing antibody responses in mucosal sites\" for non-human primates.Though these very early stage results are encouraging, Vaxart's oral S-only COVID-19 candidate, as well as its remaining pipeline, looks to be a long ways off from generating any recurring revenue. This makes Rahimi's $18 price target unlikely to be hit in 12 months, if ever.Ocugen: Implied upside of 355%However, the crème-de-la-crème of upside opportunity among COVID-19 stocks happens to be small-cap clinical-stage biotech company Ocugen. If Robert LeBoyer of Noble Financial is correct with his price target of $15 a share for Ocugen, investors would enjoy a 355% ride higher over the coming 12 months.Since this list is all about COVID-19 stocks, it shouldn't be a surprise that LeBoyer's optimism has almost everything to do with Covaxin, which is an experimental COVID-19 vaccine Ocugen has commercially licensed from India's Bharat Biotech.In 2021, Bharat Biotech conducted a large-scale study involving Covaxin with 25,800 participants in India. This clinical trial produced a VE of 78% that ultimately was the basis for Covaxin getting the green light from the WHO. In LeBoyer's view, Covaxin offers competitive advantages over other available COVID-19 vaccines in North America.But there's a really big asterisk that investors need to be aware of. Ocugen's commercial licensing of Covaxin only pertains to the U.S. and Canada. Covaxin could theoretically be approved for use in every market around the world except the U.S. and Canada, and Ocugen wouldn't see a dime. While the U.S. and Canada are generally lucrative markets for brand-name drugs, both countries have already invested heavily in COVID-19 treatments and may not have room on pharmacy shelves for a vaccine that produced \"only\" a 78% VE.The other big problem for Ocugen is that its quick path to revenue was yanked away by the U.S. Food and Drug Administration (FDA) one month earlier. On March 4, the FDA declined Ocugen's EUA request for pediatric patients aged 2 to 18. This means Covaxin's U.S. audience will only be adults, and Covaxin will have to go through the standard (i.e., slower) route of drug approval with the FDA.Although Ocugen's eye-disease-related pipeline could one day be worthwhile, it's hard to see this company getting anywhere near $15 with minimal use for Covaxin in the U.S. and Canada.","news_type":1},"isVote":1,"tweetType":1,"viewCount":380,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9083297508,"gmtCreate":1650121013192,"gmtModify":1676534651256,"author":{"id":"3578476625539127","authorId":"3578476625539127","name":"Justinslh","avatar":"https://static.tigerbbs.com/4aace6371636c60f0a3a97aacd94721c","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578476625539127","authorIdStr":"3578476625539127"},"themes":[],"htmlText":"Up up all the way after holidays","listText":"Up up all the way after holidays","text":"Up up all the way after holidays","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9083297508","repostId":"1133070824","repostType":4,"repost":{"id":"1133070824","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1649399100,"share":"https://ttm.financial/m/news/1133070824?lang=&edition=fundamental","pubTime":"2022-04-08 14:25","market":"us","language":"en","title":"Reminder: Holiday Trading Hours during Good Friday and Easter","url":"https://stock-news.laohu8.com/highlight/detail?id=1133070824","media":"Tiger Newspress","summary":"U.S. stock markets will be closed Friday, April 15in observance of Good Friday.The New York Stock Exchange and the Nasdaq will resume normal trading hours on Monday.The Securities Industry and Financi","content":"<html><head></head><body><p>U.S. stock markets will be closed Friday, April 15 in observance of Good Friday.</p><p>The New York Stock Exchange and the Nasdaq will resume normal trading hours on Monday.</p><p>The Securities Industry and Financial Markets Association recommended the U.S. bond market close Friday. It also advised that the bond market shutter early on Thursday, April14 at 2 p.m. Eastern.</p><p>U.S. commodities markets including gold and oil futures also won&#39;t be open for trading Friday.</p><p>Singapore stock markets will also close on Good Friday.</p><p>Stock markets in Europe, Hong Kong and Australia will close on Good Friday and on Monday in observance of Easter.</p><p>A-shares (Northbound) will be closed to April 18 from April 14.</p><p><img src=\"https://static.tigerbbs.com/8d9bbb655e7216a0c27a0cb94e0d0875\" tg-width=\"1482\" tg-height=\"1328\" width=\"100%\" height=\"auto\"/></p><p>Good Friday commemorates the crucifixion of Jesus Christ. It isn’t a federal holiday, which means businesses often stay open. Good Friday is the only time U.S. markets close for the day outside of federal holidays.</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Reminder: Holiday Trading Hours during Good Friday and Easter</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nReminder: Holiday Trading Hours during Good Friday and Easter\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2022-04-08 14:25</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p>U.S. stock markets will be closed Friday, April 15 in observance of Good Friday.</p><p>The New York Stock Exchange and the Nasdaq will resume normal trading hours on Monday.</p><p>The Securities Industry and Financial Markets Association recommended the U.S. bond market close Friday. It also advised that the bond market shutter early on Thursday, April14 at 2 p.m. Eastern.</p><p>U.S. commodities markets including gold and oil futures also won&#39;t be open for trading Friday.</p><p>Singapore stock markets will also close on Good Friday.</p><p>Stock markets in Europe, Hong Kong and Australia will close on Good Friday and on Monday in observance of Easter.</p><p>A-shares (Northbound) will be closed to April 18 from April 14.</p><p><img src=\"https://static.tigerbbs.com/8d9bbb655e7216a0c27a0cb94e0d0875\" tg-width=\"1482\" tg-height=\"1328\" width=\"100%\" height=\"auto\"/></p><p>Good Friday commemorates the crucifixion of Jesus Christ. It isn’t a federal holiday, which means businesses often stay open. Good Friday is the only time U.S. markets close for the day outside of federal holidays.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".DJI":"道琼斯",".SPX":"S&P 500 Index",".IXIC":"NASDAQ Composite"},"source_url":"","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1133070824","content_text":"U.S. stock markets will be closed Friday, April 15 in observance of Good Friday.The New York Stock Exchange and the Nasdaq will resume normal trading hours on Monday.The Securities Industry and Financial Markets Association recommended the U.S. bond market close Friday. It also advised that the bond market shutter early on Thursday, April14 at 2 p.m. Eastern.U.S. commodities markets including gold and oil futures also won't be open for trading Friday.Singapore stock markets will also close on Good Friday.Stock markets in Europe, Hong Kong and Australia will close on Good Friday and on Monday in observance of Easter.A-shares (Northbound) will be closed to April 18 from April 14.Good Friday commemorates the crucifixion of Jesus Christ. It isn’t a federal holiday, which means businesses often stay open. Good Friday is the only time U.S. markets close for the day outside of federal holidays.","news_type":1},"isVote":1,"tweetType":1,"viewCount":208,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9010158405,"gmtCreate":1648303083647,"gmtModify":1676534326470,"author":{"id":"3578476625539127","authorId":"3578476625539127","name":"Justinslh","avatar":"https://static.tigerbbs.com/4aace6371636c60f0a3a97aacd94721c","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578476625539127","authorIdStr":"3578476625539127"},"themes":[],"htmlText":"What trouble ahead?","listText":"What trouble ahead?","text":"What trouble ahead?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9010158405","repostId":"1196027616","repostType":4,"isVote":1,"tweetType":1,"viewCount":275,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9013042330,"gmtCreate":1648660192859,"gmtModify":1676534373493,"author":{"id":"3578476625539127","authorId":"3578476625539127","name":"Justinslh","avatar":"https://static.tigerbbs.com/4aace6371636c60f0a3a97aacd94721c","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578476625539127","authorIdStr":"3578476625539127"},"themes":[],"htmlText":"Didn't sea pull out of India?","listText":"Didn't sea pull out of India?","text":"Didn't sea pull out of India?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9013042330","repostId":"2223287458","repostType":4,"isVote":1,"tweetType":1,"viewCount":369,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9010287279,"gmtCreate":1648396789131,"gmtModify":1676534333844,"author":{"id":"3578476625539127","authorId":"3578476625539127","name":"Justinslh","avatar":"https://static.tigerbbs.com/4aace6371636c60f0a3a97aacd94721c","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578476625539127","authorIdStr":"3578476625539127"},"themes":[],"htmlText":"What about a dozen others too?","listText":"What about a dozen others too?","text":"What about a dozen others too?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9010287279","repostId":"2222855381","repostType":4,"repost":{"id":"2222855381","pubTimestamp":1648341420,"share":"https://ttm.financial/m/news/2222855381?lang=&edition=fundamental","pubTime":"2022-03-27 08:37","market":"us","language":"en","title":"2 Stocks I'm Buying No Matter What the Stock Market Does Next","url":"https://stock-news.laohu8.com/highlight/detail?id=2222855381","media":"Motley Fool","summary":"Investors should use the current market volatility to scoop up these companies and hold them for the next decade.","content":"<html><head></head><body><p>The stock market is known for its volatility, but it might as well be giving investors whiplash because of how fast it&#39;s moving up and down. The <b>Nasdaq Composite</b> index sank in the first three months of 2022, falling 20% by mid-March. After that, it shot right back up. As of this writing, it&#39;s only down 10% year to date.</p><p>Predicting where the market will go over the next week or month is next to impossible, so buying companies that you feel confident in for the next five years is often the best strategy. With this in mind, you should have a watch list full of stocks that you are ready to buy no matter what the stock market does next.</p><p>My watch list is chock-full of companies right now, but <b>Figs </b>( FIGS -2.25% ) and <b>Fiverr</b> ( FVRR -4.12% ) are near the top of it.</p><p><img src=\"https://static.tigerbbs.com/67490ad97506e19cacb499d01cca8217\" tg-width=\"700\" tg-height=\"466\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"/></p><p>Image source: Figs.</p><h2>1. Figs</h2><p>Figs is uniquely positioned with <a href=\"https://laohu8.com/S/AONE.U\">one</a> of the strongest brands in a niche market. The company sells hospital scrubs for nurses and other healthcare professionals, but it carries two characteristics: a strong brand name that no competitor has been able to reach as well as a gold-standard product in the industry. The company&#39;s Net Promoter Score (NPS) -- which measures customer satisfaction on a scale of -100 to 100, with a score of 70 being considered &#34;world-class&#34; -- was over 80 at the end of 2021. This is phenomenal, beating out even some of the strongest brands. <b>Peloton</b> only has an NPS of 68.</p><p>Figs&#39; scrubs are much higher quality than its competition. The company realizes that its customers wear its products every day, often for 10 or more hours, so it has prioritized comfort and utility. As a result of this quality and brand name, Figs has been able to price its products at a pretty penny: The company achieved a nearly 72% gross margin in 2021.</p><p>To be clear, Figs does face stiff competition and pushback from price-sensitive buyers. Jaanuu, another scrubs maker, can be more attractive to the price-sensitive consumer, and with Figs&#39; scrubs being a few dollars more expensive than those of its counterpart, that could hurt the business. Still, Jaanuu has yet to reach Figs&#39; level of brand recognition, which is a major selling point.</p><p>The company&#39;s adoption by healthcare workers has been nothing short of impressive. Figs had 1.9 million active customers in Q4 2021 who generated nearly $420 million in revenue for the year, up 60% from a year ago. And now, the company has expanded into a wider array of products, offering everything from outerwear to lifestyle products like sweatshirts and joggers that can be worn outside of work. Lifestyle products only represented 17% of revenue in Q4, but management believes this segment is just getting started.</p><p>With the U.S. healthcare apparel market worth $12 billion, Figs still has plenty of room to grow. The company also has aspirations to expand internationally, which could push its opportunity to $79 billion.</p><p>There is no doubt that the company&#39;s potential is immense, and considering Figs is trading at just 8.6 times sales -- not much higher than other apparel companies like <b>Lululemon</b> -- it&#39;s near the top of my watch list, and it should be on yours too.</p><h2>2. Fiverr</h2><p>Fiverr has been hammered recently, falling more than 77% from its all-time high set in January 2021. The company is one of the leading platforms for connecting freelancers with businesses, so it naturally gained popularity during the COVID-19 pandemic.</p><p>However, as the world began to reopen, many investors lost faith in the company, thinking that demand for its services would fall. On the contrary, Fiverr has seen continued success. Fiverr posted record revenue of $298 million for 2021, which grew a staggering 57% from 2020.</p><p>A driver of this was the company&#39;s take rate increase -- the portion of revenue that Fiverr keeps to itself from every transaction -- which is now over 29%. Considering that active buyers on the platform grew 23% year over year at the end of 2021, the value that Fiverr brings to its buyers seems to be worth the price hike.</p><p>The company did lose $65 million in 2021, but this is not as worrisome as one might think. Its $35.4 million in 2021 free cash flow can fuel most of this loss, and the $192 million in cash and securities on its balance sheet could help fund the rest.</p><p>It&#39;s clear that Fiverr&#39;s service is still valuable to millions of businesses around the world, and that might not change as long as freelancers continue to enjoy working from home. At nine times sales, the stock looks especially appealing today. Investors might want to consider owning this company, even if the market continues to swing up and down over the coming months.</p></body></html>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>2 Stocks I'm Buying No Matter What the Stock Market Does Next</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n2 Stocks I'm Buying No Matter What the Stock Market Does Next\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-03-27 08:37 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2022/03/26/2-stocks-im-buying-no-matter-what-the-stock-market/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The stock market is known for its volatility, but it might as well be giving investors whiplash because of how fast it's moving up and down. The Nasdaq Composite index sank in the first three months ...</p>\n\n<a href=\"https://www.fool.com/investing/2022/03/26/2-stocks-im-buying-no-matter-what-the-stock-market/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4539":"次新股","BK4198":"医疗保健用品","BK4535":"淡马锡持仓","FIGS":"FIGS, Inc.","BK4561":"索罗斯持仓","FVRR":"Fiverr International Ltd."},"source_url":"https://www.fool.com/investing/2022/03/26/2-stocks-im-buying-no-matter-what-the-stock-market/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2222855381","content_text":"The stock market is known for its volatility, but it might as well be giving investors whiplash because of how fast it's moving up and down. The Nasdaq Composite index sank in the first three months of 2022, falling 20% by mid-March. After that, it shot right back up. As of this writing, it's only down 10% year to date.Predicting where the market will go over the next week or month is next to impossible, so buying companies that you feel confident in for the next five years is often the best strategy. With this in mind, you should have a watch list full of stocks that you are ready to buy no matter what the stock market does next.My watch list is chock-full of companies right now, but Figs ( FIGS -2.25% ) and Fiverr ( FVRR -4.12% ) are near the top of it.Image source: Figs.1. FigsFigs is uniquely positioned with one of the strongest brands in a niche market. The company sells hospital scrubs for nurses and other healthcare professionals, but it carries two characteristics: a strong brand name that no competitor has been able to reach as well as a gold-standard product in the industry. The company's Net Promoter Score (NPS) -- which measures customer satisfaction on a scale of -100 to 100, with a score of 70 being considered \"world-class\" -- was over 80 at the end of 2021. This is phenomenal, beating out even some of the strongest brands. Peloton only has an NPS of 68.Figs' scrubs are much higher quality than its competition. The company realizes that its customers wear its products every day, often for 10 or more hours, so it has prioritized comfort and utility. As a result of this quality and brand name, Figs has been able to price its products at a pretty penny: The company achieved a nearly 72% gross margin in 2021.To be clear, Figs does face stiff competition and pushback from price-sensitive buyers. Jaanuu, another scrubs maker, can be more attractive to the price-sensitive consumer, and with Figs' scrubs being a few dollars more expensive than those of its counterpart, that could hurt the business. Still, Jaanuu has yet to reach Figs' level of brand recognition, which is a major selling point.The company's adoption by healthcare workers has been nothing short of impressive. Figs had 1.9 million active customers in Q4 2021 who generated nearly $420 million in revenue for the year, up 60% from a year ago. And now, the company has expanded into a wider array of products, offering everything from outerwear to lifestyle products like sweatshirts and joggers that can be worn outside of work. Lifestyle products only represented 17% of revenue in Q4, but management believes this segment is just getting started.With the U.S. healthcare apparel market worth $12 billion, Figs still has plenty of room to grow. The company also has aspirations to expand internationally, which could push its opportunity to $79 billion.There is no doubt that the company's potential is immense, and considering Figs is trading at just 8.6 times sales -- not much higher than other apparel companies like Lululemon -- it's near the top of my watch list, and it should be on yours too.2. FiverrFiverr has been hammered recently, falling more than 77% from its all-time high set in January 2021. The company is one of the leading platforms for connecting freelancers with businesses, so it naturally gained popularity during the COVID-19 pandemic.However, as the world began to reopen, many investors lost faith in the company, thinking that demand for its services would fall. On the contrary, Fiverr has seen continued success. Fiverr posted record revenue of $298 million for 2021, which grew a staggering 57% from 2020.A driver of this was the company's take rate increase -- the portion of revenue that Fiverr keeps to itself from every transaction -- which is now over 29%. Considering that active buyers on the platform grew 23% year over year at the end of 2021, the value that Fiverr brings to its buyers seems to be worth the price hike.The company did lose $65 million in 2021, but this is not as worrisome as one might think. Its $35.4 million in 2021 free cash flow can fuel most of this loss, and the $192 million in cash and securities on its balance sheet could help fund the rest.It's clear that Fiverr's service is still valuable to millions of businesses around the world, and that might not change as long as freelancers continue to enjoy working from home. At nine times sales, the stock looks especially appealing today. Investors might want to consider owning this company, even if the market continues to swing up and down over the coming months.","news_type":1},"isVote":1,"tweetType":1,"viewCount":119,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9013295890,"gmtCreate":1648732375353,"gmtModify":1676534387446,"author":{"id":"3578476625539127","authorId":"3578476625539127","name":"Justinslh","avatar":"https://static.tigerbbs.com/4aace6371636c60f0a3a97aacd94721c","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578476625539127","authorIdStr":"3578476625539127"},"themes":[],"htmlText":"Is it going to hit the $100 mark?","listText":"Is it going to hit the $100 mark?","text":"Is it going to hit the $100 mark?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9013295890","repostId":"1141361635","repostType":4,"repost":{"id":"1141361635","pubTimestamp":1648731658,"share":"https://ttm.financial/m/news/1141361635?lang=&edition=fundamental","pubTime":"2022-03-31 21:00","market":"us","language":"en","title":"Micron is Processing Strong Revenues, Can it Continue?","url":"https://stock-news.laohu8.com/highlight/detail?id=1141361635","media":"TipRanks","summary":"Micron Technology, Inc. (MU) is a major player in the rapidly growing semiconductor sector. Despite ","content":"<div>\n<p>Micron Technology, Inc. (MU) is a major player in the rapidly growing semiconductor sector. Despite a significant sell-off like most other semiconductor stocks over the last month due to macro issues ...</p>\n\n<a href=\"https://www.tipranks.com/news/article/micron-is-processing-strong-revenues-can-it-continue/\">Web Link</a>\n\n</div>\n","source":"lsy1606183248679","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Micron is Processing Strong Revenues, Can it Continue?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMicron is Processing Strong Revenues, Can it Continue?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-03-31 21:00 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.tipranks.com/news/article/micron-is-processing-strong-revenues-can-it-continue/><strong>TipRanks</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Micron Technology, Inc. (MU) is a major player in the rapidly growing semiconductor sector. Despite a significant sell-off like most other semiconductor stocks over the last month due to macro issues ...</p>\n\n<a href=\"https://www.tipranks.com/news/article/micron-is-processing-strong-revenues-can-it-continue/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MU":"美光科技"},"source_url":"https://www.tipranks.com/news/article/micron-is-processing-strong-revenues-can-it-continue/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1141361635","content_text":"Micron Technology, Inc. (MU) is a major player in the rapidly growing semiconductor sector. Despite a significant sell-off like most other semiconductor stocks over the last month due to macro issues and investor worries, the stock has risen about 12% in the last six months.The corporation recently reported excellent fiscal second-quarter financial results, with both revenues and profitability surpassed analyst expectations. In addition, the firm provided a positive fiscal Q3 outlook, which explains the stock’s gain on Wednesday.What do its Q2 Earnings Results Indicate?Micron has been delivering substantial growth, especially over the past couple of years. The company’s Q2 2022 results crushed the market’s expectations by reporting a nearly 25% year-over-year surge in revenues. According to MU, revenues were primarily driven by robust performance across data centers.Meanwhile, adjusted earnings per share increased 8.6% to $2.14 per share year-over-year.In addition to the exceptional results, Micron’s guidance for the upcoming quarter thrilled the market. Adjusted revenue is expected to be in the range of $8.5-$8.9 billion, with adjusted earnings of $2.36 to $2.56 per share, which is higher than consensus projections of $8.06 billion and $2.21 per share, respectively.The findings reveal that Micron is benefiting from a better price environment for both its NAND and DRAM memory products. Furthermore, as enterprises spend extensively in digital ecosystems to extend their cloud and hybrid platforms, Micron’s data center processors should continue to remain in high demand.Wall Street’s TakeOn TipRanks, Micron stock commands a Strong Buy consensus rating based on 17 Buys and one Hold. As for price targets, the average MU stock price prediction of $116.83 implies an almost 48% upside potential from the current level.Bottom LineMicron stock is all set to continue its rally in 2022, driven by the high demand for memory, storage, and advanced processors in the market. Further, Micron’s technological leadership across DRAM and NAND, 5G momentum, accelerating demand for data-center chips, strong financials, and, robust product portfolio should all help the company gain traction.However, existing supply challenges and expectations of costs to rise could limit the upside in Micron stock to some extent.","news_type":1},"isVote":1,"tweetType":1,"viewCount":510,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9013298654,"gmtCreate":1648731948452,"gmtModify":1676534387390,"author":{"id":"3578476625539127","authorId":"3578476625539127","name":"Justinslh","avatar":"https://static.tigerbbs.com/4aace6371636c60f0a3a97aacd94721c","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578476625539127","authorIdStr":"3578476625539127"},"themes":[],"htmlText":"It's about time to have some good news","listText":"It's about time to have some good news","text":"It's about time to have some good news","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9013298654","repostId":"1175936357","repostType":4,"isVote":1,"tweetType":1,"viewCount":247,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9010269056,"gmtCreate":1648397104798,"gmtModify":1676534333876,"author":{"id":"3578476625539127","authorId":"3578476625539127","name":"Justinslh","avatar":"https://static.tigerbbs.com/4aace6371636c60f0a3a97aacd94721c","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578476625539127","authorIdStr":"3578476625539127"},"themes":[],"htmlText":"Is the high iPhone price that is driving the profits?&nbsp;","listText":"Is the high iPhone price that is driving the profits?&nbsp;","text":"Is the high iPhone price that is driving the profits?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9010269056","repostId":"1155138099","repostType":4,"isVote":1,"tweetType":1,"viewCount":277,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9013042097,"gmtCreate":1648660076788,"gmtModify":1676534373494,"author":{"id":"3578476625539127","authorId":"3578476625539127","name":"Justinslh","avatar":"https://static.tigerbbs.com/4aace6371636c60f0a3a97aacd94721c","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578476625539127","authorIdStr":"3578476625539127"},"themes":[],"htmlText":"Is there any pharma or industrial stock like these?","listText":"Is there any pharma or industrial stock like these?","text":"Is there any pharma or industrial stock like these?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9013042097","repostId":"2223092538","repostType":4,"repost":{"id":"2223092538","pubTimestamp":1648644301,"share":"https://ttm.financial/m/news/2223092538?lang=&edition=fundamental","pubTime":"2022-03-30 20:45","market":"us","language":"en","title":"3 Growth Stocks With Monster Upside of Up to 331%, According to Wall Street","url":"https://stock-news.laohu8.com/highlight/detail?id=2223092538","media":"Motley Fool","summary":"Select analysts believe these fast-paced stocks can soar over the next 12 months.","content":"<html><head></head><body><p><b>KEY POINTS</b></p><ul><li>If these high-water price targets are hit, investors would enjoy upside ranging from 179% to 331%.</li><li>Analysts&#39; lofty price targets often fail to capture the challenges high-growth companies are facing.</li></ul><p>Over the long run, the stock market has proved to be a wealth-building machine. Even though corrections are commonplace, investors are typically doubling their money about once a decade.</p><p>But for a select group of high-growth stocks, simply doubling your money in a decade won&#39;t suffice. According to the high-water 12-month price targets from a group of Wall Street analysts, the following three supercharged growth stocks offer monster upside ranging from 179% on the low end to as much as 331%.</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/eb5c43d2584290008d74d267dba12d47\" tg-width=\"700\" tg-height=\"535\" width=\"100%\" height=\"auto\"/><span>Image source: Getty Images.</span></p><p><b>Rivian Automotive: Implied upside of 218%</b></p><p>The first fast-paced company with significant upside potential is the hottest initial public offering (IPO) of 2021, electric vehicle (EV) manufacturer <b>Rivian Automotive</b>. Analyst Adam Jonas of <b><a href=\"https://laohu8.com/S/MSTLW\">Morgan Stanley</a></b> boasts the highest price target on Wall Street for Rivian. If Jonas&#39;s $147 price target were to hit, it would represent an increase of 218% from where shares ended this past week.</p><p>Jonas&#39;s lofty projection is based on the expectation that Rivian will be producing 1.5 million battery EVs (BEVs) annually by 2030, and will be able to grow its software business from an estimated $641 million in 2025 to approximately $36 billion by 2040 as the installed base of Rivian BEVs grows.</p><p>Pardon the pun, but the bullishness surrounding Rivian does have some fuel behind it. In 2019, the company secured an order for 100,000 electric vans from e-commerce giant <b>Amazon</b>. Even before becoming a publicly traded company, this order provided some level of validation that Rivian was poised to become a major EV player. Also, keep in mind that Rivian&#39;s R1T electric truck looks to be in a class of its own with regard to luxury EV trucks.</p><p>Additionally, Rivian is sitting on a mountain of capital following its IPO. The company ended 2021 with $18.4 billion in cash and cash equivalents, which is allowing management to aggressively invest in production expansion efforts.  For instance, $5 billion is being spent to build a manufacturing plant in Georgia that&#39;ll produce up to 400,000 EVs annually once it begins production in 2024.</p><p>But betting on Rivian to become a $130 billion company seems like a stretch when supply chain issues have cut expected EV production to 25,000 in 2022 from an estimated 50,000.</p><p>What&#39;s more, rising material costs have put Rivian between a rock and a hard place. Earlier this month, the company announced significant price hikes on its quad-motor models, only to walk back to those hikes on people who&#39;d placed reservations with the company prior to March 1. As EV companies like <b>Nikola</b> and <b>Lordstown Motors</b> have shown, overcoming PR flubs can be very difficult. Suffice it to say, $147 doesn&#39;t look achievable anytime soon.</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/1abce5caf5e785b826f62bb98ff77b01\" tg-width=\"700\" tg-height=\"466\" width=\"100%\" height=\"auto\"/><span>Image source: Getty Images.</span></p><p><b>Ocugen: Implied upside of 331%</b></p><p>A second high-growth stock with monster upside potential, at least in the eyes of <a href=\"https://laohu8.com/S/AONE.U\">one</a> Wall Street analyst, is small-cap biotech company <b>Ocugen</b>( OCGN 6.87% ). According to Robert LeBoyer of Noble Financial, Ocugen can hit $15 a share, which would represent jaw-dropping upside of 331% from where it closed this past week.</p><p>In LeBoyer&#39;s view, Ocugen&#39;s upside is tied to COVID-19 vaccine Covaxin, which in his view holds competitive advantages over other COVID-19 vaccines already in use in North America. The U.S. Food and Drug Administration (FDA) recently removed a partial clinical hold on Covaxin in the U.S., which officially clears a path for Ocugen to submit a biologics licensing application on the drug it&#39;s commercially licensed from Bharat Biotech.</p><p>Last year, Bharat Biotech ran a large-scale study involving Covaxin on 25,800 people in India. That trial produced a vaccine efficacy (VE) of 78%. Considering that there are billions of people worldwide still in need of initial COVID-19 inoculations and/or booster shots, we&#39;re still at a stage where new and effective vaccines are welcome on the global stage.</p><p>The issue for Ocugen is that its commercial agreement with Bharat concerning Covaxin only covers the U.S. and Canada. While these are traditionally high-margin markets, the U.S. and Canada have heavily invested in COVID-19 vaccines. A large percentage of the population for both countries have already been vaccinated and/or received booster shots. Further, new vaccine options with a higher VE than Covaxin are waiting in the wings.</p><p>To make matters worse, the FDA declined to grant Covaxin a pathway to emergency-use authorization (EUA) for pediatric patients aged 2 to 18. Despite the company announcing that it would continue to work with the FDA on a possible EUA path for pediatric patients, this revenue channel looks to be shut off.</p><p>Long story short, Ocugen still looks to be a ways away from having any chance of getting Covaxin approved for use in the U.S. -- and even if it&#39;s approved, there&#39;s little assurance it&#39;ll be used over other vaccines with higher VEs. LeBoyer&#39;s $15 price target is highly unlikely to be hit.</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/51b9e73cc74dad844548f15906c23624\" tg-width=\"700\" tg-height=\"466\" width=\"100%\" height=\"auto\"/><span>Image source: Getty Images.</span></p><p><b>Plug Power: Implied upside of 179%</b></p><p>The third growth stock with salivating upside is hydrogen fuel-cell solutions provider <b>Plug Power</b>. According to H.C. Wainwright analyst Amit Dayal, Plug Power can hit $78 a share, which would represent an increase of 179% from where shares ended this past week.</p><p>Dayal&#39;s high-water price target on Plug Power is based on an expansion of the company&#39;s green hydrogen network, and the ongoing deployment of the company&#39;s hydrogen fuel-cell-powered GenDrive units. With most markets promoting clean-energy solutions, Dayal anticipates the company&#39;s margins will improve across the board.</p><p>Plug Power really put itself on the map in early 2021 when it struck two major partnerships within a span of one week. In January 2021, SK Group took a 10% equity stake in the company and formed a joint venture to bring fuel-cell solutions (for vehicles and refilling stations) to numerous Asian markets. Roughly a week later, Plug and French auto company <b>Renault</b> forged a joint venture to tackle Europe&#39;s light commercial vehicle market. These deals signaled that Plug&#39;s fuel-cell solutions were about more than just powering forklifts in warehouses.</p><p>The company has also signaled its willingness to be a key next-gen energy player with acquisitions. In December, it completed its buyout of green hydrogen solutions company Frames Group, which furthers Plug&#39;s ambitions of becoming one of world&#39;s leading green hydrogen ecosystems.</p><p>While there&#39;s little question that developed countries are pushing for green-energy alternative to fight climate change, it&#39;s not yet clear if Plug Power has the solutions that&#39;ll be preferred. Even at a $28 share price, we&#39;re talking about a company with a greater than $16 billion market cap that&#39;s losing money and hasn&#39;t yet demonstrated if it can handle rapid scaling. This isn&#39;t to say that it won&#39;t be able to scale its ecosystem, so much as to point out that its valuation implies everything will go off without a hitch. Rarely is that the case with next-gen technologies and solutions.</p><p>Although Plug Power is a company people can hope is successful, it has a lot of questions to answer at its current valuation, let alone one that would be 179% higher.</p></body></html>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Growth Stocks With Monster Upside of Up to 331%, According to Wall Street</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Growth Stocks With Monster Upside of Up to 331%, According to Wall Street\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-03-30 20:45 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2022/03/30/3-growth-stocks-monster-upside-to-331-wall-street/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>KEY POINTSIf these high-water price targets are hit, investors would enjoy upside ranging from 179% to 331%.Analysts' lofty price targets often fail to capture the challenges high-growth companies are...</p>\n\n<a href=\"https://www.fool.com/investing/2022/03/30/3-growth-stocks-monster-upside-to-331-wall-street/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"RIVN":"Rivian Automotive, Inc.","PLUG":"普拉格能源","OCGN":"Ocugen"},"source_url":"https://www.fool.com/investing/2022/03/30/3-growth-stocks-monster-upside-to-331-wall-street/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2223092538","content_text":"KEY POINTSIf these high-water price targets are hit, investors would enjoy upside ranging from 179% to 331%.Analysts' lofty price targets often fail to capture the challenges high-growth companies are facing.Over the long run, the stock market has proved to be a wealth-building machine. Even though corrections are commonplace, investors are typically doubling their money about once a decade.But for a select group of high-growth stocks, simply doubling your money in a decade won't suffice. According to the high-water 12-month price targets from a group of Wall Street analysts, the following three supercharged growth stocks offer monster upside ranging from 179% on the low end to as much as 331%.Image source: Getty Images.Rivian Automotive: Implied upside of 218%The first fast-paced company with significant upside potential is the hottest initial public offering (IPO) of 2021, electric vehicle (EV) manufacturer Rivian Automotive. Analyst Adam Jonas of Morgan Stanley boasts the highest price target on Wall Street for Rivian. If Jonas's $147 price target were to hit, it would represent an increase of 218% from where shares ended this past week.Jonas's lofty projection is based on the expectation that Rivian will be producing 1.5 million battery EVs (BEVs) annually by 2030, and will be able to grow its software business from an estimated $641 million in 2025 to approximately $36 billion by 2040 as the installed base of Rivian BEVs grows.Pardon the pun, but the bullishness surrounding Rivian does have some fuel behind it. In 2019, the company secured an order for 100,000 electric vans from e-commerce giant Amazon. Even before becoming a publicly traded company, this order provided some level of validation that Rivian was poised to become a major EV player. Also, keep in mind that Rivian's R1T electric truck looks to be in a class of its own with regard to luxury EV trucks.Additionally, Rivian is sitting on a mountain of capital following its IPO. The company ended 2021 with $18.4 billion in cash and cash equivalents, which is allowing management to aggressively invest in production expansion efforts.  For instance, $5 billion is being spent to build a manufacturing plant in Georgia that'll produce up to 400,000 EVs annually once it begins production in 2024.But betting on Rivian to become a $130 billion company seems like a stretch when supply chain issues have cut expected EV production to 25,000 in 2022 from an estimated 50,000.What's more, rising material costs have put Rivian between a rock and a hard place. Earlier this month, the company announced significant price hikes on its quad-motor models, only to walk back to those hikes on people who'd placed reservations with the company prior to March 1. As EV companies like Nikola and Lordstown Motors have shown, overcoming PR flubs can be very difficult. Suffice it to say, $147 doesn't look achievable anytime soon.Image source: Getty Images.Ocugen: Implied upside of 331%A second high-growth stock with monster upside potential, at least in the eyes of one Wall Street analyst, is small-cap biotech company Ocugen( OCGN 6.87% ). According to Robert LeBoyer of Noble Financial, Ocugen can hit $15 a share, which would represent jaw-dropping upside of 331% from where it closed this past week.In LeBoyer's view, Ocugen's upside is tied to COVID-19 vaccine Covaxin, which in his view holds competitive advantages over other COVID-19 vaccines already in use in North America. The U.S. Food and Drug Administration (FDA) recently removed a partial clinical hold on Covaxin in the U.S., which officially clears a path for Ocugen to submit a biologics licensing application on the drug it's commercially licensed from Bharat Biotech.Last year, Bharat Biotech ran a large-scale study involving Covaxin on 25,800 people in India. That trial produced a vaccine efficacy (VE) of 78%. Considering that there are billions of people worldwide still in need of initial COVID-19 inoculations and/or booster shots, we're still at a stage where new and effective vaccines are welcome on the global stage.The issue for Ocugen is that its commercial agreement with Bharat concerning Covaxin only covers the U.S. and Canada. While these are traditionally high-margin markets, the U.S. and Canada have heavily invested in COVID-19 vaccines. A large percentage of the population for both countries have already been vaccinated and/or received booster shots. Further, new vaccine options with a higher VE than Covaxin are waiting in the wings.To make matters worse, the FDA declined to grant Covaxin a pathway to emergency-use authorization (EUA) for pediatric patients aged 2 to 18. Despite the company announcing that it would continue to work with the FDA on a possible EUA path for pediatric patients, this revenue channel looks to be shut off.Long story short, Ocugen still looks to be a ways away from having any chance of getting Covaxin approved for use in the U.S. -- and even if it's approved, there's little assurance it'll be used over other vaccines with higher VEs. LeBoyer's $15 price target is highly unlikely to be hit.Image source: Getty Images.Plug Power: Implied upside of 179%The third growth stock with salivating upside is hydrogen fuel-cell solutions provider Plug Power. According to H.C. Wainwright analyst Amit Dayal, Plug Power can hit $78 a share, which would represent an increase of 179% from where shares ended this past week.Dayal's high-water price target on Plug Power is based on an expansion of the company's green hydrogen network, and the ongoing deployment of the company's hydrogen fuel-cell-powered GenDrive units. With most markets promoting clean-energy solutions, Dayal anticipates the company's margins will improve across the board.Plug Power really put itself on the map in early 2021 when it struck two major partnerships within a span of one week. In January 2021, SK Group took a 10% equity stake in the company and formed a joint venture to bring fuel-cell solutions (for vehicles and refilling stations) to numerous Asian markets. Roughly a week later, Plug and French auto company Renault forged a joint venture to tackle Europe's light commercial vehicle market. These deals signaled that Plug's fuel-cell solutions were about more than just powering forklifts in warehouses.The company has also signaled its willingness to be a key next-gen energy player with acquisitions. In December, it completed its buyout of green hydrogen solutions company Frames Group, which furthers Plug's ambitions of becoming one of world's leading green hydrogen ecosystems.While there's little question that developed countries are pushing for green-energy alternative to fight climate change, it's not yet clear if Plug Power has the solutions that'll be preferred. Even at a $28 share price, we're talking about a company with a greater than $16 billion market cap that's losing money and hasn't yet demonstrated if it can handle rapid scaling. This isn't to say that it won't be able to scale its ecosystem, so much as to point out that its valuation implies everything will go off without a hitch. Rarely is that the case with next-gen technologies and solutions.Although Plug Power is a company people can hope is successful, it has a lot of questions to answer at its current valuation, let alone one that would be 179% higher.","news_type":1},"isVote":1,"tweetType":1,"viewCount":345,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9019813276,"gmtCreate":1648572854376,"gmtModify":1676534356017,"author":{"id":"3578476625539127","authorId":"3578476625539127","name":"Justinslh","avatar":"https://static.tigerbbs.com/4aace6371636c60f0a3a97aacd94721c","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578476625539127","authorIdStr":"3578476625539127"},"themes":[],"htmlText":"iPhone se sales not as expected?","listText":"iPhone se sales not as expected?","text":"iPhone se sales not as expected?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9019813276","repostId":"1127392287","repostType":4,"isVote":1,"tweetType":1,"viewCount":472,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9011416043,"gmtCreate":1648905703548,"gmtModify":1676534420357,"author":{"id":"3578476625539127","authorId":"3578476625539127","name":"Justinslh","avatar":"https://static.tigerbbs.com/4aace6371636c60f0a3a97aacd94721c","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578476625539127","authorIdStr":"3578476625539127"},"themes":[],"htmlText":"When is it ever gg to happen,&nbsp; have been waiting for ages","listText":"When is it ever gg to happen,&nbsp; have been waiting for ages","text":"When is it ever gg to happen, have been waiting for ages","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9011416043","repostId":"1104624292","repostType":4,"repost":{"id":"1104624292","pubTimestamp":1648824223,"share":"https://ttm.financial/m/news/1104624292?lang=&edition=fundamental","pubTime":"2022-04-01 22:43","market":"us","language":"en","title":"House Set to Vote on a Bill to Legalize Marijuana Today. What That Means for Cannabis Stocks.","url":"https://stock-news.laohu8.com/highlight/detail?id=1104624292","media":"Barrons","summary":"Cannabis stocks were rising Friday ahead of a highly anticipated House vote on a bill to decriminali","content":"<html><head></head><body><p>Cannabis stocks were rising Friday ahead of a highly anticipated House vote on a bill to decriminalize marijuana.</p><p>The House of Representatives bill, called the Marijuana Opportunity Reinvestment and Expungement Act, or MORE Act, would remove marijuana from the list of scheduled substances and impose a federal tax on marijuana products.  It would also establish a process to expunge prior cannabis convictions.</p><p>On Wednesday, the House Rules Committee voted to move the MORE Act to an official floor vote scheduled for mid-morning Friday.</p><p>Pot stocks traded lower Friday in anticipation of the vote. Aurora Cannabis (ticker: ACB) was up 1.8%, Curaleaf (CURA) was rising 1.7%, and Cronos Group (CRON) climbed 1.7%. Sundial Growers ( SNDL) rose 2.8%, and Canopy Growth (CGC) gained 1.3%. Tilray Brands (TLRY) stock was up 3.4%.</p><p>Thirty six states and the District of Columbia have legalized medical marijuana over the last few years, and 19 states plus D.C. have decriminalized recreational marijuana use for adults, said House Judiciary Committee Chairman Jerrold Nadler, one of the bill’s sponsors.</p><p>“If states are the laboratories of democracy, it is long past time for the federal get to recognize that this experiment in legalization has been a resounding success,” he said at Wednesday’s committee hearing.</p><p>Federal legalization could have major ramifications for cannabis companies, which would no longer be subject to a section of the U.S. internal revenue code that prohibits taxpayers from deducting business expenses associated with controlled substances, wrote Pedro Palandrani, director of research at Global X ETFs, in an emailed statement. Palandrani oversees the firm’s cannabis ETF ( POTX ), which was down 0.4%.</p><p>Legalization also could unlock access to basic financing options, like loans and capital raising on U.S. exchanges, that were previously inaccessible to cannabis companies, he added.</p><p>“Furthermore, the possible establishment of cannabis as a commodity with futures contracts and more relaxed regulations regarding land use for cannabis cultivation could also assist developing supply chain dynamics,” Palandrani wrote.</p><p>Analysts widely expect the bill to clear the House, but are more skeptical about its prospects in the Senate. In 2020, a similar bill passed the House but stalled in the upper chamber after failing to garner sufficient support.</p><p>They are more optimistic that the Secure and Fair Enforcement Banking Act, or SAFE Act, passes later this year. The SAFE Act would prohibit federal banking regulators from penalizing banks that work with cannabis businesses legalized by states. The House passed the measure in February.</p><p>But the SAFE Act would have a limited positive impact on cannabis operators, analysts said. Weed would remain illegal at a federal level, creating an obstacle for Canadian companies like Tilray to move into the U.S.</p></body></html>","source":"lsy1601382232898","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>House Set to Vote on a Bill to Legalize Marijuana Today. What That Means for Cannabis Stocks.</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHouse Set to Vote on a Bill to Legalize Marijuana Today. What That Means for Cannabis Stocks.\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-04-01 22:43 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.barrons.com/articles/marijuana-legalization-vote-cannabis-pot-stocks-tilray-51648813285?mod=hp_LATEST><strong>Barrons</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Cannabis stocks were rising Friday ahead of a highly anticipated House vote on a bill to decriminalize marijuana.The House of Representatives bill, called the Marijuana Opportunity Reinvestment and ...</p>\n\n<a href=\"https://www.barrons.com/articles/marijuana-legalization-vote-cannabis-pot-stocks-tilray-51648813285?mod=hp_LATEST\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"CRON":"Cronos Group Inc.","POTX":"Global X Cannabis ETF","TLRY":"Tilray Inc.","CURLF":"Curaleaf Hldgs Inc.","ACB":"奥罗拉大麻公司","CGC":"Canopy Growth Corporation","SNDL":"SNDL Inc."},"source_url":"https://www.barrons.com/articles/marijuana-legalization-vote-cannabis-pot-stocks-tilray-51648813285?mod=hp_LATEST","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1104624292","content_text":"Cannabis stocks were rising Friday ahead of a highly anticipated House vote on a bill to decriminalize marijuana.The House of Representatives bill, called the Marijuana Opportunity Reinvestment and Expungement Act, or MORE Act, would remove marijuana from the list of scheduled substances and impose a federal tax on marijuana products.  It would also establish a process to expunge prior cannabis convictions.On Wednesday, the House Rules Committee voted to move the MORE Act to an official floor vote scheduled for mid-morning Friday.Pot stocks traded lower Friday in anticipation of the vote. Aurora Cannabis (ticker: ACB) was up 1.8%, Curaleaf (CURA) was rising 1.7%, and Cronos Group (CRON) climbed 1.7%. Sundial Growers ( SNDL) rose 2.8%, and Canopy Growth (CGC) gained 1.3%. Tilray Brands (TLRY) stock was up 3.4%.Thirty six states and the District of Columbia have legalized medical marijuana over the last few years, and 19 states plus D.C. have decriminalized recreational marijuana use for adults, said House Judiciary Committee Chairman Jerrold Nadler, one of the bill’s sponsors.“If states are the laboratories of democracy, it is long past time for the federal get to recognize that this experiment in legalization has been a resounding success,” he said at Wednesday’s committee hearing.Federal legalization could have major ramifications for cannabis companies, which would no longer be subject to a section of the U.S. internal revenue code that prohibits taxpayers from deducting business expenses associated with controlled substances, wrote Pedro Palandrani, director of research at Global X ETFs, in an emailed statement. Palandrani oversees the firm’s cannabis ETF ( POTX ), which was down 0.4%.Legalization also could unlock access to basic financing options, like loans and capital raising on U.S. exchanges, that were previously inaccessible to cannabis companies, he added.“Furthermore, the possible establishment of cannabis as a commodity with futures contracts and more relaxed regulations regarding land use for cannabis cultivation could also assist developing supply chain dynamics,” Palandrani wrote.Analysts widely expect the bill to clear the House, but are more skeptical about its prospects in the Senate. In 2020, a similar bill passed the House but stalled in the upper chamber after failing to garner sufficient support.They are more optimistic that the Secure and Fair Enforcement Banking Act, or SAFE Act, passes later this year. The SAFE Act would prohibit federal banking regulators from penalizing banks that work with cannabis businesses legalized by states. The House passed the measure in February.But the SAFE Act would have a limited positive impact on cannabis operators, analysts said. Weed would remain illegal at a federal level, creating an obstacle for Canadian companies like Tilray to move into the U.S.","news_type":1},"isVote":1,"tweetType":1,"viewCount":194,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9010260095,"gmtCreate":1648396920125,"gmtModify":1676534333852,"author":{"id":"3578476625539127","authorId":"3578476625539127","name":"Justinslh","avatar":"https://static.tigerbbs.com/4aace6371636c60f0a3a97aacd94721c","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578476625539127","authorIdStr":"3578476625539127"},"themes":[],"htmlText":"Can name a few other Buffet stocks?","listText":"Can name a few other Buffet stocks?","text":"Can name a few other Buffet stocks?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9010260095","repostId":"2222855376","repostType":4,"repost":{"id":"2222855376","pubTimestamp":1648341227,"share":"https://ttm.financial/m/news/2222855376?lang=&edition=fundamental","pubTime":"2022-03-27 08:33","market":"us","language":"en","title":"Have $1,000? 2 Warren Buffett Stocks to Buy","url":"https://stock-news.laohu8.com/highlight/detail?id=2222855376","media":"Motley Fool","summary":"Through up and down markets, compounding dividends can be a game-changer for long-term investors.","content":"<html><head></head><body><p>Whether you&#39;re an investor just starting out or <a href=\"https://laohu8.com/S/AONE.U\">one</a> who might have a limited budget, it&#39;s a good practice to invest an amount that you&#39;re willing to be without in the short term so that you can build for the long term. If $1,000 is that mark for you, these two Warren Buffett-backed stocks could provide the foundation you want for your long-term investment strategy.</p><p><b>AbbVie</b> ( ABBV 0.66% ) and <b>Verizon Communications</b> ( VZ 0.55% ) offer innovative products in growing markets, combined with a strategy that withstands market volatility, to reward investors with long-term gains. They also carry a special characteristic that is shared by 63% of the stocks owned by Buffett in his <b>Berkshire Hathaway</b> ( BRK.A 1.92% ) ( BRK.B 1.81% ) portfolio.</p><p><img src=\"https://static.tigerbbs.com/139f2005bebaa471067af13c958a38a8\" tg-width=\"700\" tg-height=\"393\" referrerpolicy=\"no-referrer\"/></p><p>Image source: Getty Images.</p><h2>AbbVie: Building a pipeline to keep revenue flowing</h2><p>AbbVie is one of the smallest holdings in Buffett&#39;s Berkshire Hathaway portfolio, at only 0.1% of the portfolio&#39;s total holdings. But that&#39;s the only thing small about this leading innovator in biopharmaceuticals that has seen its stock price grow 53% over the past year -- crushing the <b>S&amp;P 500</b>&#39;s 14.7% one-year return.</p><p>AbbVie has experienced strong growth of its best-selling drug, Humira, which helped the company realize a 22.7% increase in net revenue in 2021. That growth is expected to continue with an 8% increase in sales for Humira during 2022, but could come to a screeching slowdown in 2023. The company estimates a 45% erosion in sales as a result of biosimilar competition entering the U.S. market on the heels of an expiring patent, with a rebound not expected to happen until 2024.</p><p>To offset those losses, the company is depending on a spike in sales of two potential successors to Humira, Rinvoq and Skyrizi. Together these two medications brought in a combined $4.5 billion in 2021 and are expected to reach $15 billion in 2025. AbbVie is also seeing positive results from its Allergan acquisition in 2020, which netted the company Botox, contributing nearly $5 billion to total sales in 2021.</p><p>Going forward, the company has high expectations for a post-COVID rebound in sales of two leading cancer treatment drugs, as well as a pipeline of late-stage programs in cancer treatment. In total, the company has 13 drugs in phase 3 trials across immunology, neuroscience, eye care, oncology, and gastroenterology. Some of these drugs are already approved for certain indications, which could lead to a smoother path toward approval by the U.S. Food and Drug Administration.</p><p>AbbVie also offers a quarterly dividend that can help keep investors engaged during times of trouble. If you include the time before AbbVie was spun off from <b>Abbott Laboratories</b>, the company has been increasing its annual dividend for 50 years, placing it among the elite class of Dividend Kings. At the current share price, the stock&#39;s annual payout of $5.64 per share results in yield of 3.5%. Over the long term, this can be quite a hefty sum due to compounding gains.</p><p>A robust pipeline of drugs combined with a hefty dividend yield of 3.5% that leads most of its big-cap pharma peers makes AbbVie a Buffett-backed stock I&#39;d see no problem investing $1,000 in.</p><h2>Verizon: Checking off boxes to keep investors satisfied</h2><p>Verizon ranks ninth in Buffett&#39;s Berkshire Hathaway portfolio of 47 stocks in terms of portfolio holding and total value. But the company&#39;s investors have not been exempt from the broader market volatility that has impacted tech stocks, as Verizon&#39;s stock price has seen a 15% decline since May of last year.</p><p>Fortunately, CEO Hans Vestberg, who came on board in 2018 after a stint as chief technology officer, has a clear plan in place that could trigger a rebound. It includes reducing the company&#39;s capital intensity to under 12%, growing dividends, paying down debt, and speeding up a timeline for share repurchases.</p><p>Boxes are already being checked off for that plan. Verizon&#39;s Q4 report highlighted a 6.5% year-over-year growth in wireless services revenue, driven by higher revenue per account, meaning existing customers are spending more. Growth is also coming from an increase in subscriptions for wireless and broadband. FiOS (its bundled service for internet, cable, and telephone) finished Q4 of last year with a 5.7% year-over-year spike in revenue, allowing the company to post its best full-year performance for FiOS since 2014.</p><p>The company expects to check off a few more boxes during 2022, starting with a continued quarterly dividend payout of $0.64 per share, to be paid on May 2 to investors of record on April 8. This represents a 5% dividend yield, topping the telecom sector average of 4.36%.</p><p>By year-end, the company is looking to complete an accelerated plan to bring 5G ultra wideband service to an additional 30 major markets serving over 175 million people -- a full year ahead of schedule. And while doing so, Vestberg has his eyes on reducing capital expenditures 9% to $16.5 billion.</p><p>If 2022 goes according to plan, the company is projecting full-year earnings per share that just slightly tops Wall Street estimates. Management is also looking for 9% to 10% growth in services revenue. Ultimately, Verizon&#39;s technological advancements should lead to new revenue, supported by acquisitions in the telecom space and collaborations with companies such as <b><a href=\"https://laohu8.com/S/FB\">Meta Platforms</a></b> (formerly Facebook) as the two work toward building out the immersive digital world referred to as the metaverse.</p><p>Verizon investors should stand to gain from continued dividends and a wireless market that is projected to grow at a 15.4% compound annual rate through 2027. The company&#39;s shares currently trade at a P/E ratio of 9.6, far below the wireless telecom industry average of 30. All in all, Verizon is an excellent opportunity for long-term investors who are looking for somewhere to invest $1,000.</p></body></html>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Have $1,000? 2 Warren Buffett Stocks to Buy</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHave $1,000? 2 Warren Buffett Stocks to Buy\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-03-27 08:33 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2022/03/26/have-1000-2-warren-buffett-stocks-to-buy/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Whether you're an investor just starting out or one who might have a limited budget, it's a good practice to invest an amount that you're willing to be without in the short term so that you can build ...</p>\n\n<a href=\"https://www.fool.com/investing/2022/03/26/have-1000-2-warren-buffett-stocks-to-buy/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4534":"瑞士信贷持仓","BRK.A":"伯克希尔","BK4176":"多领域控股","BK4581":"高盛持仓","BK4550":"红杉资本持仓","BK4533":"AQR资本管理(全球第二大对冲基金)","ABBV":"艾伯维公司","BRK.B":"伯克希尔B","VZ":"威瑞森"},"source_url":"https://www.fool.com/investing/2022/03/26/have-1000-2-warren-buffett-stocks-to-buy/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2222855376","content_text":"Whether you're an investor just starting out or one who might have a limited budget, it's a good practice to invest an amount that you're willing to be without in the short term so that you can build for the long term. If $1,000 is that mark for you, these two Warren Buffett-backed stocks could provide the foundation you want for your long-term investment strategy.AbbVie ( ABBV 0.66% ) and Verizon Communications ( VZ 0.55% ) offer innovative products in growing markets, combined with a strategy that withstands market volatility, to reward investors with long-term gains. They also carry a special characteristic that is shared by 63% of the stocks owned by Buffett in his Berkshire Hathaway ( BRK.A 1.92% ) ( BRK.B 1.81% ) portfolio.Image source: Getty Images.AbbVie: Building a pipeline to keep revenue flowingAbbVie is one of the smallest holdings in Buffett's Berkshire Hathaway portfolio, at only 0.1% of the portfolio's total holdings. But that's the only thing small about this leading innovator in biopharmaceuticals that has seen its stock price grow 53% over the past year -- crushing the S&P 500's 14.7% one-year return.AbbVie has experienced strong growth of its best-selling drug, Humira, which helped the company realize a 22.7% increase in net revenue in 2021. That growth is expected to continue with an 8% increase in sales for Humira during 2022, but could come to a screeching slowdown in 2023. The company estimates a 45% erosion in sales as a result of biosimilar competition entering the U.S. market on the heels of an expiring patent, with a rebound not expected to happen until 2024.To offset those losses, the company is depending on a spike in sales of two potential successors to Humira, Rinvoq and Skyrizi. Together these two medications brought in a combined $4.5 billion in 2021 and are expected to reach $15 billion in 2025. AbbVie is also seeing positive results from its Allergan acquisition in 2020, which netted the company Botox, contributing nearly $5 billion to total sales in 2021.Going forward, the company has high expectations for a post-COVID rebound in sales of two leading cancer treatment drugs, as well as a pipeline of late-stage programs in cancer treatment. In total, the company has 13 drugs in phase 3 trials across immunology, neuroscience, eye care, oncology, and gastroenterology. Some of these drugs are already approved for certain indications, which could lead to a smoother path toward approval by the U.S. Food and Drug Administration.AbbVie also offers a quarterly dividend that can help keep investors engaged during times of trouble. If you include the time before AbbVie was spun off from Abbott Laboratories, the company has been increasing its annual dividend for 50 years, placing it among the elite class of Dividend Kings. At the current share price, the stock's annual payout of $5.64 per share results in yield of 3.5%. Over the long term, this can be quite a hefty sum due to compounding gains.A robust pipeline of drugs combined with a hefty dividend yield of 3.5% that leads most of its big-cap pharma peers makes AbbVie a Buffett-backed stock I'd see no problem investing $1,000 in.Verizon: Checking off boxes to keep investors satisfiedVerizon ranks ninth in Buffett's Berkshire Hathaway portfolio of 47 stocks in terms of portfolio holding and total value. But the company's investors have not been exempt from the broader market volatility that has impacted tech stocks, as Verizon's stock price has seen a 15% decline since May of last year.Fortunately, CEO Hans Vestberg, who came on board in 2018 after a stint as chief technology officer, has a clear plan in place that could trigger a rebound. It includes reducing the company's capital intensity to under 12%, growing dividends, paying down debt, and speeding up a timeline for share repurchases.Boxes are already being checked off for that plan. Verizon's Q4 report highlighted a 6.5% year-over-year growth in wireless services revenue, driven by higher revenue per account, meaning existing customers are spending more. Growth is also coming from an increase in subscriptions for wireless and broadband. FiOS (its bundled service for internet, cable, and telephone) finished Q4 of last year with a 5.7% year-over-year spike in revenue, allowing the company to post its best full-year performance for FiOS since 2014.The company expects to check off a few more boxes during 2022, starting with a continued quarterly dividend payout of $0.64 per share, to be paid on May 2 to investors of record on April 8. This represents a 5% dividend yield, topping the telecom sector average of 4.36%.By year-end, the company is looking to complete an accelerated plan to bring 5G ultra wideband service to an additional 30 major markets serving over 175 million people -- a full year ahead of schedule. And while doing so, Vestberg has his eyes on reducing capital expenditures 9% to $16.5 billion.If 2022 goes according to plan, the company is projecting full-year earnings per share that just slightly tops Wall Street estimates. Management is also looking for 9% to 10% growth in services revenue. Ultimately, Verizon's technological advancements should lead to new revenue, supported by acquisitions in the telecom space and collaborations with companies such as Meta Platforms (formerly Facebook) as the two work toward building out the immersive digital world referred to as the metaverse.Verizon investors should stand to gain from continued dividends and a wireless market that is projected to grow at a 15.4% compound annual rate through 2027. The company's shares currently trade at a P/E ratio of 9.6, far below the wireless telecom industry average of 30. All in all, Verizon is an excellent opportunity for long-term investors who are looking for somewhere to invest $1,000.","news_type":1},"isVote":1,"tweetType":1,"viewCount":236,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9010012278,"gmtCreate":1648203981692,"gmtModify":1676534316820,"author":{"id":"3578476625539127","authorId":"3578476625539127","name":"Justinslh","avatar":"https://static.tigerbbs.com/4aace6371636c60f0a3a97aacd94721c","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578476625539127","authorIdStr":"3578476625539127"},"themes":[],"htmlText":"Up&nbsp;","listText":"Up&nbsp;","text":"Up","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9010012278","repostId":"1153990586","repostType":4,"repost":{"id":"1153990586","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1648195505,"share":"https://ttm.financial/m/news/1153990586?lang=&edition=fundamental","pubTime":"2022-03-25 16:05","market":"us","language":"en","title":"Cannabis Stocks Rallied in Premarket Trading,with Clever Leaves Surging Over 25% and Sundial Growers Surging Nearly 19%","url":"https://stock-news.laohu8.com/highlight/detail?id=1153990586","media":"Tiger Newspress","summary":"Cannabis stocks rallied in premarket trading, with Clever Leaves surging over 25% and Sundial Grower","content":"<html><head></head><body><p>Cannabis stocks rallied in premarket trading, with Clever Leaves surging over 25% and Sundial Growers surging nearly 19%.<img src=\"https://static.tigerbbs.com/de2860f3b393d5f58f5e86601ff9c8be\" tg-width=\"322\" tg-height=\"208\" width=\"100%\" height=\"auto\"/>The U.S. House of Representatives will vote on the Marijuana Opportunity, Reinvestment and Expungement (MORE) Act next week.</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Cannabis Stocks Rallied in Premarket Trading,with Clever Leaves Surging Over 25% and Sundial Growers Surging Nearly 19%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCannabis Stocks Rallied in Premarket Trading,with Clever Leaves Surging Over 25% and Sundial Growers Surging Nearly 19%\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2022-03-25 16:05</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p>Cannabis stocks rallied in premarket trading, with Clever Leaves surging over 25% and Sundial Growers surging nearly 19%.<img src=\"https://static.tigerbbs.com/de2860f3b393d5f58f5e86601ff9c8be\" tg-width=\"322\" tg-height=\"208\" width=\"100%\" height=\"auto\"/>The U.S. House of Representatives will vote on the Marijuana Opportunity, Reinvestment and Expungement (MORE) Act next week.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"SNDL":"SNDL Inc.","CLVR":"Clever Leaves Holdings Inc."},"source_url":"","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1153990586","content_text":"Cannabis stocks rallied in premarket trading, with Clever Leaves surging over 25% and Sundial Growers surging nearly 19%.The U.S. House of Representatives will vote on the Marijuana Opportunity, Reinvestment and Expungement (MORE) Act next week.","news_type":1},"isVote":1,"tweetType":1,"viewCount":103,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9010016280,"gmtCreate":1648203764375,"gmtModify":1676534316789,"author":{"id":"3578476625539127","authorId":"3578476625539127","name":"Justinslh","avatar":"https://static.tigerbbs.com/4aace6371636c60f0a3a97aacd94721c","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578476625539127","authorIdStr":"3578476625539127"},"themes":[],"htmlText":"Nice","listText":"Nice","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9010016280","repostId":"2222003226","repostType":4,"repost":{"id":"2222003226","pubTimestamp":1648174848,"share":"https://ttm.financial/m/news/2222003226?lang=&edition=fundamental","pubTime":"2022-03-25 10:20","market":"us","language":"en","title":"Why Marijuana Stocks Popped on Thursday","url":"https://stock-news.laohu8.com/highlight/detail?id=2222003226","media":"Motley Fool","summary":"For only the second time ever, cannabis legalization will get a floor vote in Congress.","content":"<html><head></head><body><p><b>KEY POINTS</b></p><ul><li>The U.S. House of Representatives will vote on the Marijuana Opportunity, Reinvestment and Expungement (MORE) Act next week.</li></ul><p><b>What happened</b></p><p>Marijuana stocks exploded higher on Thursday, with <b>Aurora Cannabis</b> closing the day up 11%, <b>Canopy Growth</b> gaining 11.4%, and <b>Tilray</b> tacking on an astounding 21.8%.</p><p><img src=\"https://static.tigerbbs.com/ffdc83701e145fdc3d28db0179a8c087\" tg-width=\"420\" tg-height=\"485\" width=\"100%\" height=\"auto\"/></p><p>It&#39;s no great secret why: Federal marijuana legalization is getting a vote in Congress.</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/3973fdca864921e5174da80705ee5f1a\" tg-width=\"700\" tg-height=\"455\" width=\"100%\" height=\"auto\"/><span>Image source: Getty Images.</span></p><p><b>So what</b></p><p>As all-things-cannabis news source MarijuanaMoment.net reported Thursday afternoon, the U.S. House of Representatives has scheduled a vote on marijuana legalization for next week -- only the second time in history that such a bill has made it to the House floor for a vote.</p><p>Officially titled the Marijuana Opportunity, Reinvestment and Expungement (MORE) Act, the legislation &#34;would remove cannabis from the list of federally controlled substances and promote social equity in the industry,&#34; notes MarijuanaMoment.net. The House Rules Committee will begin preparing the bill for floor action on Monday, including figuring out any amendments that might be voted upon.</p><p>That accomplished, the bill will move to the floor for a vote by the full House. The exact date for the vote has not yet been determined.</p><p>Assuming the bill passes (as it did the last time it came up for a vote, in December 2020, by a vote of 228 to 164), it will move to the Senate for consideration.</p><p><b>Now what</b></p><p>Success is not assured. Last time the MORE Act made it to the Senate, it died there. Also worth noting is that the Senate is working on its own marijuana legalization bill, the Cannabis Administration &amp; Opportunity Act (CAOA), and if it passes that <a href=\"https://laohu8.com/S/AONE.U\">one</a>, then the two legislative bodies would need to reconcile their two bills and create one final compromise bill to send to President Biden.</p><p>Even then, success would not be assured, as -- at last report -- the president was himself personally opposed to legalizing cannabis.</p><p>That being said, hope springs eternal for marijuana sector investors, and at the very least, the fact that a bill is moving forward in the House means that there&#39;s some forward momentum here. The more votes marijuana legalization wins in whichever house chooses to pass it, the better the odds that at some point in the not-too-distant future, the stars will align and a bill of this type will become law.</p><p>Once that happens, cannabis companies can finally get to work on transforming legal sales of marijuana into actual cash profits for their shareholders.</p></body></html>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Why Marijuana Stocks Popped on Thursday</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhy Marijuana Stocks Popped on Thursday\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-03-25 10:20 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2022/03/24/why-marijuana-stocks-lit-up-on-thursday/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>KEY POINTSThe U.S. House of Representatives will vote on the Marijuana Opportunity, Reinvestment and Expungement (MORE) Act next week.What happenedMarijuana stocks exploded higher on Thursday, with ...</p>\n\n<a href=\"https://www.fool.com/investing/2022/03/24/why-marijuana-stocks-lit-up-on-thursday/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"CRON":"Cronos Group Inc.","OGI":"ORGANIGRAM HOLD","ACB":"奥罗拉大麻公司","JUSHF":"Jushi Holdings Inc.","TLRY":"Tilray Inc.","SNDL":"SNDL Inc.","CGC":"Canopy Growth Corporation"},"source_url":"https://www.fool.com/investing/2022/03/24/why-marijuana-stocks-lit-up-on-thursday/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2222003226","content_text":"KEY POINTSThe U.S. House of Representatives will vote on the Marijuana Opportunity, Reinvestment and Expungement (MORE) Act next week.What happenedMarijuana stocks exploded higher on Thursday, with Aurora Cannabis closing the day up 11%, Canopy Growth gaining 11.4%, and Tilray tacking on an astounding 21.8%.It's no great secret why: Federal marijuana legalization is getting a vote in Congress.Image source: Getty Images.So whatAs all-things-cannabis news source MarijuanaMoment.net reported Thursday afternoon, the U.S. House of Representatives has scheduled a vote on marijuana legalization for next week -- only the second time in history that such a bill has made it to the House floor for a vote.Officially titled the Marijuana Opportunity, Reinvestment and Expungement (MORE) Act, the legislation \"would remove cannabis from the list of federally controlled substances and promote social equity in the industry,\" notes MarijuanaMoment.net. The House Rules Committee will begin preparing the bill for floor action on Monday, including figuring out any amendments that might be voted upon.That accomplished, the bill will move to the floor for a vote by the full House. The exact date for the vote has not yet been determined.Assuming the bill passes (as it did the last time it came up for a vote, in December 2020, by a vote of 228 to 164), it will move to the Senate for consideration.Now whatSuccess is not assured. Last time the MORE Act made it to the Senate, it died there. Also worth noting is that the Senate is working on its own marijuana legalization bill, the Cannabis Administration & Opportunity Act (CAOA), and if it passes that one, then the two legislative bodies would need to reconcile their two bills and create one final compromise bill to send to President Biden.Even then, success would not be assured, as -- at last report -- the president was himself personally opposed to legalizing cannabis.That being said, hope springs eternal for marijuana sector investors, and at the very least, the fact that a bill is moving forward in the House means that there's some forward momentum here. The more votes marijuana legalization wins in whichever house chooses to pass it, the better the odds that at some point in the not-too-distant future, the stars will align and a bill of this type will become law.Once that happens, cannabis companies can finally get to work on transforming legal sales of marijuana into actual cash profits for their shareholders.","news_type":1},"isVote":1,"tweetType":1,"viewCount":93,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":106479075,"gmtCreate":1620141969797,"gmtModify":1704339287510,"author":{"id":"3578476625539127","authorId":"3578476625539127","name":"Justinslh","avatar":"https://static.tigerbbs.com/4aace6371636c60f0a3a97aacd94721c","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578476625539127","authorIdStr":"3578476625539127"},"themes":[],"htmlText":"?‍♂️","listText":"?‍♂️","text":"?‍♂️","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/106479075","repostId":"1140575890","repostType":4,"repost":{"id":"1140575890","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1620141444,"share":"https://ttm.financial/m/news/1140575890?lang=&edition=fundamental","pubTime":"2021-05-04 23:17","market":"us","language":"en","title":"Yellen says interest rates may have to rise somewhat to make sure economy doesn't overheat","url":"https://stock-news.laohu8.com/highlight/detail?id=1140575890","media":"Tiger Newspress","summary":"(May 4) Treasury Secretary Janet Yellen conceded Tuesday that interest rates may have to rise to kee","content":"<p>(May 4)&nbsp;Treasury Secretary Janet Yellen conceded Tuesday that interest rates may have to rise to keep a lid on the burgeoning growth of the U.S. economy brought on by trillions in government stimulus spending.</p><p>\"It may be that interest rates will have to rise somewhat to make sure that our economy doesn't overheat,\" Yellen said during a economic seminar presented by Th Atlantic. \"Even though additional spending is relatively small to the size of the economy, it could causae some very modest increases in interest rates.\"</p><p>\"But these are investments our economy needs to be competitive and productive,\" she added.</p><p>Nasdaq fell&nbsp;over 2%&nbsp;for&nbsp;now.</p><p><img src=\"https://static.tigerbbs.com/de3525661b3a7db28a0797ab745db67b\" tg-width=\"629\" tg-height=\"479\" referrerpolicy=\"no-referrer\"><img src=\"https://static.tigerbbs.com/ec61efef423e545861c0ca0126af9332\" tg-width=\"1866\" tg-height=\"894\" referrerpolicy=\"no-referrer\"></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Yellen says interest rates may have to rise somewhat to make sure economy doesn't overheat</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nYellen says interest rates may have to rise somewhat to make sure economy doesn't overheat\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-05-04 23:17</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>(May 4)&nbsp;Treasury Secretary Janet Yellen conceded Tuesday that interest rates may have to rise to keep a lid on the burgeoning growth of the U.S. economy brought on by trillions in government stimulus spending.</p><p>\"It may be that interest rates will have to rise somewhat to make sure that our economy doesn't overheat,\" Yellen said during a economic seminar presented by Th Atlantic. \"Even though additional spending is relatively small to the size of the economy, it could causae some very modest increases in interest rates.\"</p><p>\"But these are investments our economy needs to be competitive and productive,\" she added.</p><p>Nasdaq fell&nbsp;over 2%&nbsp;for&nbsp;now.</p><p><img src=\"https://static.tigerbbs.com/de3525661b3a7db28a0797ab745db67b\" tg-width=\"629\" tg-height=\"479\" referrerpolicy=\"no-referrer\"><img src=\"https://static.tigerbbs.com/ec61efef423e545861c0ca0126af9332\" tg-width=\"1866\" tg-height=\"894\" referrerpolicy=\"no-referrer\"></p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".SPX":"S&P 500 Index","SPY":"标普500ETF",".DJI":"道琼斯",".IXIC":"NASDAQ Composite"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1140575890","content_text":"(May 4) Treasury Secretary Janet Yellen conceded Tuesday that interest rates may have to rise to keep a lid on the burgeoning growth of the U.S. economy brought on by trillions in government stimulus spending.\"It may be that interest rates will have to rise somewhat to make sure that our economy doesn't overheat,\" Yellen said during a economic seminar presented by Th Atlantic. \"Even though additional spending is relatively small to the size of the economy, it could causae some very modest increases in interest rates.\"\"But these are investments our economy needs to be competitive and productive,\" she added.Nasdaq fell over 2% for now.","news_type":1},"isVote":1,"tweetType":1,"viewCount":311,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":109648921,"gmtCreate":1619695045063,"gmtModify":1704728126325,"author":{"id":"3578476625539127","authorId":"3578476625539127","name":"Justinslh","avatar":"https://static.tigerbbs.com/4aace6371636c60f0a3a97aacd94721c","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578476625539127","authorIdStr":"3578476625539127"},"themes":[],"htmlText":"$ make $","listText":"$ make $","text":"$ make $","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/109648921","repostId":"1104198438","repostType":4,"repost":{"id":"1104198438","pubTimestamp":1619623222,"share":"https://ttm.financial/m/news/1104198438?lang=&edition=fundamental","pubTime":"2021-04-28 23:20","market":"us","language":"en","title":"Here’s how Warren Buffett’s top investments fared during the pandemic","url":"https://stock-news.laohu8.com/highlight/detail?id=1104198438","media":"Yahoo","summary":"Plenty of Berkshire Hathaway's (BRK-A,BRK-B) top stock picks have been home runs during and prior to","content":"<p>Plenty of Berkshire Hathaway's (BRK-A,BRK-B) top stock picks have been home runs during and prior to the COVID-19 pandemic.</p>\n<p>The famed stock portfolio run by billionaire investor Warren Buffett ballooned to a value of $281.17 billion by the end of 2020, or more than double the cumulative cost of building these stakes at $108.62 billion, according toBerkshire's latest annual shareholder letter.The value of the portfolio's total equity investments carried at market was up 13.4% compared to year-end 2019. However, Berkshire's own stock underperformed the broader market over that time period: The S&amp;P 500 rose 16.3% in 2020, without including reinvested dividends, while Berkshire's Class B shares increased 2.4%.</p>\n<p>Berkshire's stock performance in 2020 relative to the broader market, however, belies what has been, in aggregate, decades of outperformance for the Omaha, Nebraska-based company. Berkshire Hathaway's annual compounded gain between 1965 and 2020 was 20%, versus just 10.2% for the S&amp;P 500. And the firm's cumulative returns over that period have been a whopping 2,810,526% to the S&amp;P 500's 23,454%.</p>\n<p>On May 1, Buffett and long-time business partner Charlie Munger will hold Berkshire Hathaway's annual shareholder meeting in Los Angeles. This may serve as a forum for the pair to discuss additional investments purchased and sold in the first months of 2021, ahead of formal 13-F filing reveals later in the month. Last year, Buffett disclosed at the annual meeting thatBerkshire had sold out of its entire interest in the airline stocksAmerican Airlines (AAL), United Airlines (UAL), Delta Air Lines (DAL) and Southwest Airlines (LUV)in the first quarter of 2020.</p>\n<p>Here's how Berkshire's top 10 stock investments by market value fared over the course of the pandemic, based on the stakes disclosed in the Buffett's latest annual shareholder letter.*</p>\n<p><b>Apple</b></p>\n<p>Buffett pointed to Apple (AAPL) as one of the most valuable assets for Berkshire Hathaway alongside the firm's insurance operation and BNSF Railway, thanks in large part to the iPhone-maker's hefty share repurchases.</p>\n<p>Berkshire owned 907,559,761 shares of Apple as of the end of December for a total market value of $120.4 billion. By contrast, the firm spent just $31 billion accumulating this stake since late 2016.</p>\n<p>That massive holding — comprising 44% of Berkshire's disclosed assets, according to Bloomberg data — came even after the firm pocketed $11 billion after selling a small portion of its position in 2020.</p>\n<p>\"Despite that sale – voila! – Berkshire now owns 5.4% of Apple,\" Buffett said in the shareholder letter. \"That increase was costless to us,<b>coming about because Apple</b>has continuously repurchased its shares, thereby substantially shrinking the number it now has outstanding.\"</p>\n<p>Though Buffett hashistorically steered away from investing in technology companiesin favor of businesses he has understood more deeply, Berkshire's major holding in Apple proved auspicious during the pandemic, when Big Tech companies led the market higher.</p>\n<p>Apple's stock posted a total return of 82% in 2020, outperforming every other \"FAANG\" stock including Facebook, Amazon, Netflix and Alphabet. The run-up has since cooled in early 2021, however, with the stock posting a total return of just 1.4% for the year-to-date through market close on April 27.</p>\n<p><b>Bank of America</b></p>\n<p>While Berkshire Hathaway unloaded many of its bank stock holdings over the course of 2020, it increased its stake in Bank of America (BAC).</p>\n<p>The firm held 1,032,952,006 shares of Bank of America as of the end of 2020, after adding 85.1 million shares in the third quarter alone. This gave Berkshire Hathaway an ownership stake of 11.9%.</p>\n<p>By the end of last year, the value of that holding was worth $31.3 million, and cost $14.6 million to amass.</p>\n<p>The increase in the size of Berkshire Hathaway's Bank of America holding bucked the trend of the other bank stocks in the portfolio last year. Berkshire cut its holdings of Wells Fargo (EFC) from 345.7 million shares at year-end 2019 to 52.4 million by year-end 2020, and completely exited its holdings in JPMorgan Chase (JPM) and M&amp;T Bank Corp (MTB).</p>\n<p>With interest rates sliding amid ultra-accommodative monetary policy during the pandemic, bank stocks were among the worst performers last year. Bank of America shares fell nearly 14% in 2020, underperforming against both the S&amp;P 500 and S&amp;P 500 financials sector, which dropped just 4.1%. However, with interest rates back on the rise and consumer spending accelerating, shares have already started to reverse these declines, and Bank of America shares have risen 32% so far in 2021.</p>\n<p><b>The Coca-Cola Company</b></p>\n<p>Berkshire Hathaway's stake in Coca-Cola (KO) remained unchanged between 2019 and 2020 at 400 million shares, offering 9.3% ownership in the beverage giant. Buffett has been a long-time investor in the firm, having first purchased shares in Berkshire's portfolio in 1988. It has comprised a significant portion of the firm's total holdings and mark value value ever since.</p>\n<p>This long-term investment has paid off for the company, with the market value of the shares held totaling $21.9 billion at the end of 2020. Berkshire spent just under $1.3 billion building its stake in Coca-Cola.</p>\n<p>While Berkshire's overall return on its investment in Coca-Cola has been formidable, the stock did underperform the broader market in 2020. Coca-Cola shares declined 0.9% during the year as a dearth of live events and concessions weighed on sales, though the stock did still eke out a total return of 2.44% during the year with reinvested dividends. Shares have extended a run of underperformance in 2021, with the stock falling 1.5% so far this year.</p>\n<p><b>American Express</b></p>\n<p>Berkshire Hathaway held 151,610,700 shares of American Express (AXP) as of the end of 2020, with the stock comprising another of the firm's long-standing investments. Berkshire began building its stake nearly six decades ago, paying a total of just $1.29 billion to amass a stake worth $18.33 billion at the end of 2020.</p>\n<p>As a business relying heavily on both consumer and corporate spending, however, American Express' suffered a blow in 2020, with its stock dipping 2.9%.</p>\n<p>While Buffett has characterized Berkshire's holdings of marketable stocks as a \"collection of businesses\" in which he shares in long-term prosperity but does not control operations, that hasn't stopped him from imparting advice to executives at some of his top-held companies — especially during the nadir in business and economic activity during the pandemic.</p>\n<p>\"I talked to our largest shareholder, Warren Buffett, and I've talked to him during this time, the one thing he has and will continue to always point out to us is that the brand is special,\" American Express CEO Stephen Squeri said during an analyst day presentation in mid-March 2020. \"And that brand needs to be cared for, the brand needs to be invested in and we will continue to do so through tough times and through the good times.\"</p>\n<p>More recently, however, American Express's operating results and stock have picked back up. The stock outperformed the S&amp;P 500 with a rise of 25% for the year-to-date. And Squeri saidin a fourth-quarter updatethat non-travel and entertainment spend exceeded pre-COVID levels for a second straight quarter, and that trends overall have \"continued to steadily improve,\" despite some lingering impacts from the pandemic.</p>\n<p><b>Verizon Communications</b></p>\n<p>Verizon Communications (VZ), the parent company of Yahoo Finance, was one of Berkshire's new purchases in the second half of 2020.</p>\n<p>Berkshire revealed it amassed a stake of 146,716,496 shares of the telecommunications giant last year, good for a 3.5% ownership of the company.</p>\n<p>The holding was worth $8.62 billion as of year-end, representing one of several major investments Berkshire held below cost, which in this case came in at $8.69 billion. The decline likely would have been greater had Berkshire purchased the sizable stake earlier, however, with Verizon's stock having declined 4.3% excluding reinvested dividends over the the full-year 2020.</p>\n<p>But even given the pandemic, Verizon's business held up relatively strongly. Full-year 2020 sales edged down by just 3%, and adjusted EBITDA was flat year-over-year. Still, the stock has declined by 4% for 2021-to-date, or by 2% with reinvested dividends.</p>\n<p><b>Moody's Corporation</b></p>\n<p>Berkshire Hathaway had a 13.2% ownership stake in Moody's Corporation (MCO) at the end of 2020, with 24,669,778 shares worth a total of $7.16 billion. That generated a notable return for Berkshire, with the cost of building this stake amounting to just $248 million. Berkshire first held shares of Moody's Corporation in 2000.</p>\n<p>The credit rating agency outperformed the S&amp;P 500 in 2020 and has since performed about in-line with the market during the COVID-19 recovery. Shares rose by 22% over the course of 2020 and have increased by 12.5% for the year-to-date.</p>\n<p><b>U.S. Bancorp</b></p>\n<p>U.S. Bancorp (USB) was one of a number of holdings Berkshire Hathaway trimmed during the pandemic.</p>\n<p>The firm's stake in the parent company of U.S. Bank National Association was reduced to 148,176,166 shares by year-end 2020, compared to 149,497,787 in 2019. However, Berkshire Hathaway stopped short of fully exiting its position in the firm, as it did with some other big banks. Berkshire's position in U.S. Bancorp was worth just over $6.9 billion in year-end 2020, compared to total cost of $5.6 billion.</p>\n<p>As was the case for many financial institutions during the pandemic, U.S. Bancorp's stock came under pressure in the low-rate environment of 2020, but has since rebounded. Shares slid by 21.4% in 2020, but have so far risen more than 25% for the year-to-date.</p>\n<p><b>BYD</b></p>\n<p>Shenzhen-based BYD Co. (BYDDF) marks one of just a couple non-U.S. companies in Berkshire Hathaway's portfolio as of the end of 2020. The electric-vehicle manufacturer's stock was also the best-performing in Berkshire's portfolio during the pandemic on a price-appreciation basis, consistent with the outperformance among tech and growth stocks seen over the course of last year in the broader market. In fact, the market value of Berkshire's BYD Co. stake was more than double that of its other major auto-related position in General Motors (GM).</p>\n<p>Berkshire purchased the entirety of his 225 million share stake in BYD back in 2008 for $232 million, afterBuffett's business partner Charlie Munger toutedthe vision of its founder Wang Chuanfu. The value of that stake ballooned to $5.9 billion at the end of 2020. Shares of BYD surged by 432% in 2020 alone, though they have dipped by 13.5% for the year-to-date as some of the exuberance around electric-vehicle stocks moderated at the start of this year.</p>\n<p><b>Chevron</b></p>\n<p>Berkshire Hathaway pounced at the opportunity to purchase Chevron (CVX) during a dip in oil prices and energy stocks last year, snapping up 48,498,965 million shares at a total cost of $4.02 billion. This represented 2.5% of shares outstanding for the stock.</p>\n<p>By year-end, the market value of Berkshire's stake increased slightly to about $4.1 billion, with energy prices back on the rise following the worst points of spring 2020. Chevron's stock slid 30% between year-end 2019 and year-end 2020.</p>\n<p>Berkshire's investment has already begun to appreciate in value in the early months of 2021, with energy as the best-performing sector in the S&amp;P 500 for the year-to-date. Chevron shares have risen 21.6% so far this year for a price appreciation nearly double that of the broader market, not including reinvested dividends.</p>\n<p><b>Charter Communications</b></p>\n<p>Charter Communications (CHTR) marked another holding Berkshire Hathaway trimmed in 2020. In August of last year, Berkshire reported it had cut its stake by 4% to a total of about 5.2 million shares.</p>\n<p>The sale still left Berkshire with a 2.7% stake in the company, and holdings worth $3.45 billion by year-end 2020, at a total cost of just $904 million. Berkshire had beenaccumulating its stake in Charter since 2014.</p>\n<p>Shares of Charter Communications rose 36% in 2020, but have given back some of these gains after dipping 1.2% so far in 2021.</p>\n<p><i>* This analysis excludes Berkshire Hathaway's Kraft Heinz holding of 325,442,152 shares, since this is held using a different accounting method. Berkshire reported that the market value of these shares was $11.3 billion as of December 31, 2020.</i></p>","source":"lsy1584348713084","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Here’s how Warren Buffett’s top investments fared during the pandemic</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHere’s how Warren Buffett’s top investments fared during the pandemic\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-04-28 23:20 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/heres-how-warren-buffetts-top-investments-fared-during-the-pandemic-151003576.html><strong>Yahoo</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Plenty of Berkshire Hathaway's (BRK-A,BRK-B) top stock picks have been home runs during and prior to the COVID-19 pandemic.\nThe famed stock portfolio run by billionaire investor Warren Buffett ...</p>\n\n<a href=\"https://finance.yahoo.com/news/heres-how-warren-buffetts-top-investments-fared-during-the-pandemic-151003576.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AAPL":"苹果","01211":"比亚迪股份","MCO":"穆迪","KO":"可口可乐","AXP":"美国运通","VZ":"威瑞森","CHTR":"特许通讯","USB":"美国合众银行","BAC":"美国银行","CVX":"雪佛龙","002594":"比亚迪"},"source_url":"https://finance.yahoo.com/news/heres-how-warren-buffetts-top-investments-fared-during-the-pandemic-151003576.html","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1104198438","content_text":"Plenty of Berkshire Hathaway's (BRK-A,BRK-B) top stock picks have been home runs during and prior to the COVID-19 pandemic.\nThe famed stock portfolio run by billionaire investor Warren Buffett ballooned to a value of $281.17 billion by the end of 2020, or more than double the cumulative cost of building these stakes at $108.62 billion, according toBerkshire's latest annual shareholder letter.The value of the portfolio's total equity investments carried at market was up 13.4% compared to year-end 2019. However, Berkshire's own stock underperformed the broader market over that time period: The S&P 500 rose 16.3% in 2020, without including reinvested dividends, while Berkshire's Class B shares increased 2.4%.\nBerkshire's stock performance in 2020 relative to the broader market, however, belies what has been, in aggregate, decades of outperformance for the Omaha, Nebraska-based company. Berkshire Hathaway's annual compounded gain between 1965 and 2020 was 20%, versus just 10.2% for the S&P 500. And the firm's cumulative returns over that period have been a whopping 2,810,526% to the S&P 500's 23,454%.\nOn May 1, Buffett and long-time business partner Charlie Munger will hold Berkshire Hathaway's annual shareholder meeting in Los Angeles. This may serve as a forum for the pair to discuss additional investments purchased and sold in the first months of 2021, ahead of formal 13-F filing reveals later in the month. Last year, Buffett disclosed at the annual meeting thatBerkshire had sold out of its entire interest in the airline stocksAmerican Airlines (AAL), United Airlines (UAL), Delta Air Lines (DAL) and Southwest Airlines (LUV)in the first quarter of 2020.\nHere's how Berkshire's top 10 stock investments by market value fared over the course of the pandemic, based on the stakes disclosed in the Buffett's latest annual shareholder letter.*\nApple\nBuffett pointed to Apple (AAPL) as one of the most valuable assets for Berkshire Hathaway alongside the firm's insurance operation and BNSF Railway, thanks in large part to the iPhone-maker's hefty share repurchases.\nBerkshire owned 907,559,761 shares of Apple as of the end of December for a total market value of $120.4 billion. By contrast, the firm spent just $31 billion accumulating this stake since late 2016.\nThat massive holding — comprising 44% of Berkshire's disclosed assets, according to Bloomberg data — came even after the firm pocketed $11 billion after selling a small portion of its position in 2020.\n\"Despite that sale – voila! – Berkshire now owns 5.4% of Apple,\" Buffett said in the shareholder letter. \"That increase was costless to us,coming about because Applehas continuously repurchased its shares, thereby substantially shrinking the number it now has outstanding.\"\nThough Buffett hashistorically steered away from investing in technology companiesin favor of businesses he has understood more deeply, Berkshire's major holding in Apple proved auspicious during the pandemic, when Big Tech companies led the market higher.\nApple's stock posted a total return of 82% in 2020, outperforming every other \"FAANG\" stock including Facebook, Amazon, Netflix and Alphabet. The run-up has since cooled in early 2021, however, with the stock posting a total return of just 1.4% for the year-to-date through market close on April 27.\nBank of America\nWhile Berkshire Hathaway unloaded many of its bank stock holdings over the course of 2020, it increased its stake in Bank of America (BAC).\nThe firm held 1,032,952,006 shares of Bank of America as of the end of 2020, after adding 85.1 million shares in the third quarter alone. This gave Berkshire Hathaway an ownership stake of 11.9%.\nBy the end of last year, the value of that holding was worth $31.3 million, and cost $14.6 million to amass.\nThe increase in the size of Berkshire Hathaway's Bank of America holding bucked the trend of the other bank stocks in the portfolio last year. Berkshire cut its holdings of Wells Fargo (EFC) from 345.7 million shares at year-end 2019 to 52.4 million by year-end 2020, and completely exited its holdings in JPMorgan Chase (JPM) and M&T Bank Corp (MTB).\nWith interest rates sliding amid ultra-accommodative monetary policy during the pandemic, bank stocks were among the worst performers last year. Bank of America shares fell nearly 14% in 2020, underperforming against both the S&P 500 and S&P 500 financials sector, which dropped just 4.1%. However, with interest rates back on the rise and consumer spending accelerating, shares have already started to reverse these declines, and Bank of America shares have risen 32% so far in 2021.\nThe Coca-Cola Company\nBerkshire Hathaway's stake in Coca-Cola (KO) remained unchanged between 2019 and 2020 at 400 million shares, offering 9.3% ownership in the beverage giant. Buffett has been a long-time investor in the firm, having first purchased shares in Berkshire's portfolio in 1988. It has comprised a significant portion of the firm's total holdings and mark value value ever since.\nThis long-term investment has paid off for the company, with the market value of the shares held totaling $21.9 billion at the end of 2020. Berkshire spent just under $1.3 billion building its stake in Coca-Cola.\nWhile Berkshire's overall return on its investment in Coca-Cola has been formidable, the stock did underperform the broader market in 2020. Coca-Cola shares declined 0.9% during the year as a dearth of live events and concessions weighed on sales, though the stock did still eke out a total return of 2.44% during the year with reinvested dividends. Shares have extended a run of underperformance in 2021, with the stock falling 1.5% so far this year.\nAmerican Express\nBerkshire Hathaway held 151,610,700 shares of American Express (AXP) as of the end of 2020, with the stock comprising another of the firm's long-standing investments. Berkshire began building its stake nearly six decades ago, paying a total of just $1.29 billion to amass a stake worth $18.33 billion at the end of 2020.\nAs a business relying heavily on both consumer and corporate spending, however, American Express' suffered a blow in 2020, with its stock dipping 2.9%.\nWhile Buffett has characterized Berkshire's holdings of marketable stocks as a \"collection of businesses\" in which he shares in long-term prosperity but does not control operations, that hasn't stopped him from imparting advice to executives at some of his top-held companies — especially during the nadir in business and economic activity during the pandemic.\n\"I talked to our largest shareholder, Warren Buffett, and I've talked to him during this time, the one thing he has and will continue to always point out to us is that the brand is special,\" American Express CEO Stephen Squeri said during an analyst day presentation in mid-March 2020. \"And that brand needs to be cared for, the brand needs to be invested in and we will continue to do so through tough times and through the good times.\"\nMore recently, however, American Express's operating results and stock have picked back up. The stock outperformed the S&P 500 with a rise of 25% for the year-to-date. And Squeri saidin a fourth-quarter updatethat non-travel and entertainment spend exceeded pre-COVID levels for a second straight quarter, and that trends overall have \"continued to steadily improve,\" despite some lingering impacts from the pandemic.\nVerizon Communications\nVerizon Communications (VZ), the parent company of Yahoo Finance, was one of Berkshire's new purchases in the second half of 2020.\nBerkshire revealed it amassed a stake of 146,716,496 shares of the telecommunications giant last year, good for a 3.5% ownership of the company.\nThe holding was worth $8.62 billion as of year-end, representing one of several major investments Berkshire held below cost, which in this case came in at $8.69 billion. The decline likely would have been greater had Berkshire purchased the sizable stake earlier, however, with Verizon's stock having declined 4.3% excluding reinvested dividends over the the full-year 2020.\nBut even given the pandemic, Verizon's business held up relatively strongly. Full-year 2020 sales edged down by just 3%, and adjusted EBITDA was flat year-over-year. Still, the stock has declined by 4% for 2021-to-date, or by 2% with reinvested dividends.\nMoody's Corporation\nBerkshire Hathaway had a 13.2% ownership stake in Moody's Corporation (MCO) at the end of 2020, with 24,669,778 shares worth a total of $7.16 billion. That generated a notable return for Berkshire, with the cost of building this stake amounting to just $248 million. Berkshire first held shares of Moody's Corporation in 2000.\nThe credit rating agency outperformed the S&P 500 in 2020 and has since performed about in-line with the market during the COVID-19 recovery. Shares rose by 22% over the course of 2020 and have increased by 12.5% for the year-to-date.\nU.S. Bancorp\nU.S. Bancorp (USB) was one of a number of holdings Berkshire Hathaway trimmed during the pandemic.\nThe firm's stake in the parent company of U.S. Bank National Association was reduced to 148,176,166 shares by year-end 2020, compared to 149,497,787 in 2019. However, Berkshire Hathaway stopped short of fully exiting its position in the firm, as it did with some other big banks. Berkshire's position in U.S. Bancorp was worth just over $6.9 billion in year-end 2020, compared to total cost of $5.6 billion.\nAs was the case for many financial institutions during the pandemic, U.S. Bancorp's stock came under pressure in the low-rate environment of 2020, but has since rebounded. Shares slid by 21.4% in 2020, but have so far risen more than 25% for the year-to-date.\nBYD\nShenzhen-based BYD Co. (BYDDF) marks one of just a couple non-U.S. companies in Berkshire Hathaway's portfolio as of the end of 2020. The electric-vehicle manufacturer's stock was also the best-performing in Berkshire's portfolio during the pandemic on a price-appreciation basis, consistent with the outperformance among tech and growth stocks seen over the course of last year in the broader market. In fact, the market value of Berkshire's BYD Co. stake was more than double that of its other major auto-related position in General Motors (GM).\nBerkshire purchased the entirety of his 225 million share stake in BYD back in 2008 for $232 million, afterBuffett's business partner Charlie Munger toutedthe vision of its founder Wang Chuanfu. The value of that stake ballooned to $5.9 billion at the end of 2020. Shares of BYD surged by 432% in 2020 alone, though they have dipped by 13.5% for the year-to-date as some of the exuberance around electric-vehicle stocks moderated at the start of this year.\nChevron\nBerkshire Hathaway pounced at the opportunity to purchase Chevron (CVX) during a dip in oil prices and energy stocks last year, snapping up 48,498,965 million shares at a total cost of $4.02 billion. This represented 2.5% of shares outstanding for the stock.\nBy year-end, the market value of Berkshire's stake increased slightly to about $4.1 billion, with energy prices back on the rise following the worst points of spring 2020. Chevron's stock slid 30% between year-end 2019 and year-end 2020.\nBerkshire's investment has already begun to appreciate in value in the early months of 2021, with energy as the best-performing sector in the S&P 500 for the year-to-date. Chevron shares have risen 21.6% so far this year for a price appreciation nearly double that of the broader market, not including reinvested dividends.\nCharter Communications\nCharter Communications (CHTR) marked another holding Berkshire Hathaway trimmed in 2020. In August of last year, Berkshire reported it had cut its stake by 4% to a total of about 5.2 million shares.\nThe sale still left Berkshire with a 2.7% stake in the company, and holdings worth $3.45 billion by year-end 2020, at a total cost of just $904 million. Berkshire had beenaccumulating its stake in Charter since 2014.\nShares of Charter Communications rose 36% in 2020, but have given back some of these gains after dipping 1.2% so far in 2021.\n* This analysis excludes Berkshire Hathaway's Kraft Heinz holding of 325,442,152 shares, since this is held using a different accounting method. Berkshire reported that the market value of these shares was $11.3 billion as of December 31, 2020.","news_type":1},"isVote":1,"tweetType":1,"viewCount":386,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":109842583,"gmtCreate":1619685826942,"gmtModify":1704727992390,"author":{"id":"3578476625539127","authorId":"3578476625539127","name":"Justinslh","avatar":"https://static.tigerbbs.com/4aace6371636c60f0a3a97aacd94721c","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578476625539127","authorIdStr":"3578476625539127"},"themes":[],"htmlText":"[Call]&nbsp;","listText":"[Call]&nbsp;","text":"[Call]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/109842583","repostId":"1143067327","repostType":4,"repost":{"id":"1143067327","pubTimestamp":1619684104,"share":"https://ttm.financial/m/news/1143067327?lang=&edition=fundamental","pubTime":"2021-04-29 16:15","market":"us","language":"en","title":"India Health Crisis Set to Crimp Nascent Rebound in Gold Demand","url":"https://stock-news.laohu8.com/highlight/detail?id=1143067327","media":"Bloomberg","summary":"Rising virus cases have led to dip in consumer confidence: WGC. Purchases in the world’s second-biggest consumer jumped 37% in the January to March period to 140 tons after slumping to the lowest in more than two decades last year, according to the World Gold Council. A combination of softening gold prices, a sharp pick-up in economic activity and the return of social activities such as weddings supported higher consumption, it said.“As lockdowns are re-imposed in various regions of the country ","content":"<ul>\n <li>Rising virus cases have led to dip in consumer confidence: WGC</li>\n <li>Global gold demand fell 23% on-year during January-March: WGC</li>\n</ul>\n<p>A fledgling recovery in India’s gold demand in the first three months of the year may be snuffed out by an explosive increase in coronavirus infections that keeps people at home, damping sales during the key wedding season.</p>\n<p>Purchases in the world’s second-biggest consumer jumped 37% in the January to March period to 140 tons after slumping to the lowest in more than two decades last year, according to the World Gold Council. A combination of softening gold prices, a sharp pick-up in economic activity and the return of social activities such as weddings supported higher consumption, it said.</p>\n<p>After a record-breaking rally last year, gold has lost momentum amid optimism over economies reopening and vaccine rollouts, with the advancing dollar and rising bond yields denting demand for bullion. In India, prices are down more than 15% from a record high in August.</p>\n<p>Still, demand is likely to take a hit in the second quarter as the total number of cases top 18 million, making India the second-worst affected country in the world. Many states have imposed restrictions on the movement of people and shuttered non-essential businesses as infections soar. These curbs may keep demand muted for weddings and the auspicious Hindu gold buying day of Akshaya Tritiya next month, said P.R. Somasundaram, managing director for India at the council.</p>\n<p>“As lockdowns are re-imposed in various regions of the country in response to rising Covid-19 cases, consumer confidence has dipped,” Somasundaram said. “People had just started spending and now that’s all stopped. People are more aware that it is spreading fast and that they need to be careful, so that will affect all the festivities.”</p>\n<p><b>Better than 2020</b></p>\n<p>Digital and retail strategies formed in the past year may cushion the drop this quarter, unlike&nbsp;the year-earlier period, “but the current crisis is beyond just economics and logistics, therefore, sentiment may be affected till large-scale vaccination is achieved,” Somasundaram said.</p>\n<p>Full-year consumption will be better than 2020 as vaccinations pick up pace and the economy recovers, he said. More money will flow into gold but that is more likely to happen only by the last quarter of the year, Somasundaram said, declining to give an estimate for 2021.</p>\n<p>Globally, gold demand fell 23% during the first quarter to 815.7 tons from the year-earlier period as a recovery from the pandemic drove outflows from exchange-traded funds in western markets. The decline was mitigated by strengthening demand in China and India, the world’s biggest consumers.</p>","source":"lsy1584095487587","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>India Health Crisis Set to Crimp Nascent Rebound in Gold Demand</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nIndia Health Crisis Set to Crimp Nascent Rebound in Gold Demand\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-04-29 16:15 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.bloomberg.com/news/articles/2021-04-29/india-health-crisis-set-to-crimp-nascent-rebound-in-gold-demand?srnd=markets-vp><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Rising virus cases have led to dip in consumer confidence: WGC\nGlobal gold demand fell 23% on-year during January-March: WGC\n\nA fledgling recovery in India’s gold demand in the first three months of ...</p>\n\n<a href=\"https://www.bloomberg.com/news/articles/2021-04-29/india-health-crisis-set-to-crimp-nascent-rebound-in-gold-demand?srnd=markets-vp\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://www.bloomberg.com/news/articles/2021-04-29/india-health-crisis-set-to-crimp-nascent-rebound-in-gold-demand?srnd=markets-vp","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1143067327","content_text":"Rising virus cases have led to dip in consumer confidence: WGC\nGlobal gold demand fell 23% on-year during January-March: WGC\n\nA fledgling recovery in India’s gold demand in the first three months of the year may be snuffed out by an explosive increase in coronavirus infections that keeps people at home, damping sales during the key wedding season.\nPurchases in the world’s second-biggest consumer jumped 37% in the January to March period to 140 tons after slumping to the lowest in more than two decades last year, according to the World Gold Council. A combination of softening gold prices, a sharp pick-up in economic activity and the return of social activities such as weddings supported higher consumption, it said.\nAfter a record-breaking rally last year, gold has lost momentum amid optimism over economies reopening and vaccine rollouts, with the advancing dollar and rising bond yields denting demand for bullion. In India, prices are down more than 15% from a record high in August.\nStill, demand is likely to take a hit in the second quarter as the total number of cases top 18 million, making India the second-worst affected country in the world. Many states have imposed restrictions on the movement of people and shuttered non-essential businesses as infections soar. These curbs may keep demand muted for weddings and the auspicious Hindu gold buying day of Akshaya Tritiya next month, said P.R. Somasundaram, managing director for India at the council.\n“As lockdowns are re-imposed in various regions of the country in response to rising Covid-19 cases, consumer confidence has dipped,” Somasundaram said. “People had just started spending and now that’s all stopped. People are more aware that it is spreading fast and that they need to be careful, so that will affect all the festivities.”\nBetter than 2020\nDigital and retail strategies formed in the past year may cushion the drop this quarter, unlike the year-earlier period, “but the current crisis is beyond just economics and logistics, therefore, sentiment may be affected till large-scale vaccination is achieved,” Somasundaram said.\nFull-year consumption will be better than 2020 as vaccinations pick up pace and the economy recovers, he said. More money will flow into gold but that is more likely to happen only by the last quarter of the year, Somasundaram said, declining to give an estimate for 2021.\nGlobally, gold demand fell 23% during the first quarter to 815.7 tons from the year-earlier period as a recovery from the pandemic drove outflows from exchange-traded funds in western markets. The decline was mitigated by strengthening demand in China and India, the world’s biggest consumers.","news_type":1},"isVote":1,"tweetType":1,"viewCount":377,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"lives":[]}